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ABSTRACT OF THE DISSERTATION
Protein Synthesis Adaptation to the AU-Rich Transcriptome of Plasmodium falciparum
Jessey Lee Erath
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Microbiology and Microbial Pathogenesis
Washington University in St. Louis, 2020
Dr. Sergej Djuranovic, Chair
The process of protein synthesis whereby a messenger RNA is decoded into an amino acid chain
is conserved among the domains. Fastidious protein synthesis is necessary for organism
survival. However, exceptions negatively affecting the mRNA translation cycle – inadvertently
or by design – may occur. Polyadenosine tracts are one such motif causing ribosomal stalling
and frameshifting in almost all organisms tested thus far; save Plasmodium spp. Thus, with
~60% of their protein-coding genome harboring polyadenosine tracts, the elucidation of such
paradigm-breaking adaptations enabling Plasmodium spp. to translate this typically problematic
motif without issue is salient from both basic science and clinical perspectives. Using
biochemical and structural approaches, I report on the parasite ability to express polyA motifs
and ribosome alterations enabling polylysine synthesis. The developed PP7-mRIP assay reveals
RBP differences among varying mRNA substrates, revealing a previously uncharacterized,
parasite-specific AU-rich binding protein bound to polyA tract reporter mRNA. Finally, the
parasite exhibits altered binding of the essential ribosomal protein RACK1, vital for translation
cap-dependent initiation and quality control activation, that would invariably alter ribosomeassociated quality control pathway signaling, ostensibly aiding polyA translation.
xi

Chapter 1: Introduction
1.1 The Central Dogma of Molecular Biology
The faithful maintenance, replication, and conversion of genetic information is necessary for
prokaryotic and eukaryotic organism survival. While genetic shift and drift are important for
long term evolutionary adaptation, fidelity of these processes is required for meantime
population survival. DNA maintenance is characterized by multiple DNA repair mechanisms1,
some of which are active to ensure fidelity during DNA replication via proofreading2. RNAs of
any type transcribed from DNA also require mechanisms to ensure consistency3–5. Although
typically associated with viruses, eukaryotic RNA-directed DNA polymerase6,7 and RNA
replication by RNA-dependent RNA polymerases8–10 have also been studied within eukaryotic
systems. Ultimately, the flow of genetic information in a biological system from DNA to RNA to
protein is described by the central dogma as: once this information has been synthesized into
protein, it cannot be converted backward11,12. Therefore, mRNA translation is a critical,
unidirectional, RNA-driven process.

1.2 mRNA Translation
The general process of protein synthesis in which a messenger RNA (mRNA) is decoded into a
chain of amino acids, i.e. a polypeptide chain, that is subsequently folded into a protein, is
conserved among the domains and consists of three phases: initiation, elongation, and
termination. Each of these phases are, in themselves, regulated stepwise processes. The mRNA
1

provides the information necessary not only to produce an amino acid sequence, but also to
regulation its production. The eukaryotic mRNA is comprised of a 5ʹ-m7GpppN-cap, a 5’
untranslated region (UTR), a start codon (usually AUG), an open reading frame (ORF), a stop
codon (UAA, UGA, or UAG), a 3’ UTR, and finally a 3’-poly(A) tail. These regions regulate the
process of translation in one way or another and will be briefly discussed following the general
process of translation.
Initiation is the process whereby the ribosomal machinery is assembled on the mRNA. In
eukaryotic systems, canonical mRNA translation initiation requires the 5ʹ-m7GpppN-cap and the
3ʹ-poly(A) tail13,14. These mRNA features are recognized by eukaryotic initiation factors (eIFs)
that subsequently recruit the pre-initiation complex (PIC) to the 5’ untranslated region (5’UTR)
of the mRNA14. The 43S PIC – 40S small subunit of the ribosome complexed with the peptidyl
(P)-site Met-tRNAi, eIF1, eIF1A, eIF2, eIF3, and eIF5 – then scans the 5’ UTR in search of the AUG
start codon14. Recognition of the AUG start codon halts scanning and results in the irreversible
hydrolysis of GTP in the ternary complex (eIF2-GTP-Met-tRNAi) to GDP14. This triggers the
release of the eIFs, allowing for the 60S large subunit to join forming an initiating 80S complex
with empty aminoacyl (A)-site containing the second codon in the open-reading frame
(ORF)14,15.
Elongation commences when the eukaryotic elongation factor (eEF) 1A bound to the cognate
aminoacyl (aa)-tRNA in a GTP-dependent manner delivers the tRNA to the ribosome A-site.
Correct codon-anticodon interaction, recognized by the decoding region of the 40S subunit,
2

stimulates GTP hydrolysis by eEF1A resulting in its release15. This allows for full accommodation
of the aa-tRNA in the A-site and subsequent peptide bond formation. The peptide bond is
formed by nucleophilic attack of the A-site aa-tRNA α-amino group on the carbonyl carbon of
the P-site peptide-tRNA resulting in peptide elongation16. The conformational changes driven
by peptide bond formation cause the acceptor ends of the A- and P-site tRNAs to move into the
P- and E-site, respectively, resulting in a rotated hybrid tRNA A/P and P/E state15. To facilitate
complete translocation to the canonical P- and E-sites, eEF2-GTP binds the A-site and is thought
to stabilize the hybrid state. Subsequent GTP hydrolysis by the GTPase center of the 60S
subunit is then thought to drive a conformational change in eEF2, allowing tRNA and mRNA
movement, and translocate the ribosome along the mRNA aligning the anticodon ends of tRNAs
into the P- and E-sites15. The eEF2-GTD is released and, with the ribosomes in its stable P/E
state, the A-site is again available with the next codon in the ORF ready for decoding. This cycle
is repeated until the ribosome encounters one of the typical three termination codons.
Termination codons are recognized by two eukaryotic release factors: eRF1 and eRF315. The
tRNA-shaped eRF1 protein is a class I factor with three domains15. The amino-terminal domain
recognizes the termination codons with high fidelity similar to the codon-anticodon
mechanism15. Peptidyl-tRNA hydrolysis is facilitated by the middle (M) domain15. The cterminus interacts with the class II factor eRF3, which is a translational GTPase similar to
eEF1A15. Ultimately, the eRF1-eRF3-GTP ternary complex interacts with the ribosome. GTP
hydrolysis results in a conformational change that places the M domain of eRF1 into the PTC
and the amino-terminal domain is able interrogate the stop codon while eRF3 is released15.
3

While eRF1 and eRF3 have been shown to have lower rates of ribosome recycling, the ATPase
ABCE1 is proposed to promote efficient eRF1-mediated peptide release and subsequent
ribosome subunit splitting/recycling15,17. Multiple rounds of initiation typically occur on a single
mRNA, sequentially. These initiation events often happen prior to the end of previous rounds of
translation. This results in an mRNA being translated simultaneously by more than one
ribosome, which produce molecular structures known as polysomes18.
As previously mentioned, the mRNA not only contains protein coding information, but also
regulatory information. Already noted are the 5ʹ-m7GpppN-cap and the 3ʹ-poly(A) tail13,14 that
recruit eIFs to not only promote, but also delay translation initial. The 5’ UTR may also contain
upstream ORFs (uORFs) can affect the production of desired protein products. Secondary RNA
structures in the 5’ UTR have also been shown to affect scanning and therefore change the
efficiency of translation initiation19. Lastly, binding sites for RNA binding proteins (RBPs) and
microRNAs (miRNAs), capable of promoting or repressing translation, can be found in the 5’
UTR that regulate the stability and translation of the mRNAs19–26. The 3’ UTR is also host to RNA
structures, RBP binding sites, and miRNA binding sites that affect mRNA stability and
translation21,23–28.
The ORF also contains regulatory information in multiple forms. As with 5’ and 3’ UTRs, miRNAs
and RBPs have been shown to bind within ORFs as well and exhibit regulatory function24,29–32.
Alternative start sites using either cognate start codons, near-cognate start codons, or internal
ribosome entry sites (IRESs) are able to impact mRNA products and stability33–37. Even codon
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usage, i.e. codon optimality, within the ORF can affect mRNA stability and protein synthesis38,39.
Thus, a multitude of translational control mechanisms exist at each step of the process,
affecting protein synthesis, all of which are driven by the mRNA and often its translation.

1.3 Ribosome-Associated Quality Control Pathways
Eukaryotes use multiple mechanisms of RNA surveillance and decay for its maintenance, four of
which are associated with translation (i.e. Nonsense Mediated Decay, NMD; Non-Stop Decay,
NSD; No-Go Decay, NGD; Non-functional ribosomal RNA decay, NRD). Although the canonical
mRNA substrate(s) identified to activate each is typically different, these pathways require, and
are driven by, active translation of mRNAs by the ribosome. Interestingly, one motif is capable
of activating all four pathways directly or indirectly: the polyadenosine (polyA) tract. This
particular motif is integral to this work and will be briefly associated with the context of each
mechanism; particularly NGD and NSD.

1.3.1 Nonsense Mediated Decay (NMD)
NMD results from a ribosome encountering a premature termination codon (PTC). Multiple
models of PTC recognition by the NMD machinery have been proposed and are dependent
upon whether or not an exon junction complex (EJC) exists40,41. Generally speaking, the
presence of a PTC increases the length of the 3’ UTR and therefore the distance between the
translation release factors and polyA-binding protein (PABP); a positive effector of translation
termination and inhibitor of NMD factor binding42. Upon encountering a PTC in the absence of
an EJC, it has been proposed that the release factors are able to directly recruit NMD factors
(e.g. UPF1-3) while the EJC aids in this recruitment. Ultimately the ribosome subunits are split
5

and recycled while the mRNA and nascent polypeptide are degraded40–42. The polyA tract motif
is able to induce NMD via frameshifting events that result ribosomes encountering typically
out-of-frame PTCs43–47.

1.3.2 No-Go Decay (NGD)
NGD occurs in the context of translation elongation of mRNAs containing secondary structures,
problematic nucleotide sequences, and inhibitory peptide sequences40. This is triggered by
ribosome collision, whereby a normally translating ribosome collides with a stalled ribosome48.
The resulting di-ribosome (disome) results in assembly of the ribosome-associated quality
control triggering (RQT) complex. The receptor for activated C kinase 1 (RACK1) is necessary for
pathway activation, recruiting the ZNF598 E3 ubiquitin-protein ligase – suggested to recognize
the inter-ribosomal interface of interacting RACK1 proteins – resulting in ubiquitination of uS3,
uS10, and eS1048–52. This ubiquitination recruits other RQT complex factors via ubiquitin-binding
CUE domains. The RQT response is dependent on the ATPase hydrolysis-driven helicase activity
of activating-signal co-integrator complex (ASC-1) subunit 3 (ASCC3), which is recruited by its
CUE domain containing binding partner ASCC2 in complex with the zinc-finger type protein
TRIP4; the subunits comprising the RQT complex51,53.
During NGD the endonuclease N4BP2 is also recruited via its CUE domains where it cleaves the
mRNA, which is stimulated by the complexed Pelota and HBS1-like proteins (homologous to
eRF1 and eRF3, respectively)40,54–56. The Pelota and HBS1-like complex, along with ABCE1, begin
the process of ribosome rescue by subunit dissociation40,57,58. After subunit dissociation, the
cleaved mRNA 5’ fragment is degraded by the Ski complex and exosome in a 3’ to 5’ fashion.
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The cleaved mRNA 3’ fragment is degraded by Xrn1, after Rlg1-mediated phosphorylation of
the 5’-hydroxy end59, in a 3’ to 5’ direction51.
The RQC complex (Ltn1, TCF25, NEMF and p97) rescues the 60S subunit-peptidyl-tRNA
complex51. The nascent polypeptide is elongated by the C-terminal addition of multiple alanyl
and threonyl residues (CAT-tailing) in a template-free, 40S subunit independent manner
mediated by NEMF51. This is thought to be a fail-safe mechanism ensuring efficient
ubiquitination by E3 ubiquitin ligase Ltn1, recruited by NEMF60, on the extruded lysine
residues61. Subsequently, p97 with cofactors Ufd1 and Npl4 extricate the nascent polypeptides
for proteasomal degradation51.
Intragenic polyA tracts have been demonstrated to negatively regulate gene expression
through stalling and frameshifting; ostensibly an almost universally conserved feature
conserved43,44,47. The exploitation of this conserved stalling phenotype has been well
characterized in other organisms to also generate alternative proteins44 and has been used
regularly to obtain ribosome structural data. However, the details regarding the mechanisms of
polyA tract stalling and frameshifting have remained elusive until recently. The data suggests a
two-step mechanism for stalling whereby repetitive, cumbersome lysine residues clash in the
60S peptide transferase center, reducing the rate of aminoacyl transfer and subsequently
translation. This allows for rearrangement of the 40S decoding center such that the repeating
adenosines are able to forma single-stranded mRNA helical structure mediated by 7π-stacking
interactions that conserved residues in the decoding center stabilize. This results in a
decoding-incompetent nucleotide structure, preventing canonical codon:anticodon
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interactions subsequently inhibiting delivery of the tRNA–eEF1A–GTP ternary complex62,63.
The precise mechanism driving -1 frameshifting is still unknown, but the loss of frame due
to more than 3 nucleotides in the decoding region A-site would certainly be influential.

1.3.3 Non-Stop Decay (NSD)
NSD is triggered by the lack of a stop codon; a fault in translation termination. This occurs in the
case of a truncated mRNA (stop codon-less mRNA) or the ribosome running into the poly(A) tail
(non-stop mRNA), which are identified during translation termination. Truncated mRNA
substrates can be produced either endonucleolytic cleavage in the coding region of the
ribosome or premature polyadenylation or abortive transcription64,65. Non-stop mRNAs are
generated by premature polyadenylation64,65 or frameshifting events43–46,66. The stalled
ribosome is recognized in the same fashion as NGD40,41,50,51,64,65,67,68. The stall results upon the
interaction of the positive charge of polybasic lysine stretch and the negatively charged
ribosome exit channel cause translational arrest after as few as six lysines40. The attempted
decoding of polyA tail also plays a role in stalling similar to encountering an internal polyA
tract62,63.

1.3.4 Nonfunctional Ribosome Decay (NRD)
Surveillance of ribosomal RNAs (rRNAs) is also necessary. Ribosome biogenesis is a highly
regulated and energetically expensive process41,69,70. The NRD pathway is involved in this
process to ensure initial proper ribosome synthesis. However, due to the long-lived nature of
rRNAs, they are prone to significant damage from genotoxic and proteotoxic stress70–75.
Therefore, it is also important that once released from the synthesis pathway, monitoring of
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mature rRNA function continues. This is also performed by the NRD pathway70,72–75. Previous
work has shown that this pathway can be separated into two parts, one for each ribosomal
subunit70,72,74. The 60S subunit NRD is induced by defects in the peptidyl transferase center70,72
and is associated with factors previously described in DNA repair: CDC34, Hrt1, the ubiquitin E3
ligase Rtt101p, Mms1p, and a yet to be discovered ribosome-specific adaptor protein73. This
arm of NRD has been thought to rely on ribosomal protein ubiquitination through these
proteins. The 40S subunit NRD pathway was initially shown to be dependent on defects in
translation elongation and tied into the NGD machinery70. However, recent work has
demonstrated that ubiquitination of the 40S ribosomal proteins in a site-specific, sequencedependent manner is also required for 40S NRD, namely uS3 (rps3), by the coordinated efforts
of the ubiquitin ligase ZNF598, receptor for activated C-kinase (RACK1), 76,77. This link between
the mRNA surveillance and rRNA surveillance machinery supports the possibility for mRNAinduced rRNA decay. In fact, the polyA motif has been associated with necessary ribosomal
protein ubiquitination and NRD activation78,79.
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1.4 Adaptation of Translational Machinery in Malaria
Parasites to Accommodate Translation of Poly-Adenosine
Stretches Throughout Its Life Cycle
Preface
The following work was completed by myself, Slavica Pavlovic Djuranovic, and Sergej
Djuranovic. JE produced all figures and tables. All authors contributed equally to writing and
revising of this review. This section is published in its entirety80 and is available at
https://www.frontiersin.org/articles/10.3389/fmicb.2019.02823/full. This article is distributed
under the terms of the Creative Commons Attribution License 4.0
(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original author and source are credited.

1.4.1 Abstract
Malaria is caused by unicellular apicomplexan parasites of the genus Plasmodium, which
includes the major human parasite Plasmodium falciparum. The complex cycle of the malaria
parasite in both mosquito and human hosts has been studied extensively. There is tight control
of gene expression in each developmental stage, and at every level of gene synthesis: from RNA
transcription, to its subsequent translation, and finally post-translational modifications of the
resulting protein. Whole-genome sequencing of P. falciparum has laid the foundation for
significant biological advances by revealing surprising genomic information. The P. falciparum
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genome is extremely AT-rich (∼80%), with a substantial portion of genes encoding intragenic
polyadenosine (polyA) tracks being expressed throughout the entire parasite life cycle. In most
eukaryotes, intragenic polyA runs act as negative regulators of gene expression. Recent studies
have shown that translation of mRNAs containing 12 or more consecutive adenosines results in
ribosomal stalling and frameshifting; activating mRNA surveillance mechanisms. In contrast, P.
falciparum translational machinery can efficiently and accurately translate polyA tracks without
activating mRNA surveillance pathways. This unique feature of P. falciparum raises interesting
questions: (1) How is P. falciparum able to efficiently and correctly translate polyA track
transcripts, and (2) What are the specifics of the translational machinery and mRNA surveillance
mechanisms that separate P. falciparum from other organisms? In this review, we analyze
possible evolutionary shifts in P. falciparum protein synthesis machinery that allow efficient
translation of an AU rich- transcriptome. We focus on physiological and structural differences of
P. falciparum stage specific ribosomes, ribosome-associated proteins, and changes in mRNA
surveillance mechanisms throughout the complete parasite life cycle, with an emphasis on the
mosquito and liver stages.

1.4.2 Introduction
Plasmodium spp. has been in existence long before humans were on Earth, with an estimated
origin of malaria-causing parasites appearing around 165 million years ago. Consequently,
mosquitos and malaria had millions of years to co-evolve before either ever interacted with
humans81. The infection of humans occurred evolutionarily recently, and probably with multiple
Plasmodium parasite species. P. falciparum and P. vivax established themselves as a major
11

malaria causing species. P. falciparum a most virulent agent in human malaria began speciation
around 50,000 years ago followed by the population bottleneck around 5000 years ago but
higher level of genetic diversity suggests that P. vivax is older82,83. P. malariae, P. ovale, and rare
cases of P. knowlesi were also reported in human hosts. From the mid-19th century onward,
malaria reached its global limits and exacted immensely high numbers in sickness and death.
While increased malaria prevention and control treatments have reduced the health burden of
malaria, there are still 219 million cases of infection per year resulting in 435,000 deaths84. The
complex cycle of the malaria parasite in both mosquito and human hosts has been studied
extensively (FIGURE 1.1). In each of these life cycle stages, gene expression is tightly controlled85–
92

.
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FIGURE 1.1 | Schematic presentation of P. falciparum life cycle and stage-specific ribosomal RNAs (A and S type). Human
infection by P. falciparum begins when an infected female anopheline mosquito inoculates sporozoites into the bloodstream
during feeding. The sporozoites invade liver cells and transform into trophozoites. In 6–8 days one mature schizont will release
thousands of liver-stage merozoites into the bloodstream (exoerythrocytic schizogony, the first proliferative stage). The second
asexual proliferative stage blood stage (erythrocytic schizogony) starts when the liver-stage merozoites invade the erythrocytes
About 14–16 erythrocytic merozoites are generated in a 48-h cycle for re-infection and it is the point when the symptoms start.
The merozoites may differentiate into single gametocytes, the initial stage of the sexual reproduction (gametogenesis) or
continue the asexual cycle. Mosquito infection begins when the gametocytes are taken by mosquito with the blood meal. The
male microgametocyte exflagellates into individual microgametes and fertilizes the female macrogamete. The zygote transforms
into a motile ookinete, penetrates the mosquito midgut and develops into an oocyst. After 9–14 days, thousands of sporozoites
are differentiated in the mature oocyst (sporogony), the only multiplicative stage in the mosquito. Mature sporozoites invade
salivary glands and with the next blood meal the cycle continues.
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It took years of laborious efforts to sequence P. falciparum genome93. Sequences of single or
multiple chromosomes as well as complete genome were reported over the course of 4 years94–
99

. The high AT-content of the genome made gap closure in sequences extremely difficult.

However, long-read, single molecule, real- time sequencing allowed for complete telomere-totelomere de novo assembly of the P. falciparum genome thereby overcoming the problems
associated with next generation sequencing of AT- rich genomes100. The consequence of ATrichness is the presence of extended tracts of As, Ts, and TAs in introns and intergenic
regions101,102 as well as unusually high number of genes containing coding polyadenosine
(polyA) repeats compared to the other species103,104. Repetitions of 12 or more adenosine
nucleotides in gene coding sequences, so-called polyA tracks, were recently found to act as
negative gene regulation motifs at the level of mRNA translation in all tested organisms43,47.
Consequently, polyA tracks have been evolutionarily preserved in a select set of genes, but are
generally selected against in overall gene coding sequences43.
Recent analysis of 250 eukaryotic genomes found a median of 2% of transcripts with polyA
tracks103. However, Plasmodium species represent an exception to this rule. The percentage of
polyA carrying transcripts in the genome exceeds 60% for most Plasmodium spp., including P.
falciparum (64%)104. The pervasive ribosomal stalling and frameshifting found on polyA tracks in
other eukaryotes43,47,105 would make it almost impossible for the majority of Plasmodium
proteins to be efficiently and correctly synthesized. However, global studies of Plasmodium
protein composition106,107 and protein synthesis85,89,90 do not show any reduction in either the
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protein or mRNA abundances of polyA track genes. This suggests that both ribosomal stalling
and frameshifting in Plasmodium are resolved by adaptations in protein synthesis and mRNA
quality control systems. In this review, we will discuss how the extreme AT-rich genome of
malaria-causing parasite promoted special features in P. falciparum ribosomes to enable
translation of polyA tracks throughout the complete life cycle. Additionally, genomic changes
and parasitic environment have also influenced variation in mRNA surveillance mechanism
within the organism resulting in divergence from other Eukaryotes.

1.4.3 Evolution of AT-Richness in P. falciparum
Extremes in genomic base composition toward GC- or AT- richness exist in all domains of life108–
111

. The extent of these extremes in nucleotide composition is limited by the necessity of all 20

amino acids and the subsequent requirement of all four nucleotides to encode them. As such,
long homopolymeric amino acid repeats appear to be a characteristic of genomes with either
bias102,112,113. Harboring either extreme AT- or GC-richness affects genomic structure, stability,
transcriptome, and codon bias of organisms111. As seen in Table 1.1, the P. falciparum mean ATrichness of around 80% appears to be one of the highest in all Eukaryotes95,114–116. Surprisingly,
the higher AT-content of the P. falciparum genome cannot be fully explained by increased ATrichness in intergenic regions, but rather by contributions of AT-richness in both coding 76.22%
(TABLE 1.1) and non-coding genome 90%95. Overall, gene organization patterns in P. falciparum
are not influenced by the AT-bias101,102,104. However, what distinguishes Plasmodium species
from other AT-rich organisms is distribution of consecutive adenosine nucleotides resulting in
unusually high percentage of polyA track genes (TABLE 1.2). The genomes of P. falciparum and
15

related Plasmodium species have apparently evolved independently to reach extreme AT-bias
(TABLE 1.2). Interestingly, while the two groups of Plasmodium species can be separated based
on their AT-genomic content (median of 75% versus a median of 55% AT-richness), both groups
accommodate a considerable amount of polyA tracks within the coding regions104.

TABLE 1.1 | Comparison of AT-richness and polyA track gene ratios over selected Eukaryotic species.
Organism

CDS % AT richness

PolyA track genes

Plasmodium falciparum

76.22%

63.54%

Plasmodium reichenowi

75.93%

62.93%

Dictyostelium discoideum

72.57%

20.96%

Tetrahymena thermophila

72.50%

28.19%

Saccharomyces cerevisiae

60.39%

5.51%

Plasmodium knowlesi

59.77%

41.42%

Caenorhabditis elegans

57.94%

1.93%

Plasmodium vivax

53.51%

38.85%

Drosophila melanogaster

50.66%

1.10%

Pan troglodytes

50.60%

2.17%

Homo sapiens

49.98%

1.40%

Trypanosoma brucei

49.19%

2.89%

Trypanosoma cruzi

46.83%

2.74%

Toxoplasma gondii

42.88%

1.01%

Leishmania donovani

37.63%

0.19%

Leishmania major

37.52%

0.05%

Leishmania infantum jpcm5

37.50%

0.12%

Acanthamoeba castellanii str neff

37.06%

0.11%

Emiliania huxleyi

31.38%

0.10%

Aureococcus anophagefferens

29.37%

0.33%

The coding region AT-richness from a relevant selection of organisms with high, moderate, and low AT-content was
compiled from Habich (2016) and Videvall (2018) and sorted in descending order.
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Perhaps just as interesting as the consequences of genomic base composition biases are the
factors driving it. Previous studies in P. falciparum were unable to conclude the primary role of
homopolymeric amino acid repeats in the parasite proteome113,117. Nutrient availability to
intracellular parasites – as well as endosymbionts – appears to be a major factor in driving ATrichness, particularly nitrogen availability118,119. De novo synthesis of nucleotides comes at great
metabolic expense, especially regarding G+C nucleotides119. A+T nucleotides are less
metabolically costly to create and tend to be more abundant. Consequently, A+T nucleotides
are easier to scavenge, even in intracellular environments where nutrients may not be readily
available. In the case of P. falciparum, where de novo synthesis of purines does not occur, the
parasites must rely upon purine scavenging and salvage pathways120–122. Conversely, pyrimidine
de novo synthesis occurs using glutamine and aspartic acid precursors. This appears to be the
main source for these nucleotides, with the folate pathway being required for thymidine
production123–125. However, unlike other intracellular organisms referenced above, the
intracellular environment for P. falciparum is not necessarily nutrient poor, but perhaps
nutrient selective; particularly prior to parasite augmentation of the host cell. While P.
falciparum has multiple means by which amino acids are obtained, much of its initial amino acid
supply is from proteolysis of human host red blood cell hemoglobin126–128.
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TABLE 1.2 | Comparison of AT-Richness and polyA track gene ratios over selected Plasmodium species.
Organism

CDS % AT richness

PolyA track genes

Plasmodium gallinaceum

78.81%

71.77%

Plasmodium relictum

78.43%

79.18%

Plasmodium berghei

76.26%

68.26%

Plasmodium yoelii 17x

77.03%

64.96%

Plasmodium falciparum

76.22%

63.54%

Plasmodium chabaudi

74.46%

63.37%

Plasmodium reichenowi

75.93%

62.93%

Plasmodium vinckei petteri

74.91%

62.58%

Plasmodium gaboni

77.56%

61.76%

Plasmodium falciparum camp malaysia

76.71%

61.02%

Plasmodium falciparum nf54

76.55%

60.60%

Plasmodium falciparum fch 4

76.67%

60.57%

Plasmodium falciparum ugt5 1

76.49%

60.45%

Plasmodium falciparum santa lucia

76.75%

60.42%

Plasmodium falciparum palo alto uganda

76.56%

60.33%

Plasmodium falciparum nf135 5 c10

76.56%

59.98%

Plasmodium falciparum malips096 e11

76.50%

59.81%

Plasmodium falciparum 7g8

76.65%

59.72%

Plasmodium yoelii yoelii

75.20%

51.06%

Plasmodium knowlesi

59.77%

41.42%

Plasmodium knowlesi strain h

59.76%

41.42%

Plasmodium vivax

53.51%

38.85%

Plasmodium cynomolgi strain b

57.91%

33.83%

Plasmodium inui san antonio 1

56.37%

31.12%

Plasmodium spp. coding region AT-content and the ratio of polyA affected transcripts was collected103,116. The data are
organized in the table to demonstrate a separation of two groups with high and low coding region AT-content and
subsequently the number of polyA track containing transcripts. The separation notably occurs along the line of geographic
region with the high AT-content organisms being predominantly found in Africa and the low AT-content group in Asia,
Southeast Asia, and Latin America. However, the low AT-content group still exceeds that of most organisms.
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This brings us to a second major contributor of AT-richness in intracellular organisms: oxidative
stress. Reactive nitrogen (RNS) and reactive oxygen species (ROS) generate oxidative stress
resulting in 8-oxoguanine production via guanine oxidation. If left unrepaired in DNA, 8-oxoG is
able to pair with adenosine; ultimately causing a G:C to T:A conversion. Compounding the
process, hemoglobin degradation produces free heme and H2 O2 , which generates further
oxidative stress for the parasite129. Additionally, NO and other RNS species may be important
factors in the soluble heme-hemozoin equilibration130. Interestingly, another erythrocytic
parasite from Apicomplexa phylum, Babesia microti, does not degrade hemoglobin and has a
considerably less AT-rich genome (61.02%) and polyA tracks (2.17% of genes with polyA tracks)
compared to P. falciparum104,131. Although Plasmodium spp. does supply some of its own
antioxidants to cope with oxidative assault, the higher than expected G:C to T:A conversion in
the organism suggests a lack of full compensation by the biochemical and/or DNA repair
safeguards125. While 8-oxoG could potentially result in AT-richness imprinted in the DNA
sequence, it causes more problems when found in RNA132. The oxidative lesion and
incorporation of 8- oxoG in mRNAs reduces the rate of peptide-bond formation by more than
three orders of magnitude133. The effect of 8-oxoG nucleotides in mRNAs is independent of its
position within the codon, results in stalling of the translational machinery, and finally
activation of No-Go decay mRNA surveillance mechanisms133. As such, the presence of oxidative
stress may have driven both an increase in genomic AT-richness and changes in mRNA
surveillance mechanisms of P. falciparum; which are discussed further below.
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AT-richness itself appears to provide a feedback loop in the parasite with its increased indel
rates, which are thought to be due to DNA replication slippage on AT repeats. These AT tracks
provide amplicon breakpoints for copy number variant (CNV) alteration via non-allelic
homologous repair-like mechanism that can be advantageous in altering resistance gene CNV
numbers125,134,135. Altogether, metabolic and biochemical factors continuously drive the
parasite genome toward AT richness, which, in turn, drives indels that potentiate genomic
plasticity providing an overall platform for relatively rapid adaptive evolution in the parasite.
Unarguably, these factors necessitate increased fidelity in DNA replication and RNA
transcription. While the exact details specific to Plasmodium spp. evolutionary adaptation
toward an AT-rich genome, unique codon biases, and polyA encoded lysine stretches remains
to be explored, the role ribosomes play as influential factors in this process is certain.

1.4.4 The rRNA and Specialized Ribosomes of Plasmodium
The most abundant genes in cells and genomes from bacteria to eukaryotes are those encoding
ribosomal RNA. Ribosomal RNA genes in eukaryotic cells form clusters with a highly repetitive
structure. S. cerevisiae, a single cell organism, has 150 rDNA repeats in one cluster on
chromosome XII, while human cells contain five clusters of approximately 70 rDNA repeats on
five different chromosomes136. The organization of rDNA genes in clusters is conserved among
most of the eukaryotic organisms137. Transcription of these clusters is highly coordinated to
meet the huge demand for ribosomes, which occupy ∼50% of the total protein mass in a cell138.
Plasmodium genomes, however, have only 4–8 single copy rDNA units that are encoded on
different chromosomes139–141. Such a small number of rDNA copies throughout the genome is
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seen elsewhere only in bacteria. E. coli has seven ribosomal RNA genes spread over its circular
genome and well positioned in the regions near an origin of replication. This arrangement in E.
coli enables maximum ribosomal RNA transcription while preventing possible collisions
between replication forks and transcription machinery142. Thus, while most of the other
organisms have optimized ribosome production, how the malaria-causing parasite produces its
significant ribosome numbers is still unknown. It might be possible that massive DNA
replication that occurs throughout its lifecycle (during shizogeny) in both hosts may
accommodate the rRNA production requirements.
Besides this unusual rDNA arrangement, malaria parasites are pioneers in the new era of
specialized ribosomes140,143–146. Plasmodium spp. has structurally distinct, stage-specific
ribosomes and are the most well-known case of rRNA heterogeneity144. The difference in
sequence and expression profile during the life cycle classified them into A-type (asexual stage
specific) and S-type (sporozoite specific) in the majority of Plasmodium species, including P.
falciparum; with P. vivax having a third O-type rRNA141. The A-type is present in the liver and
blood stage and S-type is sporozoite specific rRNA type that emerges during the mosquito stage
and ends during the parasite development in hepatocytes147. Here, we will focus on the process
by which the ribosome types switch and whether ribosomes with distinct rRNA play a selective
role in the mRNAs they translate.
Plasmodium spp. have adapted to translation in two different hosts. This requires translation
optimization at two distinct temperatures, one of which can be highly variable depending on
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the mosquito environment. Even though one would think that changes in temperature and
hosts would be the reason for development of different rRNAs, the presence of A-type during
the early mosquito stage and S-type during early liver stage does not support that idea148. The
rRNA sets are not expressed in an exclusive and binary (on/off) fashion, but more as a dynamic,
heterogeneous population whereby one subtype, A or S, is the more dominant rRNA type in a
particular lifecycle stage. While the idea of a thermoregulatory nature of the rRNA units has
been explored earlier in P. berghei, rodent malaria, it has not been followed since148. P. berghei,
contains four distinct copies off the rRNA (A, B, C, D) and they are divided into A-type (A and B)
and S-type (C and D). A single copy of the S-type gene, C or D was sufficient for life cycle
completion, which only affected the parasite fitness. The group was unable to disrupt both Stype genes simultaneously; nor could they disrupt either of A-type genes149. Interestingly,
authors noticed growth retardation in oocyst development, which was more pronounced in Dunit disruption rather than in C-unit149. Such difference could be explained by difference in
ribosomal levels stemming from different transcriptional levels of C- and D-units or functional
diversity of C- and D-unit containing ribosomes146,150. The disruption of specific S-type rRNA is
also associated with oocyst development defects in the second rodent parasite P. yoelii151.
Finally, van Spaendonk et al. (2001)149 note a lack in differences between core catalytic
components (e.g., GTPase center) of the ribosome large subunit in P. berghei that were
previously described in P. falciparum145. These results among species of Plasmodium potentiate
the question of some aspect of ribosomal specialization91.
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and mosquito that contain polyA tracks (Figure 4). More recently Stalls on polyA tracks can be resolved in mammalian cells by
it was also shown that the P. falciparum ribosomes have been deletion of RACK1 and ZNF598, thus enabling read-through
whole is fairly persistent throughout the complete life cycle of P. falciparum, oscillations in their
altered to accommodate the poly-lysine patches that are prolific of stall-inducing sequences (Garzia et al., 2017; Juszkiewicz
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repeats, the parasite ribosome exit channel has been altered translate through the CGA-CGA stalling sequences and increase
by increasing the channel size at key bottle necks, as well as23normally attenuated protein output (Wolf and Grayhack, 2015).
a reduction in the hydrophobicity patches typically seen in The increase in amount of synthesized protein from CGAbacterial, yeast, or human ribosomes (Djuranovic et al., 2018).
CGA sequences is a consequence of overall reduced elongation
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This does not exclude the highly sought-after notion that a specific set of ribosomes may be
optimized for specific mRNA substrates or cell populations that may also exist in Plasmodium
spp. A recent study in zebrafish showed that embryos have different subtypes of 5.8S, 18S, and
28S rRNAs, creating similar ribosome diversity seen in Plasmodium cells156. In silico data have
shown that the expanded regions of 18S subunit expressed in zebrafish embryos may
preferentially bind maternal transcripts when compared to somatic subtypes156. Similarly, a
shift in the expression of 16S rRNA ribosome variants created populations of E. coli cells that
accommodated functional differences in tetracycline binding155. As was mentioned before, the
rRNA heterogeneity that was mostly known in Plasmodium parasites139,140,146,147,157 is now
recognized in other organisms155,156. However, the role of different Plasmodium rRNAs as a
response to different environmental conditions is still not defined.
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human host (C), and polyA genes for each (B and D, respectively) are as previously defined. RNAseq data for all stages in both
hosts for these gene sets are displayed in log scale as a violin plot with all data points for comparison.

Regardless of the host, all Plasmodium spp. rRNA types must contend with the translation of
unusually high AU-content and long-coding polyA stretches in mRNAs. RNA-seq data85,86,89,90,134
indicates that the mRNA levels of genes containing polyA stretches follows the same trend as
the general gene expression for all stages in both hosts (FIGURES 1.3A–D). We can conclude that
both types of ribosomes expressed in both hosts have features allowing efficient translation of
transcripts containing long, coding polyA tracks. This indicates that P. falciparum ribosomes

FIGURE 4 | Venn Diagram of P. falciparum gene expression from RNAseq data. The expression data greater than or equal to the 80th percentile for ring, early
trophozoite, late trophozoite, schizont, gametocyte II, gametocyte V, ookinete, oocyst, and sporozoite stages was queried (López-Barragán et al., 2011; Zanghì
et al., 2018). Mosquito stage total genes were defined as those with expression data greater than or equal to the 80th percentile during gametocyte V, ookinete,
oocyst, or sporozoite stages. Mosquito host-specific genes are defined as above, but solely in mosquito host stages. Total parasite genes expressed in the human
host were defined as those with expression data greater than or equal to the 80th percentile during sporozoite, ring, early trophozoite, late trophozoite, schizont,
gametocyte II, or gametocyte V stages. Enriched parasite genes expressed in the human host are defined as above, but solely in human host stages. PolyA genes
are those defined as having one or more runs of twelve or more consecutive adenosines in the coding region of the gene.
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have higher fidelity during translation of polyA sequences and are able to accommodate long
polybasic peptides coming through their protein-exit channel. Previous ribosome mutagenesis
studies in S. cerevisiae suggested functional differences in the GTPase centers of P. falciparum
A- and S-type ribosomes145. Despite the differences in yeast viability and growth rates, chimeric
yeast ribosomes with either Plasmodium’s A- or S-type GTPase centers exhibited increased
translational accuracy145. Even though there are stage-specific ribosomes, there is a group of
genes that is present in human and mosquito that contain polyA tracks (FIGURE 1.4). More
recently it was also shown that the P. falciparum ribosomes have been altered to accommodate
the poly-lysine patches that are prolific throughout the proteome104. To allow these lowcomplexity, homopolymeric and polybasic amino acid repeats, the parasite ribosome exit
channel has been altered by increasing the channel size at key bottle necks, as well as a
reduction in the hydrophobicity patches typically seen in bacterial, yeast, or human
ribosomes104.
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Ribosome profiling and biochemical assays suggest an increased or modified fidelity such that
parasite ribosomes do not stall or frameshift on polyA tracks104. The mechanism of this altered
fidelity may result from not only modification of the ribosomal RNA sequence, but also via
changes to key protein components of ribosomes. Two P. falciparum ribosome cryoEM
structures suggest a reduced or lost interaction of the receptor for activated C kinase 1 (RACK1)
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to Plasmodium ribosomes158,159. RACK1 has been established as an integral ribosomal scaffold
protein160. Beside other non-ribosome associated functions, RACK1 was found to be important
for cap-dependent translation initiation, IRES-mediated translation, and site-specific
translation161. RACK1 also contributes to the translation arrest that is induced by translation of
polyA sequences162,163, CGA-CGA codons in yeast164, or runs of consecutive basic amino-acid163.
Stalls on polyA tracks can be resolved in mammalian cells by deletion of RACK1 and ZNF598,
thus enabling read-through of stall-inducing sequences50,77,79. S. cerevisiae ribosomes lacking
the RACK1 homolog Asc1 are able to translate through the CGA-CGA stalling sequences and
increase normally attenuated protein output164. The increase in amount of synthesized protein
from CGA- CGA sequences is a consequence of overall reduced elongation rates of yeast
ribosomes that lack Asc1165. Slower elongation rates may also influence cellular responses to
ribosome pausing. The position of RACK1/Asc1 near the mRNA exit channel on the ribosome
could be important in sensing ribosome collisions that lead to activation of ribosome rescue
and mRNA surveillance pathways132,165,166. The fact that Plasmodium ribosomes lack interaction
with PfRACK1 could be beneficial for translation of polyA tracks into poly-lysine runs. However,
based on previous conclusions concerning the role of RACK1/Asc1 in correct reading frame
maintenance during translation of stalling sequences, the majority of polyA coding sequences in
malaria parasites would be predicted to have multiple frameshifted protein products.
Previous studies163,167,168 proposed that stalling during the translation of polyA tracks is due to
synthesis of the poly-lysine rich nascent peptide. Electrostatic interactions of the polybasic
peptide and the peptide exit tunnel in the ribosome would elicit ribosomal stalling167. Recent
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studies revealed that an mRNA-mediated mechanism is directly contributing to stalling43,47,165.
Consecutive adenosines are engaged by the ribosome decoding center nucleotides, are
stabilized on both sides by rRNA base stacking interactions165, and adopt a helical conformation
typical for single stranded polyA stretches169. PolyA tracks are highly efficient at causing
ribosome stalling, and the inhibitory conformation of polyA mRNA bases can further contribute
to a polyA-mediated stalling mechanism. This conclusion is in line with the previous
observations that consecutive AAG codons are less efficient at causing stalling than AAA
codons43,47, despite coding for the same amino acid. Altogether, the charge and conformation
of the poly-lysine nascent chain in conjunction with the stacked polyA mRNA nucleotides in the
decoding center of the ribosome contribute to the overall stalling mechanism165. P. falciparum
ribosomes are again the exception to this rule. The nucleotides that make stacking interactions
with polyA repeats are conserved in P. falciparum ribosomes. However, both endogenous
transcripts and reporter sequences with long runs of polyA tracks are efficiently translated by
Plasmodium89,104,170. Thus, in order to adapt to polyA track translation for production of the
polybasic and homopolymeric lysine repeats, the malaria-causing parasite has altered the
sequence of its rRNA, its ribosome structure, its ribosomal proteins, and its mRNA translation
quality control pathways.

1.4.6 mRNA Surveillance Pathways in AU-Rich Transcriptome of P. falciparum
The core elements for mRNA translation are highly conserved in Plasmodium spp.91. The unique
features involving protein synthesis in Plasmodium, such as different types of ribosomes in
different life cycle stages, were noticed even before genome sequencing of the malaria
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parasite139,147,149,157. However, the presence of an unusual number of mRNA binding proteins
and the absence of some elements of mRNA surveillance mechanism were noticed upon
completion of the P. falciparum genome sequence52,85,89,92,139,140,149,157,171. A recent review
elaborated on the translational regulation in blood-stages of malaria parasites91. They focused
on cytoplasmic mRNA translation and the fate of mRNAs: decoding of the mRNA messages by
the 80S ribosomes, degradation of mRNAs by exo- or endonucleases (mRNA decay), and
sequestration of mRNAs by protection from mRNA decay or by inhibition of translation. We
focus here on the mechanism of activation of mRNA surveillance pathways by aberrant mRNAs
in the context of unusual AU-richness and abundance of polyA tracks in Plasmodium
transcriptome.
Eukaryotic cells have developed mechanisms to protect themselves from the production of the
possible toxic proteins due to aberrant mRNA translation events. There are three mRNA quality
control systems for translational errors in eukaryotes: Non-sense mediated decay (NMD), NoGo decay (NGD), and Non-Stop decay (NSD). NMD targets transcripts harboring “premature”
termination codons (PTC) and nascent polypeptide chains synthesized from such transcripts for
efficient degradation40. Components of NMD pathway distinguishes PTCs from authentic stop
codons in the coding sequence. PTCs are usually the product of point-non-sense mutations,
ribosomal frameshifting on slippery sequences, aberrant splicing events, or in some cases, the
consequence of targeted gene regulation through alternative splicing88,172. In higher
eukaryotes, PTCs are generally recognized by their proximity to so-called exon-junction
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complexes (EJCs), which are deposited near exon junctions during pre-mRNA splicing in the
nucleus40.
No-Go decay is an “umbrella term” for the mRNA surveillance pathway that deals with either
damaged or difficult to translate mRNA sequences that cause the ribosome to stall during the
elongation cycle of translation. Besides the previously mentioned mRNA base damages (8oxoG)132,133, mRNA translation can be stalled by lack of aminoacylated-tRNAs, strong mRNA
secondary structure (i.e., stem-loops or long GC-rich regions), or stable interaction of the
nascent polypeptide chain with the translating ribosome. Even though Non-Stop Decay (NSD)
was discovered earlier than NGD58,67,68,75,173,174, it became apparent that in mammals and higher
eukaryotes, the NSD and NGD pathways share the same effector protein complexes67. The NSD
targeted mRNAs that originate from premature 3ʹ adenylation or cryptic polyadenylation signals
found in coding sequences indeed represent a similar group of transcripts that would be
targeted by NGD pathway67,173,175. Ribosomes that translate mRNAs without stop codons would
eventually stall while translating long polyA tails into poly-lysine repeats, or because they would
simply run out of message. Recognition of these types of transcripts, as well as the
aforementioned NGD targets, trigger components of NGD/NSD pathways resulting in targeted
mRNA cleavage and degradation.

31

TABLE 1.3 | Comparison of translation quality control factors in P. falciparum and its mosquito and human hosts.
Pathway

H. sapiens

A. gambiae

P. falciparum

NMD

eRF1, eRF3, UPF1, UPF2,
UPF3A/UPF3B, eIF4AIII,
MLN51, Y14/MAGOH, BTZ,
SMG1, SMG5, SMG6, SMG7,
PP2, Musashi, PABP1

eRF1 (AGAP010310), eRF3
(AGAP009310), UPF1 (AGAP001133),
UPF2 (AGAP000337), UPF3
(AGAP006649), eIF4AIII
(AGAP003089), Y14
(AGAP006365)/MAGOH
(AGAP010755), SMG1(AGAP000368),
SMG5 (AGAP008181), SMG6
(AGAP000894), PP2A (AGAP004096),
Musashi (AGAP001930)

UPF1 (PF3D7_1005500), UPF2
(PF3D7_0925800), UPF3B
(PF3D7_1327700), eIF4AIII
(PF3D7_0422700) PF3D7_1327700),
PP2A(PF3D7_0925400 – KEGG,
PF3D7_1319700 – Hs homology, or
PF3D7_0927700 – name), Musashi
(PF3D7_0916700), PABP1
(PF3D7_1224300), eRF1
(PF3D7_0212300), eRF3
(PF3D7_1123400)

NGD/NSD

Pelota/HBS1L, RACK1,
ZNF598, N4BP2 (Cue2)

Pelota (AGAP008269), HBS1L
(AGAP002603), RACK1 (AGAP010173),
ZNF598 homolog (AGAP007725),
N4BP2 homolog (AGAP002516)

Pelota (PF3D7_0722100), RACK1
(PF3D7_0826700), ZNF598
(PF3D7_1450400)

CNOT4, ABCE1, TRIP4,
ASCC2, ASCC3, NEMF,
Listerin, UBE2D1, XRN1

CNOT4, ABCE1 (AGAP002182), ASCC2
homolog (AGAP000428), ASCC3
(AGAP001234), NEMF homolog
(AGAP002680), Ltn1 (AGAP007143),
UBE2D1 homolog (AGAP000145),
XRN1

ABCE1 (PF3D7_1368200), NEMF
homolog (PF3D7_1202600), Listerin
homolog (PF3D7_0615600), CNOT4
(PF3D7_1235300), ASCC3 homolog
(PF3D7_1439100), UBE2D1 homolog
(PF3D7_1203900) XRN1
(PF3D7_0909400)

RQC

Factors associated with NMD, NGD/NSD, and RQC pathways from the literature and KEGG pathway database in human cells
were collected176. Homologs in A. gambiae, one of the most common and effected vectors of P. falciparum177–179, were collected
using KEGG pathways and performing protein-BLAST searching using VectorBase. Confirmation to FlyBase was also used to
confirm vague annotations. P. falciparum factors were similarly documented again using KEGG pathways and PlasmoDB
protein-BLAST analysis154,176,180. Homologous gene database IDs are listed for reference. Notably, NGD/NSD factors Hbs1L and
Cue2 endonuclease are missing in P. falciparum genome.
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The majority of mRNA surveillance pathway genes have been annotated in the P. falciparum
genome (TABLE 1.3)87. However, there are no mechanistic studies to confirm the activity of
these pathways. Most of our knowledge on Plasmodium’s mRNA surveillance pathways comes
from bioinformatic searches using homologous sequences from other eukaryotes. An indirect
proof of the existence of NMD in Plasmodium is through the studies of alternative splicing of
pre-mRNA88,172. Regulated alternative splicing events generating transcripts that do not lead to
apparent protein synthesis usually carry PTCs, and thus are committed to NMD. Alternative
splicing in P. falciparum has been reported for several genes like delta-aminolevulinic acid
dehydratase (ALAD), stromal processing peptidase (SPP), and chloroquine resistance
transporter (PfCRT); among the others. Additionally, studies on the essentiality of Plasmodium
genes that use the CRISPR/Cas9 technique181 or transposon techniques182 rely partially on
silencing targeted genes through the activation of NMD. In this case, activation of NMD is the
consequence of either mutations that are generated during CRISPR/Cas9 DNA cleavage,
transposon insertion in the coding sequence, or due to aberrant splicing events caused by
transposons landing in introns of targeted genes. As noted above, more than 60% of the P.
falciparum transcripts harbor polyA track motifs that are seen as mRNA “slippery” sequences
during translation103,104. Translation of runs of poly-adenosine nucleotides results in ribosomal
frameshifting in most tested organisms causing activation of NMD pathways43,47. However,
ribosome profiling89,170 and reporter assays104 indicate that P. falciparum ribosomes maintain
fidelity during translation of rather long polyA stretches (more than 36As in a row). Therefore,
while there is indirect evidence that the NMD pathway exists in Plasmodium, it seems that this
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pathway is not upregulated during Plasmodium ribosomes’ interactions with its polyA runs and
AU- rich coding sequences. The most probable reason for this is the above-mentioned changes
in ribosome structure and fidelity.
Genomic sequencing has also revealed several critical components of surveillance pathways
that are missing. According to NCBI, KEGG, and plasmoDB databases, P. falciparum and the
majority of other Plasmodium spp. lack the NGD and NSD decay pathways components Hbs156
and Cue2-RNA endonuclease54. With the exception of S. cerevisiae, the Hbs1/Pelo protein
complex rescues stalled ribosomes on mRNAs. It was postulated that stalling events cause
ribosome collisions48, generating unique disome units consisting of the stalled ribosome and
the following colliding ribosome (Beckman and Inada). The disome, as a minimal ribosome
collision unit, is recognized by Ribosome-associated Quality Control (RQC) and NGD
pathways58,68,79,174,183. Activation of RQC and NGD leads to cleavage of stalled mRNA by Cue2,
and possibly other unknown endonucleases, which ultimately leads to ribosome rescue by the
activity of the Pelo/Hbs1 complex58,76,175,183,184. In most of the above mentioned RQC and NGD
studies, a typical substrate for ribosomal stalling is a long polyA run, ranging from 36 to 60
adenosines, coding for a peptide with 12– 20 consecutive lysine residues. However, long polyA
stretches in P. falciparum cells are efficiently translated into poly-lysine repeats89,170. Of note,
the longest endogenous polyA runs in different P. falciparum species range from 88 to 111
nucleotides and code for Plasmodium specific and hypothetical proteins103, which is longer than
the length of the normal 3ʹ polyA tail in either S. cerevisiae or human cells185–187. As such, many
endogenous Plasmodium transcripts would be NSD targets in other eukaryotic organisms. It is
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also a question as to what the signal for NSD pathway is in Plasmodium as recent study on 3ʹ
mRNA polyadenylation in apicomplexans did not find any differences in P. falciparum
polyadenylation complex, polyA binding proteins, or polyA tails when compared to other
species176,188. Because Plasmodium lacks the components to rescue stalled ribosomes, and
because Plasmodium ribosomes efficiently translate long polyA runs, the function and
mechanism of the NGD/NSD pathway in P. falciparum remains a mystery.

1.4.7 Conclusion
While it may seem reasonable that P. falciparum adapted its ribosomes for higher fidelity on
polyA runs and in parallel lost the ability to activate the RQC/NGD/NSD pathways, such a
scenario is far from obvious. The absence of mRNA surveillance pathway components or
deletion of RQC factors leads to both protein aggregation and proteotoxic stress in yeast
cells189–191. Protein aggregation is observed in P. falciparum in the absence of heat shock
protein 110192 but not due to the absence of mRNA surveillance or RQC pathways or as a
consequence of increase in both number or length of polyA tracks104. This conflicting result,
along with the surprising lack of interaction between the ribosomal scaffold protein
RACK1/Asc1 and Plasmodium ribosomes158,159, argue that the mRNA surveillance pathways in P.
falciparum are inherently different from those in other eukaryotes. The diversity of rRNAs,
Plasmodium’s ribosome structure, and the activity of yet unknown ribosome associated factors
promote the possibility of “specialized ribosomes” in Plasmodium that allow for polyA tracks
translation into functional proteins. Each of the aforementioned changes in parasites
translational machinery and mRNA quality control pathways come at the cost of self-fitness
35

that would normally be detrimental for survival of Plasmodium parasites in both humans and
mosquitos. And yet the parasite has persisted in both of these hosts for hundreds of millions of
years. Parasitologists and epidemiologists have wondered “How?” for decades; now as
translational biologists, we add our voices to the same question.

1.5 Summary
The maintenance, replication, and conversion of genetic information is vital to eukaryotic
survival. A significant amount of effort is involved in regulating these processes for not only
their faithful execution, but also necessary spatial and temporal aspects. This work examines
mechanisms of post-transcriptional regulation, specifically those requiring active translation by
the ribosome, in the context of the stall-inducing, intragenic polyA motif.
P. falciparum has over 5,000 genes, with the potential for ≥60% having stall-inducing, intragenic
polyA motifs. Previous work has shown that polyA motifs cause stalling and frameshifting,
resulting in the recruitment of various quality control factors that subsequently degrade the
mRNA, nascent protein, and, in some cases, the rRNA. However, this is not the case in P.
falciparum. Therefore, how the parasite is able to express most of its genome remains an
important question from both basic and clinical biology perspectives. In particular, is this ability
RNA-mediated, protein-mediated, RQC-pathway alteration-mediated, or a combination
thereof? Here, I report on the likelihood that a combination of these factors is at the root of
this genus-associated ability.
The work in Chapter 2 highlights the ability of P. falciparum to translate polyA tracks, without
stalling or losing frame, in reporter constructs compared to the human host and the AT-rich
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organism Tetrahymena thermophila, as well as endogenous genes. These motifs are also shown
to be conserved throughout the Plasmodium genus. Interestingly this increased transcriptome
AU-richness does not show any increased propensity for structure in the RNA. The ability to
translate lengthy polyA stretches also poses a problem for the ribosome. Increased lengths of
polylysine amino acids also cause ribosome stalling through peptide exit channel electrostatic
interactions and bulky residue clashing in the peptide transferase center. However, changes to
the peptide exit channel of the parasite ribosomes demonstrate translation machinery
modifications that would condone polylysine stretches.
In Chapter 3, I adapted RNA immunoprecipitation methods for P. falciparum. This method uses
the MS2 and PP7 bacteriophage cap proteins to tag rRNAs and mRNAs, respectively. This
method allows for the enrichment of the different rRNA types for further examinations. It also
enables the isolation of reporter constructs and subsequent analysis of their bound proteome
in a context-dependent fashion, which can differ depending on differing RNA motifs.
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In Chapter 4, I examine the binding of RACK1 in P. falciparum. Previous structural data has
suggested that RACK1 does not bind the ribosome. However, given is vital roles in translation
and ribosome-associated quality control, how the parasite is able to efficiently translate its
mRNA or handle problematic RNAs without any RACK1 interaction suggests a more nuanced
modification than the bound/unbound binary. Lastly, in Chapter 5, I discuss the potential future
directions of this work, examining vital open questions regarding protein synthesis, ribosomeassociated quality control, as well as the still-perplexing topic of ribosome switching in P.
falciparum.
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2.1 Abstract
Plasmodium falciparum is a causative agent of human malaria. Sixty percent of mRNAs from its
extremely AT-rich (81%) genome harbor long polyadenosine (polyA) runs within their ORFs,
distinguishing the parasite from its hosts and other sequenced organisms. Recent studies
indicate polyA runs cause ribosome stalling and frameshifting, triggering mRNA surveillance
pathways and attenuating protein synthesis. Here, we show that P. falciparum is an exception
to this rule. We demonstrate that both endogenous genes and reporter sequences containing
long polyA runs are efficiently and accurately translated in P. falciparum cells. We show that
polyA runs do not elicit any response from No Go Decay (NGD) or result in the production of
frameshifted proteins. This is in stark contrast to what we observe in human cells or T.
thermophila, an organism with similar AT- content. Finally, using stalling reporters we show that
Plasmodium cells evolved not to have a fully functional NGD pathway

2.2 Introduction
The complex life cycle of Plasmodium falciparum, responsible for 90% of all malaria-associated
deaths, involves multiple stages in both the human and mosquito hosts. Asexual replication
during the intraerythrocytic development cycle (IDC) is tightly regulated over a 48 hr period,
involving the expression of the majority of its genes2–4. Progression through asexual stages
(ring, trophozoite, schizont) of the IDC requires a strictly controlled panel of gene expression
profiles for each stage. A range of 16–32 daughter cells results from the IDC. Thus, a single,
originating merozoite must undergo several rounds of DNA synthesis, mitosis, and nuclear
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division in a relatively short period2–4. The apparent necessity for rapid and accurate DNA
replication needs to be accompanied by large-scale RNA transcription and protein synthesis.
These processes occur during the 24 hr of the trophozoite stage before erythrocytic schizogeny
and cytokinesis. Recent saturation-level mutagenesis of the P. falciparum genome further
emphasized and demonstrated that genes associated with cell cycle control, translation, RNA
metabolism, protein folding, and drug resistance are more likely to be essential for parasites
fitness and survival5. However, a faithful execution of these fundamental processes is
challenged by the extremely AT-rich P. falciparum genome: averaging ~81% in overall AT
content. With a relatively small difference in AT-richness between the non-coding and coding
regions; P. falciparum represents a unique case from other AT-rich organisms6–9. While the
underlying reasons for such disproportionate representation of the four nucleotides in any
given genome may be different, it is of vital importance that shifts towards extreme AT- or GCrichness must be accommodated by adaptation of the transcription and translation
apparatuses; enabling the cell to transcribe and translate each gene appropriately.
Recently, it was demonstrated that the translation of genes with polyadenosine runs (polyA
tracts), primarily coding for lysine residues, is attenuated in the majority of tested organisms
presumably due to ribosomal stalling and frameshifting on such RNA motifs by action of
ribosome-quality control complex (RQC) and mRNA surveillance mechanisms10–22. In human
tissue cultures, the presence of just 12 adenosines in an mRNA-coding region was found to
reduce the yield of protein synthesis by more than 40%, and runs of 30–60 adenosine
nucleotides reduce protein synthesis by more than 90%11,15,20. This effect on translation was
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observed in all tested organisms that include fruit flies (Drosophila melanogaster), yeasts
(Saccharomyces cerevisiae and Candida albicans), plants (Arabidopsis thaliana and Nicotiana
benthamiana) and E. coli8,11,13,17,21,22; arguing for a universal response to coding polyA repeats.
The consequence of translational arrest or slippage on polyA runs is the activation of RQC and
one or more mRNA surveillance mechanisms, mainly No-Go (NGD) and Non-sense Mediated
Decay (NMD)16. High AU-content within transcript coding regions and an extreme AAA and AAU
codon bias increase the propensity for polyA tracts in the P. falciparum transcriptome23.
Additionally, a ‘just-in-time’ transcriptional and translational model of gene expression during
the relatively short trophozoite stage of the P. falciparum IDC3,24 make a rapid protein synthesis
in an AU-rich transcriptome an appealing problem. While both, DNA and RNA polymerases
must contend with high DNA AT-content, it is also puzzling what adaptations P. falciparum have
made to its translational machinery to overcome the unusual AU-richness of mRNAs, which
would affect the fidelity and efficacy of protein synthesis. With ‘just-in-time’ translation of
numerous A-rich coding sequences7,9 and poly-lysine proteins harboring an AAA codon bias,
expressed at all stages in the parasite life cycle3,4,25, the Plasmodium translation machinery
would represent an exception in protein synthesis compared to other organisms.
Here we present data that indicate that the P. falciparum translational machinery and its NGD
pathway have adapted to translate long runs of polyadenosine nucleotides into poly-lysine
repeats. Using comparative bioinformatic analyses, we show that malaria parasites contain an
unusually high numbers of polyA-tract-containing genes compared to other eukaryotic
organisms. We find this to be a common feature of all analyzed Plasmodium species regardless
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of their AT-content, arguing for evolutionary conservation of such sequences in Plasmodium
genomes. Expression of endogenous genes and reporters with polyA tract motifs in P.
falciparum cells results in efficient and accurate protein synthesis in direct contrast to what we
observe for human-tissue cultures and T. thermophila cells. We find no evidence for either
ribosomal stalling or frameshifting during the translation of long polyadenosine runs in P.
falciparum cells. Interestingly, induction of the NGD pathway by either reporter with stable RNA
structure or isoleucine starvation results in reduced reporter protein levels but without any
detectable changes in mRNA levels, arguing for alterations in the NGD pathway. Finally, our
analysis of P. falciparum ribosome structure suggests a model whereby multiple changes may
have evolved to accommodate the unusual AU-richness and high percentage of poly-lysine runs
of the P. falciparum transcriptome and proteome, respectively.

2.3 Results
2.3.1 Plasmodium species: A paradigm-breaking genus.
Previous studies indicated that polyA runs in the coding sequences serve as hurdles to
translation10,11,15,16,18–22,26 that efficiently reduce protein yield and initiate NGD to degrade the
mRNA. Given the very high AT-content in certain eukaryotic species6 we sought to explore the
association between coding region AT-content and transcript polyA-tract-motif abundance. In
doing so, we analyzed 152 eukaryotic genomes (FIGURE 2.1A). We focused on stretches of
polyadenosine nucleotides, or as defined previously 12A-1 motifs; sequences with a minimal
length of 12 A’s allowing for one mismatched base11. We settled on 12A-1 sequence pattern
since the presence of this motif reduces protein production by 40–60% in multiple human
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genes11,13,15. Subsequent analyses indicated that the reduction in protein amounts for genes
with 12A-1 motif could be attributed to ribosome stalling and frameshifting15,17. Analyses of the
selected set of eukaryotic genomes indicate that P. falciparum and other members of the
Plasmodium genus have a much higher ratio of polyA tract genes when normalized to genomic
AT-content (FIGURE 2.1A).
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FIGURE 2.1 | Bioinformatic analysis of transcriptome polyA motifs. (A) The plot of 152 species representing a comparison of the
ratio of polyA-affected transcripts (over a total number of transcripts) to the AT content of the coding region for each organism.
H. sapiens, T. thermophila, and P. falciparum, as organisms pertinent to this paper are in black. For reference, other model
organisms of interest are displayed in gray, including a position of high (65% average) and low (35%) AT-content Plasmodium spp.
(B) Transcript counts for genes with 6 to 36 consecutive adenosines for H. sapiens, T. thermophila, and P. falciparum. H. sapiens
and T. thermophila are limited to a single transcript at length of ≤17 As. The longest P. falciparum 3D7 transcript reaches maximal
65As, with multiple transcripts of ≤36 As. (C) Violin plot of lysine codon usage distribution in tracts of four lysine residues for 152
organisms. 3AAG+1AAA, 2AAG+2AAA and 1AAG+3AAA indicate different ratios of AAG and AAA codons in runs of four
consecutive lysine codons. 4AAG and 4AAA indicate poly-lysine runs with only AAG or AAA codons, respectively. H. sapiens (circle),
T. thermophila (triangle), and P. falciparum (square) are specifically noted.
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Interestingly, this feature of Plasmodium species is conserved regardless of their genomic ATcontent, resulting in two groups (LOW AND HIGH AT-CONTENT PLASMODIUM SPP.) with unusually large
portions of polyA tract genes ranging from 35 to over 65% of the total transcriptome (FIGURE
2.1A)9. These two groups, which also appear to be separated geographically, demonstrate that
even with a reduction in genomic AT-content, selective pressure exists for Plasmodium spp. to
maintain polyA tract motifs. However, regardless of a selective reduction of AT-content in some
Plasmodium species, or an almost complete lack thereof in the case of avian Plasmodium
counterparts27, the trend of harboring a high ratio of polyA-affected transcripts given a
particular AT-richness, as well as their conservation within a significant number of genes across
species, remains a paradigm-breaking hallmark of the genus.
To further emphasize the differences between P. falciparum and other organisms, we analyzed
the number of genes that harbor polyA runs as well as the total length of consecutive
adenosine nucleotides in transcripts (SUPPLEMENTAL FIGURE 2.1 AND FIGURE 2.1B, RESPECTIVELY). P.
falciparum showed a significantly higher amount of genes with polyA runs of ≥12 A’s in a row
when compared with its human and mosquito (Anopheles gambiae) hosts (SUPPLEMENTAL FIGURE
2.1). Over 63% of genes in P. falciparum have polyA tract motifs, while only 0.7–2% of total
genes in humans and mosquito genomes, respectively, contain these motifs. We used the most
recently updated Ensembl database to look into coding sequences of lab strain of malaria P.
falciparum 3D7, H. sapiens, and T. thermophila28. While there is already a significant difference
in the number of genes with eleven consecutive adenosines (P. falciparum 3D7 - 1555, T.
thermophila - 364 and H. sapiens - 77 genes), the most striking sequence difference is
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associated with 16 consecutive adenosines (16As). The P. falciparum 3D7 genome contains 188
genes with 16As, while the human host and AT-rich T. thermophila together have only three
genes (T. thermophila two and H. sapiens 1) (FIGURE 2.1B). Additionally, T. thermophila a
protozoan with an overall 73% AT-rich genome and 24,000 predicted genes, had almost nine
times less genes with twelve consecutive adenosines than P. falciparum, 172 and 1526,
respectively. Ensembl database reports 105 P. falciparum 3D7 genes with exactly 18As and
more than 150 genes with more than 20 consecutive adenosines (20-65AS, FIGURE 2.1B).
Analyses of P. falciparum genomes in the PlasmoDB database29, curated explicitly for malaria
parasite species, report more than double that number with 329 genes having runs of ≥20
consecutive adenosines. Most of these genes appear to be annotated as Plasmodium specific.
However, PlasmoDB also shows genes with up to 59 consecutive adenosines in conserved
pathways, such as the phosphatidylinositol-4-phosphate 5-kinase gene (PfML01_010014200),
which is involved in the inositol metabolism and signaling pathways30. Finally, the maximum
length of consecutive adenosine runs in coding sequences of Plasmodium genomes indicated
111 As in P. falciparum fch four strain with the human host or 132 As in P. reichenowi, strain
causing chimpanzee malaria9,31. As such, the length of polyA runs in coding sequences of
malaria parasites exceeds the length of the average size of 3’UTR polyA tails found on the
majority of transcripts in eukaryotic species32–34. Translation of 3’UTR located polyA tail in
eukaryotic organism activates yet another mRNA surveillance pathway - non-stop decay
(NSD)12,14,35.
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The disparity in the number of genes with polyA tracts could be due to previously observed
codon biases in P. falciparum23. However, it was already shown that codon bias and tRNA
abundance do not correlate with codon selection in genes coding for lysine repeats11,17. The
poly-lysine repeats in proteins of the analyzed model organisms are usually encoded by AAG
codons. To investigate the distribution of AAA and AAG codons in poly-lysine tracts in more
detail, we analyzed transcripts from P. falciparum and 152 other eukaryotic genomes (FIGURE
2.1C). We observed a complete reversal of the trend exhibited in other organisms, including
humans and the AT-rich T. thermophila. P. falciparum had the highest abundance of transcripts
hosting four consecutive AAA codons in runs of four lysine residues (FIGURE 2.1C). This
divergence from other analyzed transcriptomes is preserved in other members of Plasmodium
spp., with P. berghei being an extreme example using only AAA codons in 68% of transcripts
coding for poly-lysine runs. Finally, we analyzed the biological function and essentiality of the
polyA tract and poly-lysine containing genes in P. falciparum genome. Previous analysis
indicated that 70–85% of orthologs of polyA tract carrying genes from P. falciparum have the
same polyA motifs in genes from other Plasmodium species, regardless of their genomic AT
content31. The high degree of the conservation of polyA tracts has also been noted for other
eukaryotic organisms11. A majority of Plasmodium polyA tracts genes and poly-lysine proteins
fall into the group of essential genes based on the recent mutagenesis studies5. This outcome is
expected given that gene ontology results indicate enrichment in gene products involved in
crucial cellular processes such as protein synthesis, RNA biogenesis, and chromosome
segregation. The same gene ontology groups were previously observed in poly-lysine repeats
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and polyA tract genes of the other organisms11. In addition to these groups, Plasmodium
species also had enrichment of polyA tract motifs in a group of genes defined as the cellular and
pathological cell adhesion ontology group (SUPPLEMENTAL TABLE 2.1). As such, our overall
bioinformatic analyses demonstrate that Plasmodium genomes represent a unique set of
organisms that have an enrichment of polyA tracts in the coding sequences. The overall
conservation of both polyA tracts in the transcriptome and poly-lysine repeats in the proteome
of P. falciparum has been evolutionary selected and conserved due to possible benefits for the
parasite.
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2.3.2 Reporters
with polyA track are not a problem for P. falciparum
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Figure 2. P. falciparum cells express reporters with long polyA71
tracts. (A) mRNA abundance of reporter constructs (+polyA36) by qRT-PCR relative to
their counterpart lacking polyA stretches (-polyA36) in H. sapiens, T. thermophila, and P. falciparum cells. Data represent three biological replicates with
a standard deviation. (B) Expression of reporter constructs in H. sapiens, T. thermophila, and P. falciparum followed by western blot analysis with aHA
or aGFP antisera. Samples from two integrated clones for the -polyA36 control (-A) and the +polyA36 reporter (+A) are shown for T. thermophila. abFigure 2 continued on next page
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FIGURE 2.2 | Expression analysis of ±polyA reporter constructs in H. sapiens, T. thermophila, and P. falciparum. (A) mRNA
abundance of reporter constructs (+polyA36) by qRT-PCR relative to their counterpart lacking polyA stretches (-polyA36) in H.
sapiens, T. thermophila, and P. falciparum cells. Data represent three biological replicates with a standard deviation. (B)
Expression of reporter constructs in H. sapiens, T. thermophila, and P. falciparum followed by western blot analysis with aHA or
aGFP antisera. Samples from two integrated clones for the -polyA36 control (-A) and the +polyA36 reporter (+A) are shown for T.
thermophila. αβ-actin, α-Histone H3 trimethyl-lysine (H3kM) and α-hDHFR are used as loading controls for western blot analysis
from H. sapiens, T. thermophila and P. falciparum cells, respectively. (C) Images from live fluorescence microscopy of P. falciparum
expression of reporter constructs with (+polyA36) and without (-polyA36) polyA tracts as well as parent (non- transfected) line,
2.5 mm scale bar. (D) Quantification of protein amounts for Thioredoxin-2HA-NanoLuciferase (Trx-2HA-NLuc) reporter without (polyA36) and with 36 adenosine stretch (+polyA36) expressed in P. falciparum cells. Western blot analysis of Trx-2HA-NLuc
reporter (SUPPLEMENTAL FIGURE 2.3) and luminescence measurements were normalized to hDHFR or cell number, respectively.
Luminescence data represent the mean value of three biological replicates with standard deviation.

As mentioned earlier, polyA tracts and poly-lysine repeats cause a reduction in mRNA stability
and protein amounts, respectively, due to the ribosomal stalling and frameshifting on such
motifs10,11,14–22. To investigate further how the AU-rich P. falciparum transcriptome with
multiple polyA tracts gets effectively translated, we used double HA-tagged reporter constructs.
The 36 adenosine nucleotide (36 As) insertion, coding for 12 lysine residues, was inserted
between the sequence of double HA-tag and a fluorescent protein (+POLYA36, SUPPLEMENTAL
FIGURE 2.2). As a control, we used a reporter that had only double HA-tag in front of the
fluorescent-protein sequence (-POLYA36, SUPPLEMENTAL FIGURE 2.2). We expressed our reporter
constructs from plasmid vectors in the P. falciparum Dd2 lab strain. In parallel, we expressed
the same constructs in human dermal fibroblasts (HDFs) and T. thermophila cells (FIGURE 2.2A–
B). We followed mRNA abundance of each construct by qRT-PCR (FIGURE 2.2A), and expression
of the reporter protein was followed by western blot detection of the double HA-tag in all three
organisms (FIGURE 2.2B). We observed robust changes in normalized mRNA levels (FIGURE 2.2A)
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and substantial losses in protein expression (FIGURE 2.2B) for reporters with polyA tracts
(+POLYA36) in both HDFs and AT-rich T. thermophila15,16. In comparison to HDFs and T.
thermophila, we observed minimal, if any, effects from polyA tract insertion on reporter mRNA
and protein expression in P. falciparum cells (FIGURE 2.2A–B). Further analysis of P. falciparum
cells by live-fluorescence microscopy confirms the equivalent expression of mCherry reporter,
judging by the intensity of fluorescence between constructs with and without polyA tract
(+POLYA36 AND -POLYA36, FIGURE 2.2C).
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Figure 3. Poly-A tracts are correctly translated in P. falciparum cells. (A) 2D gel analysis of HA-IP samples of wild type reporter (-polyA ). The western

36
FIGURE 2.3 | Analysis of ±polyA
protein expression in P. falciparum by 2D gel electrophoresis. (A) 2D gel analysis of HA-IP samples
blots show isoelectric point (pI) at 6.25 and 6.5 (arrows). (B) 2D gel of reporter with polyA tract (+polyA ) sample indicates pI 7.25 and 7.4 (arrows).( C)
36

2D gel analyses of reporter with twelve lysines coded by AAG codons (12 x AAG) indicates the same effect on pI value, pI is 7.25 and 7.4 (arrows).
of wild type reporter (-polyA36).
The western blots show isoelectric point (pI) at 6.25 and 6.5 (arrows). (B) 2D gel of reporter with

Overlay of images of PVDF membranes stained with Coomassie Brilliant Blue, and images of western blots probed with HA-antibody. The scale with pH

Figure
3 continued
on next
page
polyA tract (+polyA36) sample
indicates
pI 7.25
and
7.4 (arrows). (C) 2D gel analyses of reporter with twelve lysines coded by AAG

codons (12 x AAG) indicates the same effect on pI value, pI is 7.25 and 7.4 (arrows). Overlay of images of PVDF membranes stained
Pavlovic Djuranovic et al. eLife 2020;9:e57799. DOI: https://doi.org/10.7554/eLife.57799

with Coomassie Brilliant Blue, and images of western blots probed with HA-antibody. The scale with pH is on the bottom.
Coomassie-stained membranes show markers (right side) and tropomyosin (33 kDa) and pI at 5.2 (arrow) as an internal standard
for Isoelectric focusing (IEF).
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To assess whether the efficiency of protein synthesis is altered when the polyA tract is located
further downstream of the start codon, we designed a construct with thioredoxin (Trx) and
nano-luciferase (nanoluc) proteins separated with a double HA-tag and 36As coding for a polylysine run (SUPPLEMENTAL FIGURE 2.3). Measurement of nanoluc luminescence from the same
number of drug-selected parasites indicates similar expression of a reporter with a polyA tract
(+POLYA36) compared with the control reporter (-POLYA36, FIGURE 2.2D). We observed the same
ratio when we analyzed the expression of reporters using western blot analysis (FIGURE 2.2D
and SUPPLEMENTAL FIGURE 2.3), arguing that the position of polyA tracts in coding sequence does
not influence the efficiency of protein synthesis in P. falciparum cells.
Since polyA tracts cause ribosomal frameshifting11,17,20 we analyzed the expression of our
nanoluc and fluorescent reporters for the possible presence of frameshifted protein products.
Western blot analyses of nanoluc reporters did not indicate the HA-tagged protein band at
14kD that would represent frameshifted nanoluc (SUPPLEMENTAL FIGURE 2.3). Moreover, the
immunoprecipitation of mCherry reporters showed only equivalent amounts of the full-length
product (SUPPLEMENTAL FIGURE 2.4). There is a still possibility that ribosomal frameshifting
occurred in polyA tract reporters, but the protein product was unstable in P. falciparum cells,
and we failed to detect it. However, if such frameshifting events did happen, they did not
reduce overall levels of the full-length protein. Finally, to check whether polyA tract constructs
resulted in the synthesis of poly-lysine peptides, we analyzed all constructs using 2D PAGE
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electrophoresis (FIGURE 2.3). This analysis indicated a shift in isoelectric point (pI) of
approximately one pH unit for the (+POLYA36) construct compared to the wild-type one
(-POLYA36), 7.2–7.4 and 6.25–6.5, respectively. This shift on the 2D PAGE gels was the same for
construct with 12xAAG lysine codons and is expected based on the calculated isoelectric points
if all 12xAAA or 12xAAG codons were translated into lysine residues. Taken together, our
analyses of different reporter expression data (FIGURES 2.2–2.3, SUPPLEMENTAL FIGURES 2.3–2.4)
indicates that polyA tracts are tolerated by the parasite translational machinery, without
apparent effects on either stability of mRNA or quality of synthesized protein.

2.3.3 Endogenous polyA tract genes are efficiently expressed in P. falciparum
Due to the potential for negative selection against polyA tracts36, particularly in laboratory
conditions, we also wanted to investigate how P. falciparum translates endogenous genes with
polyA tracts. With as much as 60% of the parasite transcriptome harboring polyA tract motifs,
we performed a comparative analysis of ribosome profiling data from P. falciparum4 and
aggregated data for human tissues conveniently harmonized at GWIPS database37. We analyzed
whether endogenous polyA tracts and poly-lysine sequences induce translational pausing in
both sets of data. Ribosome stalling can be observed in the ribosome profiling data as an
increase in the abundance of ribosome footprints on sequences that cause ribosomes to pause
during translation38. Cumulative data for all transcripts with polyA tracts from human cells
indicates substantial translational pausing on these sequences (FIGURE 2.4A). The same effect
was noted on poly-lysine sequences that contained more than four consecutive lysine residues
in multiple other studies using S. cerevisiae ribosome profiling datasets with- out cycloheximide
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treatment or datasets from human tissue cultures regardless of cycloheximide treatment11,39–41.
However, analyses of previously published P. falciparum ribosome profiling dataset4 indicated
no evidence for ribosome stalling in P. falciparum transcripts containing polyA tracts.
Normalized ribosome occupancy for P. falciparum transcripts with a length of less than or equal
to 22 consecutive adenosine nucleotides (≤22 As), that code for more than seven consecutive
lysines, indicated more or less equal ribosome occupancy over polyA tract (FIGURE 2.4B). We
limited our ribosome profiling analyses of P. falciparum transcripts to polyA tracts of ≤22 As,
since the cumulative transcript analyses become hindered by the low sequence complexity of
the region, or reduced number of reads, for the long polyA tracts (SUPPLEMENTAL FIGURE 2.5). As
such, the dip in P. falciparum occupancy plot is a result of a reads mapping artifacts. The longer
the polyA segment, the harder it is to uniquely map a read – typically such reads are discarded.
This artifact is clearly seen in the SUPPLEMENTAL FIGURE 2.5, where the occupancy is shown per
length of polyA segment – the larger polyA track, the larger symmetrical gap around position 0.
The correlation holds true to about 30 nt, which is the read length in the original experiment by
Caro et al., 2014.
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Figure 4. Occupancy of elongating ribosomes (mapped to A-site) around the start of polyA segments in human (A) and P. falciparum (B). Occupancy is
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same scale. In both cases, to avoid the inclusion of sparsely mapped segments, regions with average occupancy below the mean
for the whole dataset were excluded. In the case of P. falciparum gene segments with polyA tracts shorter than 22 adenosine
Pavlovic Djuranovic et al. eLife 2020;9:e57799. DOI: https://doi.org/10.7554/eLife.57799
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nucleotides were taken into account. Centerlines show the medians; box limits indicate the 25th and 75th percentiles; whiskers
extend 1.5 times the interquartile range from the 25th and 75th percentiles. Dip in around position 0 in the P. falciparum plot is
an artifact of the reads mapping procedure shown in SUPPLEMENTAL FIGURE 2.5. It is not observed in human data, because of shorter
polyA segments and lower occupancy overall around these segments.
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Since there is a massive increase in protein synthesis in P. falciparum cells during the
trophozoite and schizont stage of IDC4,25 we analyzed whether there is a different distribution
of ribosome profiling reads surrounding polyA tracts at different stages of P. falciparum
development. We found that the translation of endogenous polyA tracts is independent of
different stages of P. falciparum IDC, as we did not notice any significant difference in the
distribution of ribosome protected fragments (SUPPLEMENTAL FIGURE 2.6) and ostensibly
irrespective of the length of polyA tracts or poly-lysine runs. While we observe a relatively small
increase in the number of elongating ribosomes on polyA segments in the late trophozoite and
schizont stages of IDC (SUPPLEMENTAL FIGURE 2.6), it is unclear if these indicate higher protein
expression or are just an artifact of a general increase in protein synthesis at this IDC stages.
In parallel with analyses of ribosome profiling data, we also selected a small subset of polyA
tract-containing genes for independent expression analysis. We followed PfGAPDH
(PF3D7_1462800) as a control gene without polyA tract, and PfZFP (PF3D7_1464200 (three
polyA tracts and run of 20 consecutive adenosines), PfCRK5 - PF3D7_0615500 (four polyA tracts
and run of 20As) and PfIWS1L - PF3D7_1108000 (three polyA tracts and run of 31As), to
represent genes with polyA tracts (SUPPLEMENTAL FIGURE 2.7). PfZFP is a zinc-binding protein with
homology to the human ZC3H6 gene (Zinc Finger CCCH Domain-Containing Protein 6), PfCRK5 is
cdc2-related protein kinase five and PfIWS1L is transcription elongation factor associated with
RNA Polymerase II. We used a sorbitol-based method to synchronize P. falciparum Dd2 strain at
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the ring stage of IDC and followed transcript profiles over the next 48 hr of the parasite life
cycle. The mRNA profiles of three polyA tract genes were analyzed using qRT-PCR and
normalized to the expression of PfGAPDH in P. falciparum Dd2 lab strain. A time-course study
of synchronized parasite culture indicated that the selected polyA tract transcripts are
efficiently transcribed at all-time points when compared to the control gene (SUPPLEMENTAL
FIGURE 2.8). Moreover, the increase in transcription of all three polyA tract genes followed
previously described just-in-time transcription profile in trophozoite and schizont IDC stage of
P. falciparum.
Finally, mRNA translation could also be affected by the ability of RNA to fold into unique
functional structures; for example RNA secondary structures have been shown to coordinate
ribosomal frameshifting42,43, slow ribosomal progression to allow protein folding44 and to affect
ribosomal density45,46. To determine the RNA structural characteristics of the P. falciparum
transcriptome, we analyzed the ability of all coding sequences to form thermodynamically
stable RNA secondary structures using an in silico approach to characterize RNA folding
landscapes46,47. We compared the relative structural stability of the P. falciparum transcriptome
to that of humans and the AU-rich T. thermophila. On average, the coding sequences from T.
thermophila and P. falciparum yielded structures with higher predicted minimum free energy
(MFE; SUPPLEMENTAL FIGURE 2.9), than those from the coding sequences of human genes; a result
which mostly correlates with the higher overall AU-content of P. falciparum and T. thermophila
transcripts. In this analysis, each MFE is also characterized by a thermodynamic z-score (SEE
MATERIALS AND METHODS). The thermodynamic z-score normalizes for nucleotide content and
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suggests whether sequences may form potentially functional structures48. Specifically, the
thermodynamic z-score indicates whether a nucleotide sequence has been ordered to adopt a
more stable secondary structure than its nucleotide content would typically produce48 (which is
the case for many ncRNAs49 as well as RNA regulatory structures embedded in mRNAs50,51).
Interestingly, transcriptome z-scores revealed no significant differences between P. falciparum
and T. thermophila (SUPPLEMENTAL FIGURE 2.9). This result indicates that while RNA folding
stability varies between species, following from skews in nucleotide content, the potential
occurrence of ordered, structured motifs does not. This suggests that globally, P. falciparum
coding sequences do not appear ordered to adopt structures any more stable than would be
expected for random sequences or with the same nucleotide content found in T. thermophila.
However, expression of reporters with polyA-tracts in T. thermophila is strongly attenuated
(FIGURE 2.2). This computational effort does not take into account the most recent work
describing the m6A mRNA methylation dynamics within P. falciparum coding sequences52. The
m6A modification may impact RNA structure and association of P. falciparum mRNAs with
certain RNA binding proteins53. However, previous work has demonstrated that m6A
methylation does not affect the ability of the ribosome to decode mRNAs but instead has a
modest impact on the rate of translation54,55, which could in-turn reduce the rate of protein
synthesis in P. falciparum. Taken together, our analyses of the P. falciparum transcriptome and
translation of genes with endogenous polyA tracts, as well as in silico assessment of overall
structure and stability of AU-rich transcripts indicates that the P. falciparum translation
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machinery adapted to long and numerous polyA tracts in coding sequences of the majority of
genes.

2.3.4 NGD pathway is not connected to mRNA degradation in Plasmodium
PolyA tracts and poly-lysine repeats are highly efficient at causing ribosome stalling and
frameshifting in bacteria and most eukaryotes10–22. However, our analyses of endogenous P.
falciparum genes and reporters with long polyA runs, as well as immunoprecipitations did not
indicate any changes in either mRNA stability, protein amounts, or protein quality (FIGURES 2.2–
2.3) that was previously observed in E. coli, yeast, and human cells11,13,15,17. So, we turned
towards analyses of mRNA surveillance pathways in P. falciparum cells and their contribution to
the synthesis of poly-lysine peptides from long polyA tracts. The NMD pathway seems to be
intact in Plasmodium cells56, while the existence of the NGD pathway has not been previously
tested. We initially focused our analysis on two proteins that have been documented to be
crucial for NGD pathways in eukaryotes, Hbs1 and Pelota35. The Pelota protein in complex with
Hbs1 recognizes and rescues stalled ribosomes with empty A site on long polyA stretches,
absence of tRNAs during starvation, damaged mRNAs, or stable RNA structures35,39,57–59. Our
bioinformatics search of the P. falciparum genome did not identify an apparent homolog of
Hbs1 nor the recently reported S. cerevisiae endonuclease Cue2 (NONU-1 in C. elegans)60–62 in
P. falciparum (SUPPLEMENTAL TABLE 2.2). To explore whether changes in the NGD pathway are
potential adaptations of P. falciparum to polyA tracts and poly-lysine repeats, we first used
CRISPR/Cas9 technology63,64 to HA-tag the endogenous Pelota homolog (PFPELO,
PF3D7_0722100, SUPPLEMENTAL FIGURE 2.10) in P. falciparum Dd2 cells.
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Figure 5. mRNA stem-loop pauses P. falciparum ribosome without mRNA degradation. (A) The western blot of –polyA36, +polyA36, and stem-loop
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reactivity in western blot analyses. (B) qRT-PCR measured mRNA levels of of reporter constructs with polyA tract and stem-loop
insertions (polyA36, +polyA36, Stl). In each case, data represent the mean value of three biological replicates with standard
Pavlovic Djuranovic et al. eLife 2020;9:e57799. DOI: https://doi.org/10.7554/eLife.57799
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deviation. (C) Distributions of mRNA (GAPDH, -polyA36, +polyA36, Stl) and rRNA, in polysome gradients as determined by RTqPCR. Error bars represent measurement variability as determined by two qPCR replicates. The position of monosome and disome
peaks is indicated in each analyzed sample (gray shade).
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Since polyA-containing reporters, as well as endogenous genes, were efficiently and correctly
translated in P. falciparum cells, we decided to test the P. falciparum NGD pathway with a
common NGD substrate35,65. We inserted a 78 bp long RNA stem-loop into the fluorescent
reporter sequence (STL, SUPPLEMENTAL FIGURE 2.11). The same stem-loop was previously
described to stall ribosomes and induce NGD response with subsequent endonucleolytic
cleavage in various reporters and multiple organisms11,65–68. We followed both protein synthesis
and mRNA abundance from the StL construct in P. falciparum cells (FIGURE 2.5A–B). Insertion of
the RNA stem-loop resulted in a severe reduction of reporter protein levels (FIGURE 2.5A,
SUPPLEMENTAL FIGURE 2.11), but moderate increase in mRNA levels (FIGURE 2.5B). While we could
not detect any HA-tagged StL reporter using western blot analyses (FIGURE 2.5A), we did notice
the small but detectable amount of fluorescent reporter in the P. falciparum cells during live
imaging (SUPPLEMENTAL FIGURE 2.11). To test whether stem-loop structure caused ribosomes to
stall, we analyzed the distribution of StL transcript in polysome profile (FIGURE 2.5C). We used
constructs with and without polyA tracts as controls. Polysome profile analyses indicated that
mRNA of StL construct was associated mostly with polysome fractions 7–9 that correspond to
the disome peak. Such mRNA distribution was in sharp contrast with the distribution of mRNAs
for constructs with and without polyA tracts (±POLYA36) and argues for the potential
translational stall (FIGURE 2.5A). mRNAs for constructs with and without polyA tracts (±POLYA36)
and for PfGAPDH were distributed more evenly along the polysome fractions (FRACTIONS 9–16).
These experiments argue that stable RNA structures in mRNAs stall P. falciparum ribosomes,
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reducing protein synthesis from such transcript, however without significant impact on mRNA
stability.
To further test whether global arrest of translation leads to the activation of RQC and NGD
mechanisms, we used isoleucine (Ile) starvation (FIGURE 2.6A) to induce widespread ribosome
pausing on Ile-codons69,70. Parasites rely on extensive proteolysis of human serum proteins to
supplement Ile, which is found in 99% of all P. falciparum proteins70. As such, the majority of
ribosomes will have either a reduced rate of protein synthesis or will be stalled on runs of Ileresidues encoded in endogenous P. falciparum transcripts. Ile starvation in P. falciparum was
previously reported to induce a state of hibernation through the arrest of protein synthesis
with phosphorylation of eIF2a, but in a GCN2-independent fashion, and without existing TORnutrient sensing pathway nor activation of ATF4 homologue69. Surprisingly, during the
metabolically induced hibernation, parasites maintain their morphology while slowing down
protein synthesis, and importantly more than 50% of parasites recover even after 4 days of
starvation69. By analyzing P. falciparum cells 72 hr into Ile-starvation, we found that expression
of PfPelo and PfHsp70 chaperone were upregulated in starved cells (FIGURE 2.6B–C). The mRNA
and protein levels of PfPelo were moderately increased (approximately two-fold), while levels
of PfHsp70 were strongly induced (five-fold increase) in response to the Ile-starvation. This
increase in PfPelo levels is reminiscent of the recently reported increased human Pelo
expression during elevated ribosome stalling and the absence of recycling during the
developmental transition from reticulocyte to erythrocyte71. The substantial increase in Hsp70
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levels upon starvation in human cells was associated with cell protective mechanisms against
global protein misfolding72,73.
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Figure 6. Isoluecine starvation in Plasmodium cells induces HSP70 and Pelo genes. (A) The schematic presentation of the starvation experiment design.
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total RNA was isolated. (B) Relative mRNA of P. falciparum GAPDH (PF3D7_1462800), HSP70 (PF3D7_0818900), Pelo
Pavlovic Djuranovic et al. eLife 2020;9:e57799. DOI: https://doi.org/10.7554/eLife.57799
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(PF3D7_0722100) transcripts after 48 hr isoleucine (Ile) starvation of the P. falciparum cells. Levels of each transcript are
normalized to total GAPDH levels and represented as a ratio of transcript levels under Ile starvation (-Ile) over the control
conditions (+Ile). In each case, data represent the mean value of three biological replicates with standard deviation. (C) Levels of
P. falciparum HSP70 and Pelo proteins after 48 hr of Ile starvation. Western blot analysis of Ile starved (-Ile), and control (+Ile)
sample are normalized to PfHAD1 (PF3D7_1033400) levels. HA-tagged P. falciparum Pelo protein was CRISPR/Cas9 engineered
and detected using mouse HA-antibody. The molecular weight of each protein is indicated. (D) qRT-PCR measured mRNA levels
of genes containing 3–7 Ile. PF3D7_0322300, PF3D7_0512700, PF3D7_0110600, PF3D7_0903400, PF3D7_1450600,
PF3D7_1364700, PF3D7_1121000, PF3D7_1341600, PF3D7_1321400, PF3D7_1138600. Levels of each transcript are normalized
to total GAPDH level and represented as a ratio of transcript levels under Ile starvation (-Ile) over the control conditions (+Ile). In
each case, data represent the mean value of three biological replicates with standard deviation.
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To test whether Ile-rich transcripts were targeted specifically by the RQC and NGD pathway
during Ile-starvation, we examined transcripts that encode Ile-rich proteins in the P. falciparum
genome. Previous studies indicated that while protein levels did not drastically change
throughout starvation, protein synthesis was significantly reduced69. The microarray analyses of
mRNAs in Ile-starvation samples also showed similar overall levels for the majority of mRNA
transcripts when compared to non-starved controls. To specifically test transcripts with three
and more consecutive Ile-codons, we analyzed mRNA abundance for nine P. falciparum genes
during Ile-starvation (SUPPLEMENTAL FIGURE 2.12). We did not observe the general reduction in
mRNA levels for Ile-rich P. falciparum genes when we compared starved to non-starved control
samples. We instead found a slight increase in mRNA abundance for several Ile-rich transcripts
during starvation (FIGURE 2.6C). This result is rather similar to Leu- and Arg-starvation in
mammalian cells, where no overall change in mRNA stability is observed during amino acid
starvation74. However, our result indicated that both increase in expression of NGD-associated
factor, Pelota, and protein chaperone HSP70 may contribute to cell survival, ribosome recycling
and mRNA stabilization during amino acid starvation in P. falciparum. This result is opposite to
the recently reported role of human Pelo protein in the regulation of global mRNA decay on
stalled mRNAs in platelets75. Transgenic overexpression of human Pelo protein potentially
releases unrecycled ribosomes and stimulates mRNA degradation during translational arrest in
platelet differentiation. This is not the case in P. falciparum, where the production of the PfPelo
protein is increased during the P. falciparum Ile-starvation; however, there was a lack of
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targeted mRNA degradation (FIGURE 2.6C). We observed, rather, stabilization of mRNAs that
should cause ribosomal stalling, like in the case of StL construct (FIGURE 2.5B). These results may
indicate that RQC and NGD pathway in P. falciparum cells are not connected, at least directly,
to targeted mRNA degradation.

2.3.5 Plasmodium ribosome structure accommodates poly-lysine repeats
In the light of our data with different reporters and analyses of endogenous P. falciparum genes
(FIGURES 2.2–2.6), we were still interested as to how the P. falciparum translation machinery
deals with polyA tracts and poly-lysine sequences. Ribosomal stalling on long poly-lysine
runs11,19,20,68,76–78 was classically explained by electrostatic interactions of the polybasic peptide
and the exit tunnel of the ribosome78. More recent studies revealed that polyA tracts and
mRNA directly contribute to ribosomal stalling and frameshifting11,12,14,17. Consecutive
adenosines are engaged by the ribosome decoding center nucleotides and are stabilized on
both sides by rRNA base stacking interactions12,14, and adopt a helical conformation typical for
single-stranded polyA stretches79. Based on these reports, we analyzed P. falciparum ribosomes
as the principal components that could accommodate translation of long polyA stretches.
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Figure 7. Polypeptide exit tunnel as predicted by MOLE service from Plasmodium ribosome (PDB:3j79) (A) and human ribosome (PDB: 6d90) (B). The
FIGURE 2.7 | Characterization of polypeptide exit tunnel in H. sapiens and P. falciparum. Polypeptide exit tunnel as predicted by
constriction site flanked by L22 and L4 is marked in the orange clamp, and lining residues in both cases are marked with ball-and-stick visualization.
et al., 2018).
of the tunnel issite
indicated
on by
the
Vertical
outline
hydrophobicity
(left)
and charge
(right) profiles
the tunnel
(Pravda (PDB:
MOLEplot
service
from
Plasmodium
ribosome
(PDB:3j79)
(A) across
and human
ribosome
6d90) The
(B).width
The constriction
flanked
scale at the bottom of the plot. The total lengths of the tunnel are indicated at the top of the plots.
L22online
and L4
is marked
in theincludes
orangethe
clamp,
andfigure
liningsupplement(s)
residues in both
cases
The
version
of this article
following
for figure
7: are marked with ball-and-stick visualization. Vertical
Figure
supplement
1. Structure of(left)
P. falciparum
(PDB (right)
code: 3JBO)
and across
H. sapiens
code:
3JAG) ribosomes
with receptor
for activated
kinase C
plot outline
hydrophobicity
and charge
profiles
the(PDB
tunnel
(Pravda
et al., 2018).
The width
of the tunnel
is
(RACK1) in magenta, previously shown to be absent from Plasmodium ribosomes (60S in green, 40S in cyan).
indicated
on the 2.
scale
at theofbottom
ofalignment
the plot.ofThe
of the tunnel
areand
indicated
of of
the
plots. H. sapiens
Figure
supplement
Segment
sequence
18Stotal
rRNAlengths
from P. falciparum
(Pf18SA
Pf18SS, at
A- the
and top
S-type
ribosomes),
(Hs18S), S. cerevisiae (Sc18S), T. thermophila (Tt18S) andE. coli16S (Ec16S).
Figure supplement 3. Polypeptide exit channel from Haloarcula marismortui ribosome (PDB: 1jj2) has one long fragment of relatively hydrophobic
lining of the tunnel at the entrance (between PTC and constriction site).

The retention and conservation
of synthesis
polyA tracts,
as well
as the residues
stage-independent
expression
accommodate
of long runs
of poly-lysine
by reducing electrostatic
barriersof
below
the PTC and at the constriction site. The resulting dynamics of translation of poly-lysine might be
high enough to reduce the chances for unfavorable interactions between mRNA and ribosome.

polyA genes (FIGURE 2.1), reveals that all rRNAs within Plasmodium spp. must deal with them.

Discussionribosomes are limited to two recent cryo-EM studies of P.
The structural data on Plasmodium
Runs of lysine and arginine residues are underrepresented in the proteome of multiple organisms
compared to the runs of other amino acids, suggesting a selective pressure against polybasic amino

acid sequences
(Karlin
al., 2002). stage
One potential
this evolutionary
selection is elecfalciparum ribosomes isolated
during
theetschizont
of theexplanation
IDC80,81.for
Both
studies reported

trostatic interactions of the polybasic peptide and the exit tunnel of the ribosome that would impact
the rate of protein synthesis (Brandman et al., 2012; Lu and Deutsch, 2008). However, multiple biothat P. falciparum ribosomes
different
structural
dynamic
features
thatanddistinguish
chemicalhave
analyses
of poly-lysine
stalling and
sequences,
in both
prokaryotic
eukaryotic systems,
revealed that runs of lysine AAA codons exhibit a more significant delay in ribosome movement than
an equivalent number of AAG lysine codons (Glöckner, 2000; Szafranski et al., 2005;
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FIGURE 2.13). The ES6S/7S is located next to the binding pocket of eIF3 and might be necessary
for translation initiation or termination30,80,82. ES9S/10S are positioned at the head of the 40S
subunit and are probably important for the recruitment of additional translation factors as well
as for mobility of the head region of 40S subunit80,81. Previous studies had shown that the
absence of ZNF598 and RACK1 would help in the resolution of putative stalling and subsequent
read through of polyA sequences18–20. However, the P. falciparum homolog of ZNF598
(PF3D7_1450400), appears to be abundantly expressed according to PaxDB database83.
On the other hand, while being essential and one of the most well-expressed proteins in P.
falciparum cells83,84, the absence of RACK1 protein on Plasmodium ribosomes could be the
most prominent features regarding the translation of polyA tracts and poly-lysine repeats
(SUPPLEMENTAL FIGURE 2.13)80,81. Asc1 (yeast RACK1 homolog) is required for endonucleolytic
cleavage of stalled mRNAs in yeast cells85,86. The deletion of RACK1/Asc1 in human or yeast cells
was also shown to increase the production of proteins with polybasic peptides, however, at the
cost of increased frameshifting20,76,87. The recent report has shown that the absence of Asc1 in
yeast generally slows down elongation, promoting frameshifting on problematic CGA-CGA
pairs14. However, the mechanisms proposed for the polyA-induced ribosome stalling involves
the inhibitory conformation of polyA tract mRNA in the A site of the ribosome12,14. This
proposed mechanism for polyA stalling induction should not depend on species, because
ribosome nucleotides interacting with π-stacked polyA sequences are universally conserved
(A1756 AND C1634, SUPPLEMENTAL FIGURE 2.14). No significant differences in the mRNA tunnel
have been observed in P. falciparum ribosome structures80,81. However, differences in the
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resolution and absence of mRNA in P. falciparum ribosome cryo-EM structures do not allow for
precise comparison of the conformation of rRNA between Plasmodium and either yeast or
mammalian ribosomes80,81. Altogether these observations do not explain why the mRNA tunnel
and interactors of the P. falciparum ribosome could influence the efficient translation of polyA
tracts.
Recently it was postulated that the stalling on the polyA tracts is an effect of a synergy between
polyA-induced suboptimal geometry at PTC and poly-lysine interactions with ribosome exit
tunnel12.To further investigate whether additional differences in the ribosome structure
contributed to P. falciparum adaptation to long polyA tracts and poly-lysine repeats, we
analyzed the ribosome peptide exit tunnel of P. falciparum as predicted by the MOLE 2.5
toolkit88 (FIGURE 2.7). While a recent study found no differences in charge pattern along the
peptide tunnel in eukaryotes, notably between P. falciparum and human89, we observed
changes in hydrophobicity across the tunnel (FIGURE 2.7 AND SUPPLEMENTAL FIGURE 2.15).
Interactions between clusters of positive charges and hydrophobic environments are generally
unfavorable even during protein translocation90. Along this line, the ribosome exit tunnel of P.
falciparum seems to be generally more hydrophilic, including the constriction site. Given a
substantial length of poly-lysine peptide required to induce stalling on downstream polyA tracts
(6 to 11, depending on the experimental system)12 it is plausible that the upper and the central
tunnel are contributing to the observed effects. This is what is observed in other organisms. The
free energy profile of lysine across the H. marismortui ribosome exit tunnel, which also has a
hydrophobic region between the PTC and constriction site (SUPPLEMENTAL FIGURE 2.15), indicates
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the presence of a significant energy barrier after the constriction site, not before91. Indeed, in
vitro translation of poly-lysine and poly-phenylalanine using E. coli ribosomes resulted in rather
different paths and rates of the extension of nascent peptide due to postulated hydrophobic
entry to the ribosome exit tunnel92. Moreover, in a recent structure of the polyA stalled yeast
ribosome, the unresolved density was also indicated in this part of the exit tunnel next to the
PTC and above the constriction site14. Taken together, it seems that the ribosome peptide exit
tunnel of parasites adapted to accommodate synthesis of long runs of poly-lysine residues by
reducing electrostatic barriers below the PTC and at the constriction site. The resulting
dynamics of translation of poly-lysine might be high enough to reduce the chances for
unfavorable interactions between mRNA and ribosome.

2.4 Discussion
Runs of lysine and arginine residues are underrepresented in the proteome of multiple
organisms compared to the runs of other amino acids, suggesting a selective pressure against
polybasic amino acid sequences93. One potential explanation for this evolutionary selection is
electrostatic interactions of the polybasic peptide and the exit tunnel of the ribosome that
would impact the rate of protein synthesis77,78. However, multiple biochemical analyses of polylysine stalling sequences, in both prokaryotic and eukaryotic systems, revealed that runs of
lysine AAA codons exhibit a more significant delay in ribosome movement than an equivalent
number of AAG lysine codons6–8,11–14,17,21,22. More recent study in mouse embryonic stem cells
indicates that besides 12A-1 sequences endogenous sites with 8–9 As are sufficient to cause
recruitment of mRNA surveillance pathways13. So as is the case of polybasic residues, analyses
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of codon usage within poly-lysine peptides revealed that the expected frequency of AAA codons
compared to AAG codons in runs of four consecutive lysine residues is lower in the coding
regions of genes for multiple organisms (FIGURE 2.1)11,17,31. However, ribosome stalling and
frameshifting induced by polyA runs depend on the sequence and conformation of the mRNA in
the ribosome, with a questionable contribution by the nascent polypeptide chain11,14,16,17. As
such, both polyA tracts and poly-lysine sequences are unfavorable in mRNAs or proteins,
respectively, of most tested organisms.
Data presented here indicate P. falciparum, the most studied malaria-causing human pathogen,
is an exception to this rule. With an 80% AT-rich genome and more than 63% of transcripts
containing polyA tracts, P. falciparum represents a paradigm breaking species for polyA tracts
(FIGURE 2.1). The atypical enrichment in polyA tracts in the coding sequence of mRNAs,
translated into long poly-lysine runs in proteins, is a feature that is conserved in most
Plasmodium species (FIGURE 2.1)4,29,31,83. Such species-specific evolutionary conservations
usually result in traits that are beneficial for survival. The increased AT-richness and number of
polyA tracts in P. falciparum, as such, could be a result of selective pressure on biosynthetic
pathways (AT vs. GC biosynthesis)94,95 and the oxidative intraerythrocytic environment96. An
increase in poly-lysine runs might have been of different etiology. Gene ontology analyses of
polyA tract and poly-lysine genes in P. falciparum suggested cellular and pathological adhesion
proteins as one of the enriched gene groups (SUPPLEMENTAL TABLE 2.1). It is attractive to
speculate that advantages for the parasites to synthesize proteins with poly-lysine repeats
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could be solely driven by benefits in the adhesion and invasion of host cells97,98 or export of
numerous parasite proteins to the surface of infected erythrocytes99–101.
Our data further indicate that the P. falciparum translational machinery permits the translation
of polyA tracts and poly-lysine repeats without mRNA degradation, protein synthesis
attenuation, nor obvious activation of translational surveillance pathways (FIGURES 2.2–2.5). The
biochemical assays with reporter sequences (FIGURES 2.2, 2.3, AND 2.5) as well as analyses of
ribosome profiling data4 (FIGURE 2.4) suggest that parasite ribosomes do not stall or frameshift
on long polyA tracts and poly-lysine runs. Even though RNA folding propensity in P. falciparum
has been skewed due to the nucleotide content, the predicted stability of native P. falciparum
transcripts did not show differences compared to human cells. However, the change in
nucleotide composition and a number of long polyA tracts of P. falciparum (FIGURE 2.1) probably
shaped NGD/NSD mRNA surveillance responses in parasites (SEEN IN FIGURES 2.5–2.6). Insertion
of the stable stem-loop structure (StL) in the reporter construct resulted in reduced protein
synthesis and ribosome stalling but without noticeable mRNA degradation (FIGURE 2.5 AND
SUPPLEMENTAL FIGURE 2.11). Our results with stem-loop construct and Ile-starvation are rather
disparate to experiments in other eukaryotes, including the human host11,65–68, and argues for
significant differences between human and Plasmodium NGD mRNA surveillance pathways.
Similarly, while following the general cellular response to induced metabolic stress with Ilestarvation we noticed the upregulation of Pelo and Hsp70 levels71–73, however again with the
lack of targeted mRNA degradation of Ile-rich transcripts or reduction in global mRNA stability
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(FIGURE 2.6)69. It seems plausible that amino acid starvation could allow uncharged Ile-tRNAs to
fill the A-site and block Pelo binding thus preventing NGD and RQC activation in this case.
Similarly, Leu- or Arg-starvation experiments in HEK293 cells do not result in global change in
mRNA stability but rather increase in translation termination and ribosome recycling74. While
authors in Hek293 amino acid starvation studies did not follow changes in Pelota protein levels,
it was shown recently that transgenic overexpression of Pelo protein in human platelets led to
rapid degradation of most cytoplasmic platelet transcripts75. Our studies indicate that increased
P. falciparum Pelo levels, at least during the amino acid starvation, do not cause targeted mRNA
degradation. However, future studies on the role PfPelo levels during amino acid starvation, its
role in ribosome recycling as well as identification of missing P. falciparum Hbs1 protein will
give more insight in NGD and RQC process in Plasmodium. Nonetheless the results with StL
construct and amino acid starvation suggest a difference between human and Plasmodium NGD
mRNA surveillance and mRNA degradation pathways in both signaling and resolution of
ribosome stalling events102. One of these differences could be potentially attributed to the loss
of recently reported NGD endonucleases60–62 in P. falciparum cells. The bioinformatics analyses
of the P. falciparum genome did not indicate a homolog of either Cue2 or Nonu-1 endonuclease
(SUPPLEMENTAL TABLE 2.2)60–62. However, the loss of Cue2/Nonu-1 in Plasmodium cells can not
completely explain the lack of mRNA degradation on the stem-loop construct (FIGURE 2.5) or in
Ile-starvation experiments (FIGURE 2.6). Given that the majority of observed NGD-induced mRNA
decay is processed by canonical exonucleolytic decay by Xrn160,62, stabilization of NGD
substrates in P. falciparum remains puzzling.
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It is apparent that the accommodation of polyA tracts and poly-lysine repeats in translation
required multiple adaptations to be vital and typically highly conserved components of the
translation and mRNA surveillance pathways. Unambiguously, P. falciparum ribosomes had to
change to accommodate correct and efficient protein synthesis from the runs of coding polyA
tracts that are longer than the average size of 3’-UTR polyA tails in other organisms32–34. The
fact that recent cryo-EM structures indicated that the Plasmodium ribosome lacks interaction
with PfRACK1 protein (FIGURE 2.7) could be beneficial for the translation of polyA tracts into
poly-lysine runs80,81. Albeit, it is not clear what would substitute the role of RACK1/Asc1 in the
correct reading frame maintenance during translation of long polyA tract or other stalling
sequences14,20,76,87. The lack of Asc1/RACK1 association with P. falciparum ribosomes could
affect its association with other RQC protein homologs, such as ZNF598, which can influence
the activation of RQC pathway and endonucleolytic cleavage86. It is possible to speculate that P.
falciparum specific ribosome extension segments in the 40S subunit may have the role in
recruiting other Plasmodium proteins that may help with translation of polyA tracts and polylysine repeats80,81. However, it was recently indicated that an inhibitory conformation of mRNA
in the A-site of the ribosome, as well as the polybasic character of the nascent polypeptide
chain in the ribosome, peptide exit tunnel, are crucial for the poly(A)-mediated stalling
mechanism12,14. It is not clear from the conservation of the 18S rRNA sequence (SUPPLEMENTAL
FIGURE 2.14) and structure of the ribosome A-site in P. falciparum ribosomes80,81 how parasite
ribosomes would circumvent an inhibitory conformation of the polyA mRNA in the A site seen
in yeast and mammalian ribosomes12,14. It might be that changes in the peptide exit tunnel of P.
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falciparum ribosomes (FIGURE 2.7) have partially contributed to the adaptation to the synthesis
of long poly-lysine runs by reducing the potential stalling effects associated with translocation
of polybasic peptides through hydrophobic environment90. However, contributions of
Plasmodium’s ribosome exit tunnel in overcoming poly-lysine induced ribosome stalling still
need to be tested experimentally. It is also plausible that translation rate is also a factor here.
Chandrasekaran and coworkers12 in their polyA stalling study had observed a significantly
different in number of lysines required for stalling between in vitro system and cells. They have
explained the observation by 5-fold differences in translation rate.
In conclusion, to adapt to polyA tract translation for the production of the polybasic and
homopolymeric lysine repeats, the malaria-causing parasite has altered its mRNA translation
quality control pathways as well as its ribosomal proteins and ribosome structure. The
additional diversity of Plasmodium spp. rRNAs103–105 and possible activity of yet unknown
ribosome-associated factors promote the possibility of Plasmodium ‘specialized ribosomes,’
which allow for polyA tract translation into poly-lysine sequences of functional proteins. Further
insights into differences between components of translational machinery and mRNA
surveillance pathways present in P. falciparum and host organisms, as well as the physiological
role(s) of conserved poly-lysine repeats, will provide answers to these questions and enable
identification of new drug targets against malaria.
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2.5 Materials and Methods
KEY RESOURCES TABLE
Reagent type (species)
or resource
Gene (Plasmodium
falciparum)

Designation

Source or
reference

Identifiers

Additional information

Pelota gene

This paper

PF3D7_0722100

CRISPR/Cas9 engineered
with C-terminal 3xHA tag

Cell line (Plasmodium
falciparum)

Dd2 strain

Goldberg lab

Cell line
(Homo sapiens)

Dermal fibroblast
(normal, Adult)

http://neurolex.co
m/
wiki/NCBITaxon:57
267

ATCC

PCS-201–012

Cell line
(Homo sapiens)

Adult erythrocytes
(primary cell line)

Goldberg lab and
BJCIH Children
Hospital

Cell line
(Tetrahymena
thermophila)

strain B2086 (II)

Chalker Lab

Recombinant DNA
reagent

pBSICY-gtw (plasmid)

Chalker Lab

Recombinant DNA
reagent

pc-DNA-DEST40
(plasmid)

Thermo Fisher
Scientific

Recombinant DNA
reagent

pHHT-TK (plasmid)

Goldberg lab

Recombinant DNA
reagent

pyDHOD-2A-Cas9
(plasmid)

Goldberg lab

http://neurolex.co
m/
wiki/NCBITaxon:59
11

RRID:
Addgene_45597

Deidentified human
blood. 50% haematocrit,
washed in complete
medium (MCM)

·PMCID:
·PMC3232721
·T. thermophila
transfection plasmid
HDF transfection plasmid
Plasmid for standard
CRISPR/Cas9 knock out
approach in P.
falciparum cells.
All-in-one Cas9+gRNA
cassette vector
DSM-1 resistance
WB (1:5000), used also
as HRP conjugated

anti-HA antibody (mouse
monoclonal antibody)
anti-mouse (horse
unknown clonality)
anti-rabbit (goat
polyclonal antibody)
Anti-HSP70 (rabbit
polyclonal antibody)

Santa Cruz
Biotechnology
Cell Signaling
Technology
Cell Signaling
Technology
AgriSera

WB (1:1000)

anti-PfHAD1 rabbit

Odom lab

WB (1:10000)
PMID:25058848

Cycloheximide

Sigma Aldrich

Cat# C1988

200 μM

WR99210

Sigma Aldrich

Cat# W1770

10 nM

Chemical compound,
drug

DSM1

Sigma Aldrich

Cat#533304

Commercial assay or kit

llustra triplePrep Kit

GE Healthcare

Cat# 28942544

Antibody
Antibody
Antibody
Antibody
Antibody
Chemical compound,
drug
Chemical compound,
drug

Cat# sc-7392,
RRID: AB_627809
Cat# 7076, RRID:
AB_330924

P. falciparum strain used
for all experiments

WB (1:5000)
WB (1:5000)

DHODH Inhibitor 1.5 μM
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DNA, RNA and protein
isolation kit

2.5.1 Parasite culturing
P. falciparum line Dd2 was cultured at 2-5% hematocrit in O+ erythrocytes in RPMI 1640
supplemented with 5 g/L Albumax II (Gibco), 0.12 mM hypoxanthine (1.2 mL 0.1M
hypoxanthine in 1 M NaOH), 10 μg/mL gentamicin106. Cultures were grown statically in a candle
jar atmosphere. As required, cultures were synchronized with 5% (w/v) sorbitol. Medium for
Isoleucine starvation: 16.1g RPMI medium 1640 per l (ME011232P1 Gibco), 2 g of sodium
bicarbonate, 0.12 mM hypoxanthine, 10 μg/mL gentamicin, and with and w/o 100 μM
Isoleucine.

2.5.2 Generation of mCherry-GFP–Expressing plasmids with and without 12
lysines coded with 36 As in a row (polyA- and polyA+)
mCherry with and without polyA was amplified from plasmids previously created11
pBttlysforXhoI 5ʹ- gcgcctcgagatgggctacccatacga-3ʹ (XhoI site underlined) and mCherryrevAvrII
5ʹ- gcgccctaggcttgtacagctcgtccatgccg3ʹ (AvrII site highlighted) digested with XhoI and AvrII, and
ligated into the same sites of the episomal over-expression (EOE) a containing the promoter
region for PfHsp86, a C-terminal GFP tag, and a human dihydrofolate reductase (hDHFR) drugselection cassette107. mCherry reporter in pc-DNA-DEST40 previously published11,15 used to
transfect HDF cells.
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2.5.3 HDF cells culturing and transfection
HDF cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco) and
supplemented with 10% fetal bovine serum, 5% minimum essential medium nonessential
amino acids (100×, Gibco), 5% penicillin and streptomycin (Gibco), and L-glutamine (Gibco).
mCherry reporter in pc-DNA-DEST40 plasmid (1 μg) was introduced to the cells by the Neon
Transfection System (Invitrogen) with 100 μL tips according to cell-specific protocols
(www.lifetechnologies.com/us/en/home/life-science/cell-culture/transfection/transfection-- selection-misc/neon-transfection-system/neon-protocols-cell-line-data.html). Cells
electroporated with DNA plasmids were harvested after 48 hours if not indicated differently11.

2.5.4 Parasite transfection
Asynchronous Dd2 parasites were incubated with 100 μg of maxi-prep DNA of each of the EOE
constructs described above encoding mCherry-GFP (with and w/o polyA), transfected in BioRad Gene Pulser cuvette (0.2 cm), 0.31 kV, 950 up, infinity resistance. 10 nM WR99210 was
added to parasite 48 h after transfection and used to select resistant parasites108.

2.5.5 Saponin lysis of infected red blood cells (iRBCs)
The cell iRBCs were resuspended in two volumes of PBS containing 0.15% saponin, and
incubated on ice for 10 min, with vigorous mixing every 3 min. Afterward, the samples were
centrifuged 7000g, 5 min, 4°C, and the pellets were washed three times more with the same
buffer.
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2.5.6 Genomic DNA isolation
The extraction of gDNA was done from samples pretreated with a saponin lysis buffer, and we
followed the protocol of the DNeasy Qiagen kit.

2.5.7 RNA extraction and qRT-PCR
Total RNA was extracted from iRBCs using the RiboZol RNA extraction reagent (Amresco) with
some changes (protocol from Jabos-Lorrrena Laboratory at Johns Hopkins School of Public
Health), or we used Illustra triplePrep Kit GE Health Care. In 1 mL of pelleted iRBCs (500g, 5min,
room temperature), parasitemia 5-7%, 5 mL of RiboZol was added. It was mixed thoroughly that
all cells lysed. At this step, the sample can be snap-frozen and stored at -80°C or proceed
further. Add 1 mL of chloroform and mix for 20 sec. Transfer the aqueous phase to a new tube
and add 1/10th of the volume of 3 M sodium acetate, mix well and add 10 μL GlycoBlue. Add 2.5
mL of cold iso-propanol and leave overnight at -80°C. After overnight precipitation, the samples
were centrifuged at 16000xg, 1h, 4°C. The supernatant was discarded and washed twice with 5
and 1 mL of cold ethanol. The pellets were dried and resuspended in pure water. RNA
concentration was measured by NanoDrop (OD260/280). For total RNA extraction using Illustra
TriplePrep Kit (item# 28942544 GE Health Care), we used 200 μL of iRBCs, parasitemia 5-7%.
The cell pellet was resuspended in 600 μL PBS buffer containing 0.15% saponin (item# 4703650G-F Sigma), cOmplete™ Protease Inhibitor Cocktail without EDTA (item# 11873580001
Roche), RNase OUT 1ul/mL (item# 10777019 Invitrogen), and incubated at RT for 10 min on ice.
Afterward, it was centrifuged 7000xg, 5 min, 4°C, and the pellets were washed three times

102

more with the same buffer. After this pretreatment to get rid of hemoglobin pellets were used
for total RNA isolation following Illustra TriplePrep Kit protocol.
iScript Adv cDNAkit for RT-qPCR (item# 172-5037, Bio-Rad) or SuperScript IV VILO Master Mix
(item# 11756050 Life Technologies Corporation), was used with 100-200 ng of total RNA
following the manufacturer’s protocol. iQ SYBR Green Supermix (item# 1708886, Bio-Rad)
protocol was used for qRT-PCR on the CFX96 Real-Time system with Bio-Rad CFX Manager 3.0
software11. Cycle threshold (Ct) values were normalized to the hDHFR resistance gene expressed from
the same plasmid or HSP86, GAPDH genes.

2.5.8 qPCR Primers
PF3D7_1462800
2GAPDHqf 5ʹ-ACCAAAGGATGACACCCCAA
2GAPDHqf 5ʹ-ACCACCCTTTGATGGACCAT
PF3D7_1464200
610gf 5ʹ-CGACAAGGCCATTTTAGAGAA-3ʹ
610gR 5ʹTTTCGTTTTATCTCCGCTTACA-3ʹ
PF3D7_0615500
0615500for 5ʹ-CCACAATTGGAGTCGTCGTA-3ʹ
0615500rev 5ʹ-TCAAATCGAATTCTGTGACTCCT-3’
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UniProtKB - P00374
qPCR_ hDHFR_F_5ʹ-TCCTCCTGGACATCAGAGAGA-3ʹ
qPCR_ hDHFR_R_5ʹ-CTCAAGGAACCTCCACAAGG-3ʹ
PF3D7_0818900
Hsp70qf 5ʹ-GAATCGGTTTGTGCTCCAAT-3ʹ
Hsp70qr 5ʹ-CAACTGTTGGTCCACTTCCA-3ʹ

PF3D7_1108000
qPCRrevIWS1w 5ʹ-TGGTTGAAGAGGATGAGGAGA-3ʹ
qPCRrevIWS1w 5ʹ-ACCTTGTGCATATCATCATTTTCC-3ʹ
mCherryqF 5ʹ-TGACGTACCGGATTATGCAA-3ʹ
mCherryqR 5ʹ-ATATGAACTGAGGGGACAGG-3ʹ
Ile rich genes
PF3D7_0322300_F 5ʹ-TGGATGATCTGAGCAACAAAA-3ʹ
PF3D7_0322300_R 5ʹ-GGGTGGATCTTTATGCAAGC-3ʹ
PF3D7_0512700_F 5ʹ-TGGAACAGCATTAACGGAAA-3ʹ
PF3D7_0512700_R 5ʹ-GAGGTATTCCTACCCTTTTCTCAA-3ʹ
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PF3D7_0110600_F 5ʹ-AGCATCACGACCTTTCCATC-3ʹ
PF3D7_0110600_R 5ʹ-TTGCATAAGCATTGGGATGA-3ʹ
PF3D7_0903400_F 5ʹ-TTCCATTATTGCATGCTCTCC-3ʹ
PF3D7_0903400_R 5ʹ-TCACACATGGATGTTGCTCA-3ʹ
PF3D7_1450600_F 5ʹ-ACGGATTACATGCAGCACAA-3ʹ
PF3D7_1450600_R 5ʹ-GATGACGTGTCGTCAAAAA-3ʹ
PF3D7_1364700_F 5ʹ-AAGGAAGCTCGGTTTTATTTGA-3ʹ
PF3D7_1364700_R 5ʹ-AAACCCTTCTTTTGTTTTGACA-3ʹ
PF3D7_1121000_F 5ʹ-CAAAAACAAATCCCGTAGATCC-3ʹ
PF3D7_1121000_R 5ʹ-CGATACAATTGTTGACCCACAT-3ʹ
PF3D7_1341600_F 5ʹ-GGGAATGGGAACCTTGTGTA-3ʹ
PF3D7_1341600_R 5ʹ-TCTTCATTTATCCATGCGTCA-3ʹ
PF3D7_1321400_F 5ʹ-TCCTTTCCATCCTCCCTTTT-3ʹ
PF3D7_1321400_R 5ʹ-TGGATTTTATCCACGGGTGT-3ʹ
PF3D7_1138600_F 5ʹ-ACAAGCGGAAAATATCGAATG-3ʹ
PF3D7_1138600_R 5ʹ-TCGTCTAAGTCCACTTCACTGC-3ʹ

2.5.9 Immunoblotting and Antibodies
Samples pretreated with lysis buffer supplemented with cOmplete™ Protease Inhibitor Cocktail
without EDTA were prepared with passive lysis buffer (Promega), BioRad sample buffer and
BioRad reducing buffer. For immunoblotting, the PVDF membranes were blocked in 5% milk in
PBS. The membranes were probed with anti-HA, or Anti-HA HRP (sc-7392, sc-7392HRP, Santa
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Cruz) or anti-HA mouse or rabbit antibody (7076s, 7074s respectively, Cell Signaling) diluted in
2.5% milk in PBS-Tween20 0.1% PBST) 1: 5000, an anti-hDHFR mouse antibody (sc-377091,
Santa Cruz) diluted 1:5000 in 2.5% milk in PBST, anti- HSP70 mouse (AS08 371, Agrisera,
generous gift of Goldberg lab) 1:1000 in 2.5% milk in PBST, anti- PfHAD1 rabbit antibody
(generous gift of Odom lab) 1:10000 in 2.5% milk PBST. Secondary HRP-labeled anti-mouse or
anti-rabbit antibodies are diluted 1:5000 in 2.5% milk in PBST and incubated for an hour. After
incubation with the primary antibody, the PVDF membranes were washed three times for 5 min
in PBST, Prepare Working Solution by mixing equal parts of the Stable Peroxide Solution and the
Luminol/Enhancer Solution (34577 SUPERSIGNAL WEST PICO PLUS, 34096 SUPERSIGNAL WEST
FEMTO MAXIMUM SENSITIVITY SUBSTRATE respectively). We incubate the blot in Working
Solution for 5 minutes. Remove the blot from Working Solution and drain excess reagent.
Afterward we took images were generated by BioRad Molecular Imager CHemiDoc XRS System
with Image Lab software.

2.5.10 Starvation assay
Asynchronous P. falciparum Dd2 parasites clones, with HA-tagged Pelota gene cultured in
complete RPMI at 5% hematocrit and grown to ∼3–5% parasitemia. The parasites were washed
twice in PBS, equally partitioned, and washed in complete, isoleucine-free, and then were
replated in their respective medium. Parasite cultures were incubated at 37 °C, in a candle jar
atmosphere for 48h. After incubation, parasites were harvested. After harvesting, infected RBCs
were lysed for total RNA/protein isolation or polysome profiling69.
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2.5.11 Polysome-associated RNA isolation
For polysome/RNA isolation we did according to published protocols25,109. Shortly,
cycloheximide (100 mM) was added to parasite-infected red blood cell cultures to a final
concentration of 200 μM. The culture was incubated for 10 minutes at 37°C following with
pelleting erythrocytes (5 minutes at 500 x g at room temperature) and washed twice in PBS
containing 200 μM cycloheximide. After the last wash, pellets were kept on ice and were
subsequently lysed by adding 2.2 volumes of lysis buffer (1% (v/v) Nonident P-40 and 0.5%
(w/v) sodium deoxycholate in polysome buffer (400 mM potassium acetate, 25 mM potassium
HEPES pH 7.2, 15 mM magnesium acetate, 200 μM cycloheximide, 1 mM dithiothreitol (DTT),
and 1mM 4-(2-aminoethyl) benzenesulfonyl fluoride HCl (AEBSF))) or cOmplete™ Protease
Inhibitor Cocktail without EDTA (Roche), RNase OUT 1 μL/mL (Invitrogen) . After a 10 minute
incubation on ice, lysates were centrifuged for 15 minutes at 20,000xg at 4°C, at this point, the
pellets were flash-freeze and stored at -80°C. The clarified lysates were then loaded on top of a
sucrose cushion (35% sucrose in polysome buffer) to concentrate the ribosomes (4 mL
polycarbonate ultracentrifuge tubes and then centrifuged for two h at 150000xg at 4°C in a
Type 100.3 Ti rotor (Beckman Coulter, Brea, CA, USA). Ribosome pellets were resuspended in
polysome buffer. Afterward, the ribosome suspension was layered on top of a 15 mL
continuous linear 15 to 60% sucrose (w/v) 2h 40 min 260343xg (Beckman Optima XPN-90 and
the swinging bucket rotor SW41 Ti). Fractions of 500 μl were collected using a UA-5 UV detector
and model 185 gradient fractionator (ISCO, Lincoln, NE, USA). RNA was extracted with acid-
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phenol: chloroform pH 4.5 (Life Technologies), extracted twice with chloroform, and then
precipitated using isopropanol.
Plasmodium falciparum Sucrose Cushion for Polysome Profiling: This prep is used to isolate
crude ribosome pellet, removing hemoglobin, which can then be later used for polysome
profiling. We used 2 mL 100% hematocrit erythrocytes 8% parasitemia. The pellets were
washed with 10 mL PBS and flash freeze in liquid nitrogen. Samples were stored at -80C before
further use. Reagents: To make 10 mL Plasmodium falciparum Polysome Lysis Buffer (2.2
V/sample), we used 25 mM K-HEPES (1 M stock) 250 μL, 400 mM K-OAc (4 M stock) 1000 μL, 15
mM Mg-OAc (1 M stock) 150 μL, 1% Igepal CA-360 (100% stock), 100 μL 0.5% Na Deoxycholate
(10% stock) 500 μL, 200 μM cycloheximide (100 mM stock) 20 μL, 1 mM AEBSF (200 mM stock)
50 μL, 1 mM DTT (1 M stock) 10 μL, RNase Inhibitory (40 U/μL stock) 10 μL, Molecular Grade
Water 7 mL, 910 μL. Plasmodium falciparum Sucrose Cushion for Polysome Profiling (15 mL),
25 mM K-HEPES (1 M stock) 375 μL, 400 mM K-OAc (4 M stock) 1500 μL, 15 mM Mg-OAc (1 M
stock) 225 μL, 200 μM cycloheximide (100 mM stock) 30 μL, 1 mM AEBSF (200 mM stock) 75 μL,
1 mM DTT (1 M stock) 15 μL, 40 U/mL RNase Inhibitory (40 U/μL stock) 15 μL, Ultrapure sucrose
5.135 g, Molecular Grade Water (to start, complete to 15 mL after dissolved and all
components added) 7.5 mL. Plasmodium falciparum Polysome Wash Buffer (1.5 mL/sample)
25 mL. 25 mM K-HEPES (1 M stock) 625 μL, 400 mM K-OAc (4 M stock) 2500 μL, 15 mM Mg-OAc
(1 M stock) 375 μL, 200 μM cycloheximide (100 mM stock) 50 μL, 0.1 mM AEBSF (200 mM
stock) 12.5 μL, 1 mM DTT (1 M stock) 25 μL, 10 U/mL RNase Inhibitory (40 U/μL stock) 6.25 μL,
Molecular Grade Water 21 mL. 406.25 μL Plasmodium falciparum Polysome Lysis Buffer (500
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μL/sample) 2.5 mL 25 mM K-HEPES (1 M stock) 62.5 μL 400 mM K-OAc (4 M stock) 250 μL,
Plasmodium falciparum Sucrose Cushion for Polysome Profiling - 15 mM Mg- OAc (1 M stock)
37.5 μL, 1% Igepal CA-360 (100% stock) 25 μL, 200 μM cycloheximide (100 mM stock) 5 μL, 1
mM AEBSF (200 mM stock) 12.5 μL, 1 mM DTT (1 M stock) 2.5 μL, 40 U/mL RNase Inhibitory (40
2 mL, were lysed with 2.2 V of lysis buffer, vortex to mix well. Incubate at 4°C for 10 mins while
rocking or rotating. Centrifuge 11,800xg, move lysate to the fresh tube (~ 6.2 mL) For Sucrose
Cushion Setup, we needed 3 cushions per sample. We were using 1 mL cushion per ~2 mL
lysate. Add 1 mL sucrose to each tube. Layer sample lysates over sucrose cushion. Add 2 mL to
each, then split the remainder (usually a few hundred microliters) over the 3 tubes. We used
TLA 100.3 rotor (kept cold in the refrigerator) for ultracentrifugation. Speed: 100,000 x g, Time:
1 hour 30 mins. Temp: 4°C. When the centrifugation is finished, carefully aspirate off
supernatant without touching sides so as not to disrupt pellets. Wash pellet 3X with 500 μL
wash buffer, gently pipetting on the side opposite the pellet near the bottom of the tube.
Resuspend and combine pellets for each sample in a total of 500 μL ribosome resuspension
buffer. Pipet to disperse pellet. Use 200 μL tips to further disperse. Move to 1.5 mL
microcentrifuge tube Incubate at 4°C, rotating end-over-end, for at least 10 min. To remove
remaining hemoglobin, set up another 1 mL sucrose cushion for each sample as previously23. A
quick spin to collect samples to the bottom of the tube. Layer ribosome suspension over
sucrose cushion, balance using ribosome resuspension buffer. Centrifuge as previously. Wash
3X with 500 μL wash buffer as previously. Resuspend in 500 μL ribosome resuspension buffer as
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previously. If not, proceed to the next steps immediately, flash-freeze in liquid nitrogen and
store at -80°C.

2.5.12 Parasite live imaging
To image P. falciparum Dd2 strain episomally expressing polyA- and polyA+ constructs, we used
50 μL of infected erythrocytes, washed two times in PBS. The nucleus was stained with 1:1000
dilution of Hoechst® 33342 for 10 min at room temperature. The cells were washed two times
with PBS (500xg, 5 min, room temperature). After the washing step, the cells were resuspended
in PBS (500 μL), 5μL of cell resuspension was put on positively charged slides and put Zeiss
cover glasses (item number: 474030- 9000-000). The cover glasses were sealed with nail polish,
and subsequently, microscopy was performed.
Samples were visualized using an upright Zeiss Examiner.Z1-based 880 LSM with a 100x/1.46
oil- immersion objective. DAPI was excited using a 405 nm diode laser, mCherry was excited
with a 561 nm DPSS laser, and GFP was excited with an Argon laser tuned to 488 nm. Optical
sections (0.3 μm) were acquired with an Airyscan super-resolution detector and were
processed using ZEN Blue v. 2.3.

2.5.13 Generating Tetrahymena thermophila expressing YFP plasmids without
(polyA-) and with (polyA+) coding for 12 lysines
Tetrahymena thermophila strain B2086 (II) was used for all experiments reported. Similar
results were obtained with strain CU428 [(VII) mpr1-1/mpr1-1]. To assess the effect of LysAAA
codons on protein accumulation, we modified a fluorescent protein tagging vector, pBSICY110

gtw110 so as to fuse YFP to the carboxyl-terminus of a macronucleus-localized protein of
unknown function (TTHERM_00384860), separated by a Gateway recombination cassette
(Invitrogen/Life Technologies, Inc), and expressed from the cadmium inducible MTT1
promoter111. The TTHERM_00384860 coding region was amplified with oligonucleotides 5’ ALM
Bsi’ 5’ - CAC CCG TAC GAA TAA AAT GAG CAT TAA TAA AGA AGA AGT-3’ and 3’ ALM RV 5’- GAT
ATC TTC AAT TTT AAT TTT TCT TCG AAG TTG C 3’ and cloned into pENTR-D in a topoisomerase
mediated reaction prior to digesting with BsiWI and EcoRV and inserting into BsiWI/PmeI
digested pBSICY-gtw. Subsequently, LR Clonase II was used to insert a linker containing the
sequence coding for an HA epitope tag alone (N) or the tag plus 36 adenosines (K12) in place of
the Gateway cassette. The expression cassette is located within the 5’ flanking region of a
cycloheximide resistant allele of the rpL29 gene to direct its integration into this genomic locus.
These constructs were linearized with PvuI and SacI in the region flanking the Tetrahymena
rpl29 sequences and introduced into starved Tetrahymena cells by biolistic
transformation112,113. Transformants were selected in 1X SPP medium containing 12.5 μg/mL
cycloheximide. To control for copy number, PCR assays with primers MTT2386 5’- TC TTA GCT
ACG TGA TTC ACG -3’and Chx-117, 5’- ATG TGT TAT TAA TCG ATT GAT -3’ and Chx85r, 5’- TCT
CTT TCA TGC ATG CTA GC – 3’ verified that all rpL29 loci contained the integrated expression
construct. Transgene expression was induced by addition of 0.4 μg/mL CdCl2 and cells were
grown 12-16 hours before monitoring protein accumulation. YFP accumulation was visualized
by epifluorescence microscopy as previously described114. Whole cells extracts were generated
by boiling concentrated cell pellets in 1x Laemmli sample buffer, followed by were fractionation
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on 10% SDS polyacrylamide gels and transferred to nitrocellulose. YFP accumulation was a
monitored with mouse anti-GFP antisera (G28R anti-GFP (OAEA00007) antibody, Aviva Systems
Biology) and normalized to acetylated Rabbit anti- Histone H3 trimethyl-lysine (Upstate
Biotechnologies/Millipore, NY, 07-473). Accumulation of transcripts was assessed on Northern
blots as previously described using a 32P-random-primer-labeled YFP probe115.

2.5.14 2 D-electrophoresis
2 mL (100% hct) of P. falciparum infected erytrocyes (HA-pelo Dd2 strain, parasitemia 7-9%)
were treated with PBS saponin 0.15%, and protease inhibitor w/o EDTA. The pellets were
washed in PBS- saponin buffer 3 times. Afterwards, the samples were used to do
immunoprecipitation (IP). We used Pierce HA-magnetic beads 25 μL and further proceeded
with cell lysis: Lysis Buffer: 150 mM NaCl, 50 mM Tris pH 7.5, 1% IGPAL-CA-630 (Sigma, #I8896),
5% Glycerol, Protease (1mM PMSF) and phosphatase inhibitors. Sample wash: Wash Buffer: 150
mM NaCl, 50 mM Tris pH 7.5, 5% Glycerol. After the washing step the samples were snap frozen
in liquid nitrogen for 2D gel analysis.
Two-dimensional electrophoresis was performed according to the carrier ampholine method of
isoelectric focusing116,117 by Kendrick Labs, Inc. (Madison, WI) as follows: Isoelectric focusing
was carried out in a glass tube of inner diameter 2.0 mm using 2% pH 3-10 isodalt servalytes
(Serva, Heidelberg, Germany) for 9600 volt-hrs. One μg of an IEF internal standard,
tropomyosin, was added to the sample. This protein migrates as a doublet with lower
polypeptide spot of MW 33,000 and pI 5.2. The enclosed tube gel pH gradient plot for this set
of ampholines was determined with a surface pH electrode.
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After equilibration for 10 min in Buffer 'O' (10% glycerol, 50 mM dithiothreitol, 2.3% SDS and
0.0625 M tris, pH 6.8), each tube gel was sealed to the top of a stacking gel that overlaid a 10%
acrylamide slab gel (0.75 mm thick). SDS slab gel electrophoresis was carried out for about 4 hrs
at 15 mA/gel. After slab gel electrophoresis, the duplicate gel for blotting was placed in transfer
buffer (10mMCaps, pH 11.0, 10% MeOH) and transblotted onto a PVDF membrane overnight at
200 mA and approximately 100 volts/ two gels. The following proteins (Millipore Sigma) were
used as molecular weight standards: myosin (220,000), phosphorylase A (94,000), catalase
(60,000), actin (43,000) carbonic anhydrase (29,000) and lysozyme (14,000). These standards
appear as bands at the basic edge of the Coomassie Brilliant Blue R- 250-stained membrane.

2.5.15 Coding Sequence Metrics
Coding sequences for each organism (Plasmodium falciparum 3D7 - EPr 1, Tetrahymena
thermophila – JCVI-TTA1-2.2, and human - GRCh38.p7) were downloaded from their respective
Ensembl BioMart pages (accessed on March 19th 2018). Each set of genes was filtered to
include only the longest coding sequence variant. The resulting sequences were each analyzed
using a folding window approach; a window of 120 nt was scanned across each sequence with a
single nucleotide step size. Each window sequence was folded (using RNAfold) to determine its
minimum free energy structure/value (MFEnative)118. At the same time, MFE values were
calculated for 30 randomized versions of the native window sequence (MFErandom). The mean
of MFErandom values were compared to that of the native in a method adapted from Clote et
al., 2005 and illustrated in the following equation:
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The mean window MFE and z-score values of each gene were calculated and compiled in
separate spreadsheets. Box and whisker plots (generated using BoxPlotR119 are shown,
depicting the distribution of these means for each organism.

2.5.16 Bioinformatics analyses
2.5.16.1 Ribosome profiling
GWIPS database was used as the source of ribosome profiling data. We downloaded Caro et al.,
2010 dataset for Plasmodium falciparum (the only dataset available for that species), while for
humans, we used aggregate for all deposited studies. In both cases, we took a dataset for
elongating ribosomes mapped to A-site.
The definition of polyA-tracts was taken from Arthur et al., 2015, which is twelve consecutive
adenines allowing for one mismatch. Genomic coordinates of such segments were downloaded
from PATACSDB31. We took 50 residues upstream and downstream from the beginning of the
polyA segment, preserving the proper strand orientation. Occupancy plot was generated with
two conditions:
1. discarding fragments that had less than five occupancy values in the given window of

101 nucleotides
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2. taking into account fragments that had the average occupancy equal or higher than the

mean for the dataset (this was to remove the influence of poorly mapped segments
from the plots)
To make occupancy plots between different life stages comparable (SUPPLEMENTAL FIGURE 2.5),
we have introduced a normalization mechanism, where occupancy of polyA region was divided
by a mean from similarly sized distribution of random fragments of the same length that had
the 0 position within the coding region. Randomization was preserving chromosome
distribution of the original polyA-carrying genes dataset. All the analyses were done using R
language.
2.5.16.2 Gene ontology analysis
Gene Ontology analysis was done using the Gene Ontology Enrichment tool at PlasmoDB
website29, using default options. For SUPPLEMENTAL TABLE 2.1 we took only those terms that had
Bonferroni-adjusted p-value better than 0.05.
2.5.16.3 Structural analyses
Structural analyses were done using MOLEonline service version 2.5120 using default
parameters, with manual selection of the proper tunnel among all predicted by this service.
Due to limits of the method, it was not possible to enforce the same length of the channel in all
structures, yet the hydrophobic patches formed by interaction with rRNA and L4/L22 proteins
were easy to observe in all structures.
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Figure 1—figure supplement 1. Percentage of genes with !12A (white) and !12A-1 (gray) consecutive adenosine nucleotides for each organism.
SUPPLEMENTAL FIGURE 2.1 | Percentage of genes with ≥12A (white) and ≥12A-1 (gray) consecutive adenosine nucleotides for each
Number of genes was calculated as percentage of total number of genes with !12 or!12A-1 consecutive adenosine nucleotides over total number of
genes
for each organism.
organism.
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Figure 2-figure supplement 1.
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SUPPLEMENTAL FIGURE 2.2 | Generalized scheme of reporter constructs used for expression in H. sapiens, T. thermophila, and P.
falciparum.
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SUPPLEMENTAL FIGURE 2.3 | Generalized schematic of Thioredoxin fusion NanoLuc reporter construct used for episomal expression
in P. falciparum cells (Trx-2HA-Nluc) .
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SUPPLEMENTAL FIGURE 2.4 | HA-pull-down assay of -polyA36, +polyA36 reporters.
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x

SUPPLEMENTAL FIGURE 2.5 | Ribosome occupancy around polyA segment of P. falciparum transcripts (summarized across all life
stages) and grouped by polyA segment length (12–68 adenosine nucleotides in a row transcripts are shown).
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Figure 4-figure supplement 2.

SUPPLEMENTAL FIGURE 2.6 | Occupancy of elongating ribosomes (mapped to A-site) around start of polyA segment in Plasmodium
at different life stages.
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PF3D7_1464200zincfingerprotein
ATGGAAAAAATAAACGACAAGGCCATTTTAGAGAAAATATCTGACATAACAGGAAATACAACCAAGAATACTCTTCTTAGCTTTAAAAAAAAGAAGAAAAAAAAAAAAAAAAAAA
ATGTAGATGTAAGCGGAGATAAAACGAAAAAGATAAAAAATAAAAAAATTAACAAGACAGAAAACACTTTTGATAATTTTAAATATGAACCAAAAAAAGAAACATGTAAATTTTT
TTTTAAAAAAGGGAAATGTATACATAATGATAAATGTACTTATTCACATGATGTTATTCCAATATATAAAATATCAAAGTTATGTAAATTTTTAGTTAAAGGTACATGTCATAAA
CAAAATTGTATCTTTTCTCATGATTATCAACTTTTTTATTGTCGTAATAATGTTATATATAATTCATGTCATAATCCTGCATGTAAATTTAAACATGTAAAAATAGATAATAGTA
TTAATAATGCAGATGAATATAATAAAGAAGTAGATAATGTTCTAACAAAAGATGATAAAATTAGATTTCTTTATAATAATAAAAATTATATAATGGAGTTATTAATTCATAAATA
TCATACTTTTGATAATACGGATCATAAAATAAATATAGATAATTTAATAAAAAAAAATAATTATCCATGGTTTATTAATGGAATTATAGATATTATTAAGTTAGACTTTAAATAT
AATAAAGCAGATAGTTTTTTTAAATTAATAAATATAGCCAAAAATAATCAAAATAATAATTTAAAATCATACATGGATAATTCTGCTAATCAAAATGATCAAAATAATGATCTTA
CAAATAACACAAATGTCAATAATCAAGATATTAAATCATCACAGCCGTCAATAAAAGATGGGGAATTCAAAAATAATAATGATAATCAAAATGGGGATAACAAATTAGAAAATAA
TGTGGAACAAAATTTCGATGACTATAATTTCTATTCAAGTGAAGAAGAAGATTATACGCAGTACTTGAATAAGTACTTTGACATGGACACATAA
PF3D7_0615500cdc2-relatedproteinkinase5
ATGTTTGGAATTACATTAACAAAGTGCAAAATATACTTCAATAATATATATTCGACCGTATCTCTCGAAGAAAAATTAGGGGGGGGCACCTATGGTGACGTGTACAAAGGGAAAG
TAATAAAATATAATAATAATAATAATAATAATGATTTATATCAAAATACAAATTATTTACCTTATGATTATTATACTGATGAATTTGTTTTTTTTCGTAAAAATGTTTATGCCAT
AAAATTTTTTCGAGACGATTTAAGGACCATAAATGAAGAAGGTATAAGTTGTACAACATTAAGAGAATTAAGCTGTTTAAAAAATATTGGGAGGCATCCTAATATCCTTCGTTTA
ATAGATGTTACTATAGATAGACAAAAGCTTATAAGTGAATATATAAATAGACAGATATTACAACATTATACATCAAATTATCATCATCATCATCATAGTAAATTAGATATCACAC
CCTTGGCAGCTGATCAGAAATTTATTTTTGCTGCTTATGAATATTGTGATGGTGGAGATCTAAAAAAGCTTATACAAAAAACAAAAATTAGTGATGATCAAGCGGGACTTAATTT
GAAAGAAGCCAAATGGCTATCCTTCCAACTATTAAATGGATTAGCTTATTTACATAATAATAAAATGTGTCATAGAGATTTGAAACCTGAGAATGTTATGTTACAAGAGACATCT
AATCATAAGTATCTTTTAAAAATTGGAGATTTAGGTTTATGCAGAGAATTAAAAAACGATGGTGACATGACACCTACTGTTTGTACAATATATTACCGACCTTTGGAAGTGCTGC
TTTCGAAATTTGAATTATCTAATAAGCATCATCATAAAAGTCATGCAACAAATCATAGAAGGGATGACAATGATGATGATGAAGATGAAGATGATGATGATGATGAAGATGAAGA
TGATGATGATGAAGAAGAAGAAGATGACGATGTAGATGAAAATGTAGAAGTAAAATTACATGGTCGTAATAAAACTAGTAGTAATAATAAAAATAATAATAACAAAAACCATAAT
AGTAACATTAATTATAATAACCACAATTGGAGTCGTCGTAAAAATAAAATGAAAAAAAAAAAAAAAAAAAAGAAAAAAAAAAAAGAGCAAGATGATGATTATTATAATAAAGATT
TTCAATATGGTTTAAATGTTGATATATGGTCAGCTGCATGCATTATATGTGAACTTATTATTGGAAGACCTCTTTTTAAAGGAGTCACAGAATTCGATTTGATTATTAGGATCGT
TAATTCTTTAGGTAAACCTAATAAAGATGAACTAGAATTTTTTAGTAATTCCCGTTTTTATCCTTTAAAGGAGGATTTTTTTAATGTTCATATAAAAAATAAAAAGGATGCTTTA
AACGTTATTACGAATGGACGAATAGACGAGTTAGGTATTGATTTGCTTGTTAAGATGTTGAAATATAATCCGAATGATCGTATTACGGCAGCTGATGCTTTATCGCATCCTTGGT
TTTCAGATATAAGATTTGATAACTTGGATGGTATAGGTGTTTATAATTGGTATGTACATTGTTTAAAATATTATATTGGTATTAAAACTTTTAGAGAAATTGAACAAAAAAAAAA
AAATTTACTTACGACAACTATGATTTCTCATTTTTTATGTAAATCAAATGATAAGTATGCTAAGGTTATTTTTAAGTTAATTAATGATACCTTTAAAAATTTAGGAGGATATAAA
AAAAGTGGACGAAGATCTTTTGCTATTTTTTCAGATAAATATGCTCATGATGAAAAGAATACAAATGGATTTATTAAAAGAGCAAGTATTAAAGTATTAAATGATATGAAAGAAA
AAAATGTGAAAGAAACAAAAGAAGAGTTTTCTTTTTATGATGAAAGTACAACTTATATGACACCACCAACATCTGTTAAAAGAAGAAAATTCAATAGATCAAGTTATCATGTTAT
GAACCCAGAACATTCATATGAATTTACAAATAAAATCAGAATGAAAAGAAATCTATCCATTCCAGATTTTTCAACACCTGATAAAAGTATACAAAAACAAAAAAAAATAAAAGCT
GCTACGACAAAGAATAAAGCAAGTCATCTAGAATTTTCTCATTTTTAA

x

PF3D7_1108000IWS1-likeprotein
ATGGATAGCGATTCAAATAAGAATGACCACGAGTCGTTAGAAAACTCAGGTTTATTCAACGACGAAAATGCATCTGATGGAAATAATGTTGAGAACTTTAAGAAAAAAATGAAAA
TGATAAAAGTATTAAATGTAAAGAAAAATAAAGAAATAAAGAAAGATAGAAAGGATAAGAAGAAAAGAAAACTTCAAAGGATTATCGATGATGATAATGAAGATGAAGATGATGT
TATTGAGAAAGAAAATGATCAAGGAAAAGATCAAGGAAAAGATCAAGGAAAAGATCAAGGAAAAGATCAAGAGGATGTGTTTCTTTTTGGTAATGATGATTTGGTTGAAGAGGAT
GAGGAGAGACATAAGAAGAAAAGGAAAAAAGAAAAGGAAGAAAGAGGTAAACACAAAAAAAAAAAAAGTATAAAGCGAATAATGGAAAATGATGATATGCACAAGGTTCATAGTG
ATGATAGTAATTATAATAATAATAACAATAATATTAGTGATGATAATAATAATAATAATATTAGCGATGATTATAATAATAATAATATTAGCGATGATGATGATAGTAATAATAG
TGATAGCAGCTATGATAATACTATGAGTGATCATAGTGATATGAAGAAGAAGAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAGCGAATTTATCGATACCATTGCAGAAGAAGGT
GATGAAGATGAAAAAGAAGAAGATGACGATTATGATGATGAAAATAATATAAATATAGATAAAATGACCAACGAAAATAAAAAATCGAAGAAAATAGATTTTGATAAATTAGGCT
TAGGTGATGATGATGAAGACGAGGATAATTATATGAACGATTTTGGAAATCATTCTAATATATCTGAAAAAAAAAAAAAATCTCATTTTGACGAAATATTAGAAAATTTTAAATC
GAAAAGAAAAAGAGTTCATAAAATTTCAGAAGATGATGGATTAGAATATTGTGAAAATATTTTGAATCAGATGATATTAATGCATGAACAAGATTTAAAAAGTATGAAAGAAAAA
AAACCAGCAACAGCTAAATTACAAATTATAGATAATGTTTGTAAAATATTGACAAAACCGAAATGGAAACCATTCTTTATGAAACTAAATATATATCATGTATTAGCCTTATGGT
TGATGCCGACATCCAAAAATACATTACCCAATTTTACTATAAGAACGAATTTATTAAAAGTAATTCAACAATTACCAATTACTATTAAATCATTAAGAGGAAGCCAGCTAGGAAA
AATATTGACTTACCTACATTCACATAAACATGAAACAGAAGAAAATAAAAAACTCATAAAAAATATTATGCAAAATTGGATGGGCCCAATTATAGGAATTAATACGAACTATAAA
CAATATTTAAAAGAAAGACAAAAAAGGATATCTGAAAATCCTGAATATCACAAAAAAGTTCTTGAAAAGGCAAAAACATTAATACCTGATTCAATATGTATAGAAAAGGAAGAAG
AACAAAATGAAATGAAAAGACATGCAAGTATTCCTTATAATAGTGAATGCTCATTTCTAATTAATGTCCCCTCTTCTATACCTAGTATTAGTAAAAAAATCATTCCCAAAAGTAA
AATTAAGAGGTTAACAGATAATATGAAATTGTTAAAAAGATGTAAAAAAATGCAAAAGGTTTCAATTGAAGGAAAGGGTGTAGCTGTTGCACCATAA
PF3D7_1462800glyceraldehyde-3-phosphatedehydrogenase(GAPDH)
ATGGCAGTAACAAAACTTGGAATTAATGGATTTGGTCGTATCGGACGTTTAGTATTTAGAGCAGCCTTTGGAAGGAAAGATATCGAAGTAGTTGCTATTAACGACCCATTTATGG
ACCTTAACCACTTATGCTATCTCTTGAAATACGATTCAGTACATGGTCAATTTCCATGTGAGGTAACCCACGCTGATGGATTTTTATTAATCGGAGAAAAGAAAGTCAGTGTTTT
TGCTGAAAAGGATCCATCTCAAATTCCTTGGGGAAAATGCCAAGTAGATGTTGTATGTGAATCAACTGGTGTATTTTTAACCAAAGAATTAGCTAGCAGTCACCTTAAGGGAGGA
GCCAAGAAGGTTATTATGTCCGCCCCACCAAAGGATGACACCCCAATTTATGTTATGGGTATTAACCACCACCAATATGATACCAAACAACTTATTGTTTCCAATGCATCATGTA
CCACAAACTGCTTAGCTCCATTAGCTAAAGTTATTAATGATCGTTTTGGAATTGTTGAAGGTTTAATGACCACCGTTCATGCATCCACTGCTAACCAATTAGTTGTTGATGGTCC
ATCAAAGGGTGGTAAGGACTGGAGAGCAGGTAGATGTGCATTATCCAACATTATTCCAGCTTCCACTGGTGCAGCTAAAGCTGTAGGTAAAGTTTTACCTGAACTTAATGGAAAA
TTAACAGGTGTAGCTTTCAGAGTACCAATTGGAACTGTATCAGTTGTTGATTTAGTTTGCAGATTACAAAAACCAGCAAAATATGAAGAAGTTGCTTTAGAAATTAAAAAAGCTG
CTGAAGGTCCACTTAAAGGAATCTTAGGATACACTGAAGATGAAGTTGTTTCTCAAGATTTCGTTCATGATAACAGATCATCAATCTTTGACATGAAAGCTGGTTTAGCCTTAAA
CGACAATTTCTTCAAATTAGTTTCATGGTACGATAATGAATGGGGATACTCAAACCGTGTTCTTGATTTAGCCGTACACATTACTAACAACTAA

SUPPLEMENTAL FIGURE 2.7 | Sequences of three P. falciparum polyA tract genes (PF3D7_1464200, PF3D7_0615500,
PF3D7_1108000).
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SUPPLEMENTAL FIGURE 2.8 | Endogenous polyA genes are expressed in P. falciparum. Time course mRNA expression analysis of
three genes (PF3D7_1464200, PF3D7_0615500, PF3D7_1108000) containing polyA stretches of varying lengths (largest: 20, 20,
and 31 adenosines respectively) normalized to GAPDH (PF3D7_1462800) starting with highly synchronized rings at time zero.
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Figure 4-figure supplement 5.

A.

B.

SUPPLEMENTAL FIGURE 2.9 | MFE from scanning window analysis in H. sapiens, T. thermophila, and P. falciparum. Box and whisker
plots showing the distribution of mean folding energy values (kcal/mol; measures the stability of RNA structure) calculated for
each coding sequence from H. sapiens, T. thermophila, and P. falciparum, resulting from a scanning window analysis (SEE MATERIALS
AND METHODS).
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Figure 5-figure supplement 1.
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SUPPLEMENTAL FIGURE 2.10 | Alteration of endogenous PfPelo gene by CRISPR/Cas9. (A) Schematic of CRISPR/Cas9 engineering of
P. falciparum Pelo (PF3D7_0722100 gene; human Pelo homolog). Two sets of gRNAs creating clone 1 and clone 2(red) were used
to create independent clones 1 and 2. Recombined sections of PfPelo gene are indicated in purple and gray, respectively. Primers
used for creation of recombinant DNA and target sequences of gRNAs are indicated in teal, yellow and red, respectively. (B)
Western blot analysis of endogenous HA-tagged PfPelo protein from two Cas9 engineered clonal lines (Clone one and Clone 2) of
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P. falciparum Dd2 cells. Control (con) represents non-engineered P. falciparum Dd2 parent line. Biorad Precision Plus Protein
molecular weight markers (MWM) are indicated.

Figure 5-figure supplement 2.
StL

VPDYAELDIPWRGAWWRLQPPPRAPPRHIVDVSKGEED
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SUPPLEMENTAL FIGURE 2.11 | Schematic of stem-loop reporter construct (StL) used for expression in P. falciparum.
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Figure 6-figure supplement 1.

SUPPLEMENTAL FIGURE 2.12 | Schematics of nine P. falciparum genes with runs of 3 and more consecutive isoleucine (Ile) residues
used in analyses shown in FIGURE 6D.
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ure 7-figure supplement 1.
H. sapiens 80S Ribosome
(3JAG)

P. falciparum 80S Ribosome
(3JBO)

x

SUPPLEMENTAL FIGURE 2.13 | Structure of P. falciparum (PDB code: 3JBO) and H. sapiens (PDB code: 3JAG) ribosomes with receptor
for activated kinase C (RACK1) in magenta, previously shown to be absent from Plasmodium ribosomes (60S in green, 40S in
cyan).
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Figure 7-figure supplement 2.
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CUGCAACUCGACUCCAUGAAGUCGGAAUCGCUAGUAAUCGUGGAUCAGAAUGCCACGGUGAAUACGUUCCCGGGCCUUGUACACACCGCCCGUCACACCAUGGGAGUGGGUUGCAAAAGA
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SUPPLEMENTAL FIGURE 2.14 | Segment of sequence alignment of 18S rRNA from P. falciparum (Pf18SA and Pf18SS, A- and S-type
of ribosomes), H. sapiens (Hs18S), S. cerevisiae (Sc18S), T. thermophila (Tt18S) and E. coli 16S (Ec16S).
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Figure 7-figure supplement 3.

x

SUPPLEMENTAL FIGURE 2.15 | Polypeptide exit channel from Haloarcula marismortui ribosome (PDB: 1jj2) has one long fragment
of relatively hydrophobic lining of the tunnel at the entrance (between PTC and constriction site).
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SUPPLEMENTAL TABLE 2.1 | GO Term analysis in P. falciparum.
Bgd count

Result
count

Pct of bgd

single
organismal
GO:0016337
cell-cell
adhesion

57

56

98,2

1,56

33,76

8,98E-11

6,69E-08

1,34E-07

single
GO:0098602 organism cell
adhesion

57

56

98,2

1,56

33,76

8,98E-11

6,69E-08

1,34E-07

GO:0007155 cell adhesion

77

71

92,2

1,47

7,15

2,66E-09

1,32E-06

3,97E-06

GO:0009405 pathogenesis

101

81

80,2

1,28

2,44

ID

Name

Fold
Odds ratio
enrichment
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P-value

Benjamini Bonferroni

0,00010834 0,04035608 0,16142433

Ribosome Quality Control

No-Go Decay/Non- Stop Decay

SUPPLEMENTAL TABLE 2.2 | Constituents of NGD/NSD, and RQC pathways in H. sapiens and P. falciparum.

Homo sapiens

Plasmodium falciparum

Pelota

+

+ (PF3D7_0722100)

HBS1L

+

-

RACK1

+

+ (PF3D7_0826700)

XRN1

+

+ (PF3D7_0909400)

N4BP2 (Cue2, Nonu-1)

+

-

CNOT4

+

+ (PF3D7_1235300)

ABCE1

+

+ (PF3D7_1368200)

ZNF598

+

+ (PF3D7_1450400)

ASCC3 (Slh1)

+

+ (PF3D7_1439100)

NEMF

+

+ (PF3D7_1202600)

Listerin

+

+ (PF3D7_0615600)

UBE2D1

+

+ (PF3D7_1203900)

145

Chapter 3: Immunoprecipitation of RNA
Species via Aptamer Tagging in Plasmodium
falciparum
3.1 Abstract
The AU-rich transcriptome and multiple, distinct ribosomes of P. falciparum, as well as other
Plasmodium spp., lend the organism to significant study in the realm of protein synthesis. The
ability to translate lengthy polyA tracts and the multiple ribosome types are hallmarks of the
genus. High-fidelity translation of polyA tracts in P. falciparum appears to be driven by multiple
factors, however the extent and impact of ribosome modifications, identity and function of
aiding RBPs, as well as the functionality and tailoring of RQC machinery are all unknown. While
the ribosomes of Plasmodium spp. exist as a regulated, heterogeneous pool, the factors that
recognize environmental cues and subsequently drive alteration of the ribosome population
remain elusive. More fundamentally, does the heterogeneous pool ribosome subunit types lead
to heterogeneously derived 80S ribosomes and, if not, how is this maintained?
Current methodologies used in Plasmodium spp. are unable to address these questions because
of their inability to extract and examine specific parts of the dynamic whole directly. Here, we
demonstrate two applications, PP7 mRNA immunoprecipitation (PP7-mRIP) and MS2 rRNA
immunoprecipitation (MS2-rRIP), never before implemented in P. falciparum using different
bacteriophage coat proteins each recognizing their own RNA aptamer. The PP7-mRIP assay is
146

able to generate differential, substrate-driven mRNA proteome profiles, the constituents of
which are identifiable by mass spectrometry. The MS2-rRIP assay demonstrates significant
enrichment of tagged versus untagged ribosomes. PP7-mRIP and MS2-rRIP allow for the direct
examination of mRNA-bound proteomes and distinct ribosome types, respectively, in P.
falciparum and therefore could prove instrumental in answering many of the long-lingering
questions surrounding post-transcriptional gene regulation and ribosome switching in malaria
parasites.

3.2 Introduction
The AU-rich transcriptome1–6 and multiple, distinct ribosomes7–13 of P. falciparum, as well as
other Plasmodium spp., lend the organism to significant study in the realm of protein synthesis.
The ability to translate lengthy polyA tracts and the multiple ribosome types are hallmarks of
the genus. While some of the “hows” and “whys” surrounding these peculiarities have been
discovered1,2,14,15, many remain unclear. For instance, the high-fidelity translation of polyA
tracts in P. falciparum appears to be driven by multiple factors: the ribosome, proteins (RBPs,
RNA helicases, etc.), and the ribosome-associated quality control machinery1,2,16,17. However,
the extent and impact of ribosome modifications, identity and function of aiding RBPs, as well
as the functionality and tailoring of RQC machinery are all unknown.
Expressing multiple ribosome types, although not a common phenomenon found throughout
the kingdoms, is not exclusive to nor unexpected of Plasmodium spp. where protein synthesis
occurs in multiple hosts with dramatically different system temperatures. Even bacteria have
rRNA genes associated with stress response18. An analysis of curated 18S sequence data from
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the various EuPathDB databases show that other Apicomplexa phylum members such as
Cryptosporidium and Babesia, as well as those of the phylum Microsporidia (e.g.
Encephalitozoon spp.), appear to have multiple 18S rRNAs (FIGURE 3.1)19; all of which can be
human infective.
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Plasmodium spp.

FIGURE 3.1 | Evolutionary tree of 18S/16S rRNAs from selected species. The 18S rRNA sequences collected from EuPathDB19,
Saccharomyces Genome Database20, and EcoCyc E. coli Database21 and a phylogenetic tree generated using RStuio.

The ribosomes of Plasmodium spp. exist as a regulated, heterogeneous pool11, with one type
being the dominant member during different points in the parasite life cycle. The regulation of
ribosome population dynamics in P. falciparum are linked to parasite development11,13,14,22,23
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and enthalpy changes driven by the parasites’ environment15. The parasite alters the ribosome
population by increased transcription of one ribosome type24 and active rRNA degradation of
the other14. However, what is unknown are the factors that recognize environmental cues and
subsequently drive alteration of the ribosome population. At an even more root level: while
both subunit types exist within the pool, are the 80S ribosome comprised of homogeneous or
heterogeneous subunits and, if so, how is this maintained?
Current methodologies used in Plasmodium spp. are unable to address these questions because
of their inability to extract and examine specific parts of the dynamic whole directly. Here, we
demonstrate two applications, PP7 mRNA immunoprecipitation (PP7-mRIP) and MS2 rRNA
immunoprecipitation (MS2-rRIP), never before implemented in P. falciparum using different
bacteriophage coat proteins each recognizing their own RNA aptamer. The PP7-mRIP data show
the ability of the assay to identify mRNA substrate-specific RBPs showing the assay’s potential
in identifying RBPs associated with mRNA translation in the parasite; particularly those involved
in polyA translation fidelity. While the MS2-rRIP assay is able to enrich tagged rRNAs over the
untagged rRNAs, allowing for further detailed study of the multiple, distinct Plasmodium
ribosome types, nonfunctional ribosome decay, and more.
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3.3 Materials and Methods
3.3.1 Parasite culture and transfection
P. falciparum Dd2 was cultured at 2-5% hematocrit in O+ erythrocytes in Malaria Culture
Medium (MCM): RPMI 1640 supplemented with 5 g/L Albumax II (Gibco), 0.12 mM
hypoxanthine (1.2 mL 0.1M hypoxanthine in 1 M NaOH), 10 μg/mL gentamicin25. Cultures were
grown statically in candle jar atmosphere. As required, cultures were synchronized with 5%
(wt/vol) sorbitol.
Asynchronous P. falciparum Dd2 parasites were washed twice in 15 mL incomplete Cytomix (25
mM HEPES, 0.15 mM CaCl2, 5 mM MgCl2, 2 mM EGTA, 120 mM KCl, 5 mM K2HPO4, 5 mM
KH2PO4) and resuspended in a total 525 μL with 100 μg of maxi-prep plasmid DNA dissolved in
incomplete cytomix (125 μL packed iRBCs and 400 μL DNA/incomplete cytomix), The parasites
were transfected in Bio-Rad Gene Pulser cuvette (0.2 cm), 0.31 kV, 950 up, infinity resistance.
Selection (10 nM WR99210 or 2 μM DSM-1) was added to parasite 48 h after transfection and
used to select resistant parasites26.

3.3.2 Saponin lysis of infected red blood cells (iRBCs)
The cell iRBCs were resuspended in two volumes of PBS containing 0.15% saponin, and
incubated on ice for 10 min, with vigorous mixing every 3 min. Afterward, the samples were
centrifuged 7000g, 5 min, 4°C, and the pellets were washed three times more with the same
buffer.
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3.3.3 Cap Protein Expression and Purification
Briefly, 2.5 mL of overnight culture was inoculated into 500 mL LB-carb and grown to an OD of
~0.6 (about 3 hours). The Rosetta Blue (Millipore Sigma #71059, St. Louis, MO) or BL21 Star
(Thermo Fisher Scientific #C601003, Waltham, MA) cells were then induced with a final
concentration of either 0.5% arabinose of 1 mM IPTG for 4 hours. The cells were collected by
centrifugation and the supernatant aspirated. The cells were resuspended in total of 10 mL
TGI+PI buffer (20 mM Tris-HCl pH 7.5, 10% glycerol, 20 mM imidazole with protease inhibitors)
and stored overnight in -20℃. The inductions were then thawed and sonicated using a probe
sonicator (Amplitude 60, 10 sec on, 45 sec off, 5 mins) on ice. Cellular debris was removed by
centrifugation (18,000 x g, 4℃, for 30 min). The supernatant was treated with DNaseI for 20
min on ice. It was then filtered through 0.22 μm syringe filter. The FPLC Ni-NTA column was
washed with 5 column volumes (CV) of TGI Buffer with 250 mM NaCl. The clarified lysate was
loaded onto the column. The column was washed with 10 CV of TGI Buffer with 250 mM NaCl.
The protein was then eluted in three steps with a combination of TGI and TGI with 250 mM salt
and 550 mM imidazole (TGI+) buffer: 1) 95% TGI, 5% TGI+, 2) 62% TGI, 38% TGI+, 3) 100% TGI+.
Those containing purified protein were pooled. Samples were concentrated using an Amicon
Ultra centrifugal concentrator (Millipore Sigma, St. Louis, MO) with a 3 kDa cutoff and applied
to a gel filtration column (GE Healthcare HiPrep™ 26/60 Sephacryl™ S-200 HR Cat #170119501), previously washed with 0.5 column volumes of distilled water at 1.3 mL /min, then 2
column volumes of TBS at 2.6 mL/min. The column was eluted into 100 fractions. Fractions with
a 260 nm peak were analyzed by SDS-PAGE and Coomassie blue staining. Samples with the
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purest protein were again pooled, concentrated, and buffer exchanged (TGI with KCl and
protease inhibitors) using an Amicon Ultra centrifugal concentrator (Millipore Sigma, St. Louis,
MO) with a 3 kDa cutoff.

3.3.4 Design of 3xFlag-PP7 cap protein and PP7 aptamer tagged reporter
constructs
The 3xFlag tagged PP7 cap protein (3xFlag-PP7cp) was designed with a 3xFlag tag motif
followed by an enterokinase cleavage site with an additional human rhinovirus (hRV) 3C
protease cleavage site allowing for optional protease cleavage elution during RNA affinity
immunoprecipitation. This was followed by the Pseudomonas aeroginosa bacteriophage 7 coat
protein (PP7cp)27 amino acid sequence. The construct was cloned using Rosetta Blue cells into
the pBAD arabinose-inducible vector using the NcoI and XhoI sites, which add a 6x histidine tag
for purification of the 3xFlag-PP7cp protein, to generate the pBAD-3xFlag-ppSite-PP7cp-6xHis
construct. Clones were selected and confirmed by Sanger sequencing (Genewiz, South
Plainfield, NJ). The selected clone was then induced with a final concentration of 0.5%
arabinose to express the 3xFlag-ppSite-PP7cp-6xHis protein and fractions isolated as above.
Fractions were examined by SDS-PAGE and Coomassie blue staining. The sample was then
analyzed by western blot.
The mRNA reporter constructs were generated by adapting previously used mCherry-GFP–
expressing plasmids28 to have tandem 3ʹ UTR PP7 and tobramycin aptamers separated between
and on each side by non-structure forming CAA repeats to prevent aptamer collapse. Then,
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upon confirmation by Sanger sequencing (Genewiz, South Plainfield, NJ), then twelve lysines
encoded by the AAA codon (K12AAA) or AAG codon (K12AAG) and the previously used stem loop
(StL) construct were cloned into the vector between the 2xHA tag and the mCherry protein.
Upon confirmation by Sanger sequencing (Genewiz, South Plainfield, NJ), these constructs were
then transfected into P. falciparum Dd2 parasites and selected for the WR drug resistance
marker. Confirmation of plasmid was done by PCR and SDS-PAGE.

3.3.5 Design of MBP-MS2 cap protein and MS2 aptamer tagged ribosomal RNAs
The pMAL-MBP-zz-MS2cp-6xHis protein was generously provided by the Zaher Lab (Washington
University, St. Louis, MO). The plasmid was cloned into BL21 cells. The selected clone was
grown over night and induced with a final concentration of 1 mM IPTG to express the pMALMBP-zz-MS2cp-6xHis protein and fractions isolated as above. Fractions then examined by SDSPAGE and Coomassie blue staining. The sample was then analyzed by western blot.
The 18S A- and S-type rRNAs were generated by PCR from P. falciparum Dd2 cDNA and cloned
into the Zero Blunt™ PCR cloning vector with an N-terminal XhoI site and a C-terminal NotI site.
The clones were verified by Sanger sequencing (Genewiz, South Plainfield, NJ). A PmeI
restriction site was then introduced into the spur region near the 5ʹ end of the gene between
two nucleotides (A-type: A75/T81, S-type: G75/T76) by PCR mutagenesis and Sanger sequence
verified. The MS2 aptamer was then introduced into the region, using the PmeI site to linearize
the vector, flanked by two NheI sites using In-Fusion® recombination cloning (Takara #638910).
The constructs were again Sanger sequence verified. These constructs were then cloned into
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the EOE vector previously used with the XhoI and NotI sites28. The constructs were then
introduced into P. falciparum Dd2 by transfections as described above and selected with WR.

3.3.6 Pre-RIP Sample Preparation
Parasite cultures may be prepared in a variety of ways depending on the RNA species to be
examined as well as the aspect of the parasite life cycle. Here, parasites were grown
asynchronously to a 7-10% parasitemia, with stage emphasis on the increased translation that
occurs during late stage trophozoites, in at least 1 mL of packed RBCs. The parasites as
centrifugated at 500 x g for 5 minutes and the growth media is aspirated from the culture and
replaced with MCM containing 200 μM cyclohexamide (CHX), which is optional, and incubated
for 10 minutes at 37℃. The parasites are centrifuged as above and the MCM+CHX aspirated.
The culture is washed three times with 1X PBS with 200 μM CHX. The parasites are then left on
ice until ready for use. At this point, the parasites may be exposed of UV radiation to crosslink
proteins and RNA. This is done by resuspending the parasites in 5 mL ice-cold with 1X PBS with
200 μM CHX and placing them in a petri dish. The parasites are then placed in a UV-crosslinking
with the lids off and exposed to 400 mJ/cm2 three times for a total of 1200 mJ/cm2 with a oneminute rest on ice, lid closed, while shaking to resuspend the culture between each exposure as
done previously16. However, crosslinking was seen to increase background, potentially
increases nonspecific interactions, and was not done for the data shown here. The parasites are
then lysed with saponin lysis buffer as above with 200 μM CHX and 15 mM MgCl2 can be added
to increase 80S stability. Once the parasite pellet is cleared of hemoglobin, it is ready for
parasite lysis. At this point, the parasite pellet may be store at -80℃ or lysed by resuspension
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in, here 200 μL, of RIP lysis buffer (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 10% Glycerol, 1%
NP40, 15 mM MgOAc, 1X complete protease inhibitors (EDTA-Free), add fresh: 200 μM
cyclohexamide, 1 mM DTT, 1 mM AEBSF, 40 U/mL RNAse Inhibitor) and rotated for 10 minutes
at 4℃. The lysate may also be flash-frozen in liquid nitrogen and stored at -80℃.
Lastly, prior to loading onto the beads, the total protein was measured using the Bio-Rad DC
protein assays. Briefly, a standard curve of biotechnology grade BSA (Amresco #0903-5g) in RIP
lysis buffer was made from a 10 mg/mL stock at concentrations 0.0 μg/μL, 0.25 μg/μL, 0.5
μg/μL, 1.0 μg/μL,1.5 μg/μL, 5.0 μg/μL, 10.0 μg/μL. The sample lysate was diluted 1:5 in RIP lysis
buffer and 20 μL of the diluted sample lysate or the standard was used with 100 μL of Aʹ
reagent (20 μL reagent S for each 1 mL reagent A) and 800 μL reagent B. The sample was
vortexed and incubated for 15 minutes. A NanoDrop 2000c (Thermo Fisher Scientific, Waltham,
MA) was used with disposable cuvettes (BRAND #759075D) blanked with RIP lysis buffer. The
standard curve was read (R2 ≥ 0.9). The sample protein concentrations were evaluated. A total
of 200 μg was used for each sample. Alternatively, total RNA could be measured and used as a
means for equal loading, which requires equipment capable of accurately measuring RNA in a
mixed species sample.

3.3.7 Immunoprecipitation of PP7 aptamer tagged reporter constructs - mRIP
Prior to thawing samples, prepare the protein G magnetic beads as follows. As a single batch
using 12.5 μL of beads volume per sample, wash the beads with 4X total volume (bead slurry is
50% beads) with 1X PBS + 0.1% Tween 20 by inversion for 1 min, collect beads using magnet
and discard supernatant. Resuspend the beads in α-Flag (mAb 1 μg/μL stock) + ice cold 1X PBS +
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0.1% Tween 20 using the same volume as above for the was with 5 μg of antibody per 12.5 μL
of beads (Life Technologies, #10007D, binding capacity: 8 μg Hs IgG/mg beads). Incubate 30
mins at 4℃ while shaking at 1350 RPM. Use the magnet to remove antibody binding solution.
Using the same volume, wash 3x with ice cold of 1X PBS + 0.1% Tween 20, vortexing for 10 s
each and discarding the wash supernatant using the magnet. Next, bind the PP7cp to the
protein G::α-Flag complexed beads and block. Use 10 μg of PP7cp in in 100 μL RIP Lysis Buffer
with DTT/AEBSF but without CHX/RNase Inhibitor per sample. Bind for one hour at 4℃ while
shaking at 1350 RPM. Remove supernatant using magnet and wash 3x with 500 μL Low-Salt RIP
wash buffer (50 mM Tris-HCl pH 7.8, 150 mM NaCl, 10% Glycerol, 0.1% Tween 20, 15 mM
MgOAc, add fresh: 1 mM DTT, 0.1 mM AEBSF, 200 μM cyclohexamide, if desired). Block with
500 μL PP7 blocking buffer (RIP lysis buffer + 0.5 μg/μL of S. cerevisiae tRNAs (Invitrogen
#AM7119 10 mg/mL stock) + 5% BSA) for one hour at 4℃ while shaking at 1350 RPM. Remove
blocking buffer using magnet and wash 3x with 500 μL Low-Salt RIP wash buffer. Store in 100
μL/sample complete RIP Lysis Buffer (w/200 μM cyclohexamide, 1 mM DTT, 1 mM AEBSF, 40
U/mL RNase inhibitor) on ice until ready to be aliquoted into samples. Using 200 μg total
protein for each sample in 100 μL RIP lysis buffer, combine with 100 μL blocked protein G::αFlag::PP7cp complexed beads in RIP lysis buffer. Bind 1 hour at 4℃ while shaking at 1350 RPM.
Using magnet, transfer flow-through into a new, labeled microcentrifuge. Wash beads four
times with 500 μL of Low Salt RIP wash buffer, vortex 10s, using magnet remove and discard
rinses. For increased stringency, wash beads with two to four times with High Salt RIP wash
buffer (Low Salt RIP wash buffer with 500 mM NaCl). Elution may be carried out in a number of
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ways depending on subsequent applications. To elute by hRV 3C protease (GenScript # Z03092),
use 1 μL of hRV 3C protease in 35 μL Low Salt RNA-IP Wash Buffer + 1 mM AEBSF + 40 U/mL
RNase inhibitor and incubate overnight at 4℃ shaking at 1350 RPM. Remove and save o/n hRV
3C protease eluate using the magnet. Again, use 1 μL of hRV 3C protease in 35 μL Low Salt RNAIP Wash Buffer + 1 mM AEBSF + 40 U/mL RNase Inhibitor and incubate 2 hours at 4℃ shaking at
1350 RPM. Remove using the magnet and combine with previous hRV 3C protease eluate.
Finally, 35 μL Low Salt RNA-IP Wash Buffer + 1 mM AEBSF + 40 U/mL RNase inhibitor and
incubate 30 mins at 4℃ shaking at 1350 RPM. Remove using the magnet and combine with
previous hRV 3C protease eluates. This may then be used for downstream processes.
Alternative, the beads may be boiled in sample buffer, but this will increase background. To
elute protein for whole eluate sample mass spectrometry, mass spectrometry elution buffer
(MSE buffer: 2 M urea, 50 mM Tris-HCl (pH 7.5), 1 mM DTT, 5 μg/mL trypsin) was used. To each
sample, 80 μL was added to each tube and incubated for one hour at 25℃ while shaking at
1400 RPM. The beads were washed twice with 60 μL of MSE buffer, using the magnet, and
combining with previous eluates (~200 μL final). The samples were then reduced by adding 4
mM DTT and incubating for 30 mins at 25℃ while shaking at 1000 RPM. Samples were
subsequently alkylated by adding 10 mM iodoacetamide (500 mM stock) and incubating for 45
mins at 25℃ while shaking at 1000 RPM. Finally, samples were digested by adding 0.5 μg
trypsin (0.5 mg/mL stock) and incubating overnight at 25℃ while shaking at 1000 RPM. Samples
were store at -80℃ when complete.
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3.3.8 Immunoprecipitation of MS2 aptamer tagged reporter constructs - rRIP
Blocking of MS2 is dependent on application. If examining rRNA modifications, tRNA should not
be used for blocking as the tRNA modifications will interfere with downstream processing. BSA
may also be used, however can obscure downstream protein bands in SYPRO ruby staining.
Here, MS2cp and amylose resin were blocked with 5% BSA and 0.5 μg/μL of S. cerevisiae tRNAs
for one hour at ambient temperature. To pulldown, use 500 μg of MS2cp in 100 μL RIP buffer
per 100 μL amylose resin to be used. Bind at least 100 μg total protein of each sample to MS2cp
in total of 200 μL RNAIP blocking buffer overnight at 4℃ while rotating. Wash amylose resin
with RIP blocking buffer three times, centrifuge at 2000 x g for 2 mins at 4℃. The samples were
then bound to 100 μL packed amylose resin for one hour at 4℃ while rotating. Samples were
washed three times in 500 μL RIP wash buffer. Optionally, samples can be divided, treating half
with Micrococcal nuclease for one hour at 4℃ while rotating. Again, washed three times in 500
μL RIP lysis buffer. Samples were then eluted for RNA. Samples were eluted using proteinase K
and urea, followed by RNA isolation by acid phenol/chloroform isolation29. Resin was treated
with 200 μL Proteinase K Elution Buffer (160 µL 1.25X Proteinase K Buffer + 5 µL Proteinase K
[100 µg, Qiagen stock 20 mg/mL] + 35 µL molecular grade water -> pre-incubate 10 mins at
37℃ to remove RNase. 1.25X Proteinase K Buffer: 125 mM Tris-HCl pH 7.8, 62.5 mM NaCl, 12.5
mM EDTA). Incubate for 20 minutes at 37℃, shaking at 1000 rpm. Then add 200 µL of PK/Urea
buffer (100 mM Tris-Cl pH 7.8, 50 mM NaCl, 10 mM EDTA, 7 M Urea). Incubate as above.
Alternatively, this can be done by treating sample-bound beads with 500 μL ribozol (VWR N580)
and subsequently following the company protocol for RNA isolation. Centrifuge as above and
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move supernatant (eluate) to new tube. Add 400 µL acid phenol/chloroform. Vortex and let
stand for 5 minutes. Centrifuge at max (16,000 x g) for 15 minutes at 4℃, take aqueous phase.
Add one tenth volume 3 M sodium acetate, pH 5.5 and 2.5 volumes 100% ethanol and vortex. If
desired, at 10 µL glycogen to help with RNA pellet visualization. Incubate overnight at -80℃.
Centrifuge pellet while still frozen at max speed for one hour at 4℃. Remove supernatant.
Wash with 70% ethanol. Centrifuge at max speed for 20 minutes at 4℃. Resuspend in
nuclease free water.
Note: magnetic beads with α-MBP (Sigma: M6295, 6.5 mg/mL binding capability) may also be
used for this protocol, however the amount of MS2cp to be used must be adapted to the
binding capability of the antibody.

3.3.9 Immunoblotting
Samples were loaded onto SDS-PAGE gels, running at 15 W, 1h 10 mins. The gels were then
transferred to PVDF membrane using semi-dry transfer method running at 25 V for 40 minutes.
The PVDF membranes were blocked in 5% milk in PBS + 0.1% Tween 20 (PBST) for 1 hour at
room temperature or overnight at 4℃. The membranes were probed with diluted primary
antibody (SUPPLEMENTAL TABLE 3.2) in PBST with 5% milk. Membranes incubated with HRPconjugated primaries were incubated similarly, proceeding to imaging instead of secondary.
After incubation with the primary antibody, the PVDF membranes were washed three times for
5 min in PBST. Membranes incubated with HRP-conjugated primaries were incubated and
washed similarly, washing with PBS, and then proceeding to imaging instead of secondary. The
membranes were then incubated with HRP-conjugated secondary antibody diluted 1:2500 in
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PBST with 5% milk for 1 hour at room temperature. The membranes were washed as above.
Then rinsed with PBS. Prepare Working Solution by mixing equal parts of the Stable Peroxide
Solution and the Luminol/Enhancer Solution (34577 Supersignal West Pico Plus and 34096
Supersignal West Femto Maximum Sensitivity Substrate, respectively). We incubate the blot in
Working Solution for 5 minutes. Remove the blot from Working Solution and drain excess
reagent. Afterward we took images were generated by BioRad Molecular Imager ChemiDoc XRS
System with Image Lab software.

3.3.10 Protein analysis by SYPRO ruby staining
Samples from immunoprecipitations were loaded onto SDS-PAGE gels, running at 15 W, 1h 10
mins. Gels were then stained with SYPRO Ruby stain (BioRAD #1703125) over night at ambient
temperature while shaking. Gels were then rinsed in SYPRO Ruby destain (7% acetic acid, 10%
methanol) twice and destained for one hour. Finally, gels were washed and stored with MilliQ
water to remove destain reagent. The gel was then imaged using a BioRad Molecular Imager
ChemiDoc XRS System with Image Lab software.

3.3.11 Protein analysis by mass spectrometry
Mass spectrometry analysis of PP7-mRIP samples was performed in a variety of ways, involving
both whole eluate sample analysis as well as band or lane analysis subsequent to SYPRO Ruby
staining. To analyze entire sample eluates, samples were eluted as above for whole eluate
sample analysis. Samples were sent to the Jovanovic Lab at Columbia university for mass
spectrometry analysis. Samples that were analyzed after SDS-PAGE separation and SYPRO Ruby
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staining were excised from the gel and sent to the Donald Danforth Plant Science Center Proteomics and Mass Spectrometry core.

3.3.12 Generation of 18S/16S rRNA Evolutionary Dendrograms
The 18S rRNA sequences were collected from EuPathDB19, Saccharomyces Genome Database20,
and EcoCyc E. coli Database21. Sequences were then read into RStudio, a guided tree generated,
and a multiple sequence alignment performed using the Bioconductor Biostrings package30. The
RNA MSAs were adjusted, staggered, and a distance matrix was calculated using the
Bioconductor DECIPHER package31. The distance matric was used to generate a hierarchical
cluster, which was then used to make a phylogenetic tree. The ggplot232 and ggtree33,34
packages were used to draw the dendrogram.

3.3.13 rRNA enrichment analysis by RT-PCR
RNA isolated from MS2-rRIP was measured and DNase I treated using the TURBO™ DNase kit
(Invitrogen #AM2238) and, using the NanoDrop 2000c, 100-250 ng of total RNA was used to
generate cDNA using the SuperScript™ IV VILO™ Master Mix kit (item# 11756050 Life
Technologies Corporation) for each sample including no reverse transcriptase and no template
controls following the manufacturer’s protocol. The iQ SYBR Green Supermix (item# 1708886,
Bio-Rad) protocol was used for qRT-PCR on the CFX96 Real-Time system with Bio-Rad CFX
Manager 3.0 software35. To determine the fold enrichment of tagged ribosomes vs untagged
ribosomes, the Ct values of the MS2-tagged ribosomes were normalized to untagged A-type
ribosomes within the flow-through and elution samples. The fold enrichment was then
calculated by normalizing the elution sample Ct values to those of flow-through. The final
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enrichment was then calculated by raising two to the inverse of this difference. This results in
the following set of calculations:
,2
,2
∆𝐶𝑡(,/)0 23')453) = 𝐶𝑡+78
− 𝐶𝑡90#

Equation 3.0

-/4
-/4
∆𝐶𝑡(-/4#$)!) = 𝐶𝑡+78
− 𝐶𝑡90#

Equation 3.1
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Equation 3.2
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Equation 3.3
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3.4 Results
3.4.1 General description of PP7-mRIP
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FIGURE 3.2 | Design of PP7-mRIP System and Workflow. The PP7cp is expressed in bacteria and purified while the PP7 aptamer
tag is inserted into the mRNA of choice. Parasites can be treated with CHX to halt translation and the proteins cross-linked
(xlinked) to the mRNA to if desired. Parasites are freed from RBCs by saponin lysis (SEE MATERIALS

AND

METHODS). The

immunoprecipitation is then performed. Analysis of eluates can be performed by the desired method.

While RNA aptamers have been used to control gene expression36,37, such an mRIP system has
not been used before in P. falciparum. The PP7 system components have been previously
demonstrated in mammalian cells to pull down on noncoding RNAs (ncRNAs) and mRNAs in
search of RBPs38,39. Here, the PP7cp has been N-terminally tagged with a 3xFlag tag that is
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followed by both an enterokinase and hRV 3C protease cleavage site followed by a C-terminal
6x His tag for purification (FIGURE 3.2). The 3xFlag-PP7cp-6xHis protein was expressed and
purified as mentioned previously. The 3ʹ UTRs of reporter mRNA constructs were tagged with a
single PP7 aptamer surrounded by the non-structure forming CAA repeats to prevent aptamer
collapse. Although dependent upon the protein and RNA variant, PP7cp binds the PP7 aptamer
with relatively high affinity (kd ≅ 10-9 M)40. As with previous work, this allows for the use of a
single aptamer; while the tobramycin aptamer was included should a subsequent affinity
purification step be desired39.
An mRNA of interest is expressed using the EOE vector with and without the PP7 aptamer in P.
falciparum (FIGURE 3.2). Once selection is complete, a parasite lysate is generated as described
above using the desired conditions. A Flag monoclonal antibody (mAb) is bound to protein G
magnetic beads (α-Flag magnetic beads may be substituted). The Flag-tagged PP7cp is then
bound the α-Flag::Protein G magnetic bead complex and blocked with bovine serum albumin
and yeast tRNAs to reduce non-specific protein and RNA interactions. The
PP7cp::α-Flag::Protein G magnetic bead complex is then incubated with the parasite lysate. The
washed beads can then be eluted in a variety of ways depending on subsequent assays. The
hRV 3C protease cleavage site will release the expressed mRNA and its bound proteome from
the bead complex and any contaminating proteins or RNAs. The hRV 3C protease is also tagged
with a 6x His tag allowing for its removal if desired. Thus, this is the suggested method of
elution. The protein can then be analyzed by the desired method (SDS-PAGE with total protein
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staining or western blot, mass spectrometry, etc.). RNA may also be analyzed should the
circumstances require.
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3.4.2 PP7-mRIP produces transcript-selective protein profiles
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FIGURE 3.3 | PP7-mRIP System Plasmids and SYPRO Ruby Analysis of Eluates. (A) Plasmids used to express PP7cp (left) and the
mRNA reporter constructs with PP7 aptamers (right). (B) SYPRO Ruby analysis of PP7-mRIP eluates eluted using sample buffer.
Red arrow indicates an example of differential banding pattern. Black arrows represent IgG heavy and light chain. PP7cp also
indicated by black arrow.
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Eluates from the PP7-mRIP assay were analyzed by SDS-PAGE/SYPRO Ruby staining, mass
spectrometry, or a combination thereof. Samples were also analyzed by RT-qPCR showing that
the tagged mRNAs are more efficiently enriched than untagged mRNAs (SUPPLEMENTAL FIGURE
3.1). Visualization of PP7-mRIP pulldowns show transcript-dependent protein profiles (FIGURE
3.3). However, the elements used in the PP7-mRIP assay appear to dramatically increase
background (e.g. magnetic beads), but also have the potential to mask the isolation of proteins
that may be in lower abundance (e.g. antibody light and heavy chains, PP7cp, etc.), which are
seen even with protease elution (FIGURE 3.4).
TABLE 3.1 | Mass spectrometry analysis of whole lane PP7-mRIP eluates.
Protein

KG12 Apts - WT Apts

K12 Apts - WT Apts

K12 Apts - KG12 Apts

60S rp L37 (PF3D7_0706400)

-0.29

2.66

2.95

Stevor (PF3D7_0402600)

0.02

2.89

2.86

60S rp L7-3 (PF3D7_1424400)

-0.29

2.24

2.53

60S rp L24 (PF3D7_1309100)

-0.15

2.24

2.40

Hsp110 (PF3D7_1344200)

0.27

2.01

1.74

60S rp L10 (PF3D7_1414300)

-0.58

1.35

1.92

eIF4A (PF3D7_1468700)

0.18

2.10

1.92

Hsp DNAJ homologue Pfj4 (PF3D7_1211400)

0.61

2.52

1.90

PfRACK1 (PF3D7_0826700)

0.17

-0.24

-0.40

To better examine the both specific protein bands as we as the differential complement of
proteins between constructs, samples were sent for analysis by mass spectrometry. Initially, a
single, prominent band was analyzed in the 37 kDa region (TABLE 3.1), which made evident the
concerns regarding visible masking of lower abundance proteins those in higher abundance.
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A

B
K0

K12AAA

K12AAG

StL

254 Total Protein Hits

220
160
120
100
90
80
70
60
50
40
30
25
20

(AAA)

Enriched RNA Binding Proteins:
AU-Rich Binding (PF3D7_1139100, PF3D7_0823200)
poly(rC) Binding (PF3D7_0605100)
DDX5 RNA Helicase (PF3D7_1445900)

15
10

FIGURE 3.4 | Analysis of Whole Lane PP7-mRIP Eluates. (A) Samples were eluted by hRV 3C protease and subsequently ran on
tobramycin matrix. Eluates were analyzed by SDS-PAGE followed by SYPRO Ruby staining. While lanes (red boxes) were excised
and sent for mass spectrometry. (B) Venn diagram of proteins with unique peptides determined by mass spectrometry. A total
of 254 hits were found, with a majority found to be shared, as expected, among the samples.

Whole lanes were then sent for analysis, providing a more distinct analysis of the differential
mRNA bound proteomes (FIGURE 3.4). The proteins shared between the samples were those
expected during routine mRNA translation, while those mRNA substrate-specific proteins could
be directly linked to their function and known binding motifs (FIGURE 3.4). Finally, whole eluates
were sent for analysis by mass spectrometry, revealing even more mRNA-specific RBPs (TABLE
3.2). Thus, despite high background during analysis by visualization, the PP7-mRIP assay is able
to probe the RBP population for mRNA substrate-specific proteins.

TABLE 3.2 | Mass spectrometry analysis showing normalized unique peptide counts of whole PP7-mRIP eluates.
Protein

MW (kDa)

60S ribosomal protein L7, putative (PF3D7_0307200)

31

40S ribosomal protein S11 (PF3D7_0516200)

16

169

TobPelletWT

TobPelletK12

TobPelletStL

1
4

5

4

60S ribosomal protein L12, putative (PF3D7_0517000)

18

3

5

4

40S ribosomal protein S9, putative (PF3D7_0520000)

22

40S ribosomal protein S16, putative (PF3D7_0813900)

16

40S ribosomal protein S2 (PF3D7_1026800)

30

5

7

6

40S ribosomal protein S4, putative (PF3D7_1105400)

30

3

2

2

60S ribosomal protein P0 (PF3D7_1130200)

35

11

12

9

60S ribosomal protein L6, putative (PF3D7_1323100)

22

1

1

60S ribosomal protein L18, putative (PF3D7_1341200)

22

3

2

2

60S ribosomal protein L5, putative (PF3D7_1424100)

34

2

6

2

60S ribosomal protein L7-3, putative (PF3D7_1424400)

33

2

1

1

40S ribosomal protein S5 (PF3D7_1447000)

30

2

1

60S ribosomal protein L27 (PF3D7_1460700)

17

2

2

2

40S ribosomal protein S3 (PF3D7_1465900)

25

10

9

8

40S ribosomal protein S8e, putative (PF3D7_1408600)

25

2

5

60S ribosomal protein L4 (PF3D7_0507100)

46

2

2

60S ribosomal protein L14, putative (PF3D7_1431700)

19

2

3

40S ribosomal protein S19 (PF3D7_0422400)

20

2

5

40S ribosomal protein S3A, putative (PF3D7_0322900)

30

2

60S ribosomal protein L24, putative (PF3D7_1309100)

19

1

ATP-dependent RNA helicase UAP56 (PF3D7_0209800)

52

7

peptide chain release factor subunit 1, putative (PF3D7_0212300)

48

3

RNA-binding protein, putative (PF3D7_0605100)

86

1

erythrocyte membrane-associated antigen (PF3D7_0703500)

265

1

2
1

7

4

Obg-like ATPase 1, putative (PF3D7_0722400)

45

2

2

3

ATP-dependent RNA helicase DBP1, putative (PF3D7_0810600)

109

2

3

2

RNA-binding protein, putative (PF3D7_0823200)
single-strand telomeric DNA-binding protein GBP2, putative
(PF3D7_1006800)
PRE-binding protein (PF3D7_1011800)
conserved Apicomplexan protein, unknown function
(PF3D7_1105800)
nucleic acid binding protein, putative (PF3D7_1132300)

32
30

5

6

4

132

2

7

8

tudor staphylococcal nuclease (PF3D7_1136300)

129

RNA-binding protein, putative (PfDd2_110042100)

210

polyadenylate-binding protein 1, putative (PF3D7_1224300)

97

DNA/RNA-binding protein Alba 2 (PF3D7_1346300)

25

DNA/RNA-binding protein Alba 4 (PF3D7_1347500)
rRNA 2'-O-methyltransferase fibrillarin, putative
(PF3D7_1407100)
CUGBP Elav-like family member 2, putative (PF3D7_1409800)

42

1

31
32

170

1
2

2

1

2

3

1
2

5

3

3

1

5

6

4

35

3

1

1

59

1

tRNA import protein tRIP (PF3D7_1442300)

46

2

2

ATP-dependent RNA helicase DDX5, putative (PF3D7_1445900)

60

4

4

MA3 domain-containing protein, putative (PF3D7_1457300)

76

1

2

eukaryotic translation initiation factor 4E (PF3D7_0315100)

27

1

3

eukaryotic initiation factor 4A-III, putative (PF3D7_0422700)
eukaryotic translation initiation factor 3 subunit B, putative
(PF3D7_0517700)
eukaryotic translation initiation factor 3 subunit E, putative
(PF3D7_0528200)
translation initiation factor IF-2, putative (PF3D7_0607000)
eukaryotic translation initiation factor 3 subunit L, putative
(PF3D7_0612100)
eukaryotic translation initiation factor 3 subunit I, putative
(PF3D7_0716800)
eukaryotic translation initiation factor 2 subunit alpha
(PF3D7_0728000)
elongation factor 1-beta (PF3D7_0913200)
eukaryotic translation initiation factor 2 subunit beta
(PF3D7_1010600)
translation elongation factor EF-1, subunit alpha, putative
(PF3D7_1123400)
eukaryotic translation initiation factor 3 subunit C, putative
(PF3D7_1206200)
eukaryotic translation initiation factor 3 subunit A, putative
(PF3D7_1212700)
elongation factor 1-gamma, putative (PF3D7_1338300)

45

1

84

3

3

61

2

4

112

1

78

2

37

3

38

1

32

7

25

1
6
1

63
116

4

1
4

166

5

4

1

1

48

3

5

5

elongation factor 1-alpha (PF3D7_1357000)
eukaryotic translation initiation factor 2 subunit gamma, putative
(PF3D7_1410600)
elongation factor 2 (PF3D7_1451100)

49

71

71

70

51

3

2

1

94

13

17

21

eukaryotic initiation factor 4A (PF3D7_1468700)

45

21

24

19

Ribosomal proteins in blue.
RNA binding proteins in grey.
Translation factors in orange.
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3.4.3 General description of MS2-rRIP

MBP

H

H

H

H

H
H

MS2cp
A

UU

System Setup
Express/Purify MS2cp

A

G-C
U-A
A
G-C
U-A
A-U
G-C
U U
U
U
U U
C-G
G-C
A-U
U-A
C-G
GAAAGTATATATATAG-CTATGTAGAAACTGCG

Express MS2 apt rRNAs

Sample Preparation
Treat Parasites (CHX/xlink)

Isolate Lysates

Perform rRIP
±RNase

Elute Protein

Elute RNA

Analyze Eluates
SYPRO Ruby/Western Blot/Mass Spectrometry/RT-qPCR

MS2

rRNA
FIGURE 3.5 | Design of MS2-rRIP System and Workflow. The MS2cp is expressed and purified while the MS2 aptamer tag is
inserted into the rRNA of choice. Parasites can be treated with CHX to halt translation, the proteins cross-linked (xlinked) to the
rRNA, or the polysomes separated into monosomes by RNase treatment to if desired. Parasites are freed from RBCs by saponin
lysis (SEE MATERIALS AND METHODS). The immunoprecipitation is then performed. Analysis of eluates can be performed by the desired
method.

The MS2 system has been used previously for the affinity purification of ribosomes with a single
aptamer placed in a ‘spur’ of either rRNA subunit41. The dissociation constant of the MS2
system can vary depending on the cap protein and aptamer sequence variants that are used.
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However, the range of dissociation constant values are generally high with the Kd ≅ 10-9 M40.
The use of an RNA aptamer precludes the need for ribosomal proteins42 that may be
heterogeneous in organisms with multiple, distinct ribosomal RNAs such as P. falciparum,
necessitating the tagging of the core component of the ribosome: its RNA. To compound this
issue, whatever the selected complement of ribosomal proteins on the different ribosomes of
P. falciparum, there is only a single, complete repertoire of ribosomal proteins in the parasite
genome2. Thus, tagging of a single ribosomal protein will allow for the differential purification
of ribosome types from P. falciparum.
The maltose binding protein (MBP) N-terminally tagged MS2cp was generously supplied by the
Zaher Lab (Washington University, St. Louis, MO) on the IPTG-inducibal pMAL plasmid (NEB)
with a 6x His C-terminal tag. The MBP-MS2cp-6xHis protein was expressed and purified as
described previously. A single MS2 aptamer sequence was inserted into a spur near the 5ʹ end
of the A- and S-type 18S genes. The constructs were then transfected into the parasite and
selected with WR (FIGURE 3.5). Parasite lysates are then generated using the desired,
downstream driven conditions previously described. Lysates are then bound to either a blocked
amylose matrix or magnetic beads displaying an α-MBP mAb. The washed beads are then
eluted for protein or RNA and utilized in downstream applications (RNA or protein gels, mass
spectrometry, qPCR, etc).

173

A

MS2 apt

3.4.4 MS2-rRIP enriches aptamer tagged rRNAs.
TEV Protease Site
pBAD

MBP

MS2

6xHis

PfRNAPI pro

18S (A/S)

hDHFR

Amp

B

PfRNAPI term

2x attP

C
8192.00

1.20

4096.00
2048.00

1.00

1024.00
Fold Enrichment (Log2 Scale)

512.00
0.80

0.60

0.40

0.20

256.00
128.00
64.00
32.00
16.00
8.00
4.00
2.00
1.00
0.50

0.00
A-type

A-type w/MS2

A-type

MS2 (A-type)

0.25

S-type w/MS2

FIGURE 3.6 | MS2-rRIP System Plasmids and RT-qPCR Analysis of Eluates. (A) Plasmids used to express MS2cp in bacteria (left)
and the MS2-tagged 18S rRNA expression constructs (right). (B) RT-qPCR analysis of plasmid-expressed MS2-tagged A-type and
S-type 18S rRNAs vs. untagged endogenous A-type rRNA (C) RT-qPCR analysis of MS2-rRIP eluates using MS2-tagged A-type and
endogenous A-type specific primers.

Samples from MS2-rRIP were eluted using proteinase K, the RNA isolated, cDNA generated, and
qPCR was performed. The MS2-rRIP qPCR data shows an approximate 10 cycle increase in
untagged A-type ribosomes, a 210 decrease in RNA, and a 3 cycle decrease in MS2-tagged A-type
ribosomes, a 23 increase in RNA, from flow-through to elution. The fold enrichment was
calculated as described above, showing >4000-fold increase in MS2-tagged ribosomes (FIGURE
3.6C). Additionally, SYPRO Ruby staining was also performed but showed background issues
with visualization much like the PP7-mRIP assay (Supplemental FIGURE 3.2). Regardless,
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ribosome enrichment by the MS2-rRIP assay could therefore provide many insights into
ribosome interactions in P. falciparum.

3.5 Discussion
Many questions surrounding protein synthesis of the AU-rich transcriptome using multiple,
distinct ribosome in P. falciparum still remain. However, the means to address these questions
have not been previously available. Here, using two aptamer-based systems, also capable of
being used in combination43, were ported into P. falciparum. The PP7-mRIP assay is able to
generate differential mRNA proteome profiles, which are substrate driven, and the constituents
of each profile identifiable by mass spectrometry (FIGURES 3.3–3.4 AND TABLES 3.1–3.2). The PP7mRIP assay provides a means of examining mRNA specific RBPs, RQC machinery recruitment
and gene discovery, and many other post-transcriptional elements of gene expression in P.
falciparum. The significant enrichment tagged versus untagged ribosomes demonstrated by the
MS2-rRIP assay (FIGURE 3.6C) allows the study of ribosome type switching, 80S subunit
composition, ribosomal protein repertoire selection, preferential mRNA translation, NRD
pathway characterization, and more.
While these systems enable the study of several post-transcriptional gene expression and
regulation questions previously out of reach, they are not without their limitations. However,
there are many modifications that would help to overcome or reduce them. A main issue is the
background and non-specific binding even with blocking generated by the system components
(e.g. magnetic beads, antibodies, etc.). To overcome this, pre-incubation of lysates with beads,
beads alone, or beads and mABs would help to deplete non-specific interacting proteins and/or
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RNAs. Co-expression of the aptamer binding proteins in the parasite could also improve
specificity, although using inducible methods would be recommended as in vivo binding may
affect the function and stability of the RNA substrate. The use of higher-affinity aptamer
sequences, such as those generated using the SELEX system44, could also reduce background
and improve efficiency. The use of tandem RIP tags (e.g. tobramycin aptamer) and protocol can
also improve specificity but may also result in loss of some RBPs given the change in
experimental conditions. Lastly, rRNAs are highly expressed and long-lived. Even with few
genes, P. falciparum show a high abundance rRNAs, the means of which is also of experimental
import. This can affect the enrichment of tagged ribosomes and result in contamination of
samples with untagged ribosomes. Although previous work has shown that rRNA sequence
drives its localization to the nucleolar region in P. falciparum45, expression may be increased by
modifying plasmids to have the RNAPI promoter and terminator. However, these are unknown
in the parasite and lengthy promoter regions may be necessary short regions (≤1000 bp) did not
improve expression over the RNAPII promoter.
The development and adaptation of PP7-mRIP and MS2-rRIP allow for the direct examination of
mRNA-bound proteomes and distinct ribosome types, respectively, in P. falciparum. These
systems could also be used in the mosquito vector, as well as ported into other Plasmodium
species. Thus, PP7-mRIP and MS2-rRIP could prove instrumental in answering many of the longlingering questions surrounding post-transcriptional gene regulation and ribosome switching in
malaria parasites.

176

3.6 References
1.

Pavlovic Djuranovic, S., Erath, J., Andrews, R. J., Bayguinov, P. O. & Joyce, J. Plasmodium
falciparum translational machinery condones polyadenosine repeats. Elife 9, e57799
(2020).

2.

Erath, J., Djuranovic, S. & Djuranovic, S. P. Adaptation of Translational Machinery in
Malaria Parasites to Accommodate Translation of Poly-Adenosine Stretches Throughout
Its Life Cycle. Front. Microbiol. 10, 2823 (2019).

3.

Szafranski, K., Lehmann, R., Parra, G., Guigo, R. & Glockner, G. Gene Organization
Features in A/T-Rich Organisms. J. Mol. Evol. 60, 90–98 (2005).

4.

Glockner, G. Large Scale Sequencing and Analysis of AT Rich Eukaryote Genomes. Curr.
Genomics 1, 289–299 (2000).

5.

Vembar, S. S. et al. Complete telomere-to-telomere de novo assembly of the Plasmodium
falciparum genome through long-read (>11 kb), single molecule, real-time sequencing.
DNA Res. 23, 339–351 (2016).

6.

Gardner, M. J. et al. Genome sequence of the human malaria parasite Plasmodium
falciparum. NatureNature 419, (2002).

7.

Rogers, M. J. et al. Structural features of the large subunit rRNA expressed in
Plasmodium falciparum sporozoites that distinguish it from the asexually expressed
subunit rRNA. RNA 2, 134–45 (1996).

8.

McCutchan, T. F. et al. Primary sequences of two small subunit ribosomal RNA genes
177

from Plasmodium falciparum. Mol. Biochem. Parasitol. 28, 63–68 (1988).
9.

McCutchan, T. F., Li, J., McConkey, G. A., Rogers, M. J. & Waters, A. P. The cytoplasmic
ribosomal RNAs of Plasmodium spp. Parasitol. Today 11, 134–138 (1995).

10.

Nishimoto, Y. et al. Evolution and phylogeny of the heterogeneous cytosolic SSU rRNA
genes in the genus Plasmodium☆. Mol. Phylogenet. Evol. 47, 45–53 (2008).

11.

Thompson, J. et al. Heterogeneous ribosome populations are present in Plasmodium
berghei during development in its vector. Mol. Microbiol. 31, 253–260 (1999).

12.

Gunderson, J. et al. Structurally distinct, stage-specific ribosomes occur in Plasmodium.
Science (80-. ). 238, 933–937 (1987).

13.

Li, J. et al. Regulation and trafficking of three distinct 18 S ribosomal RNAs during
development of the malaria parasite. J. Mol. Biol. 269, 203–213 (1997).

14.

Waters, A. P., Syin, C. & McCutchan, T. F. Developmental regulation of stage-specific
ribosome populations in Plasmodium. Nature 342, 438–440 (1989).

15.

Fang, J. & McCutchan, T. F. Thermoregulation in a parasite’s life cycle. Nature 418, 742–
742 (2002).

16.

Bunnik, E. M. et al. The mRNA-bound proteome of the human malaria parasite
Plasmodium falciparum. Genome Biol. 17, 1–18 (2016).

17.

Wong, W. et al. Cryo-EM structure of the Plasmodium falciparum 80S ribosome bound to
the anti-protozoan drug emetine. Elife 3, (2014).

18.

Leppek, K. & Barna, M. An rRNA variant to deal with stress. Nat. Microbiol. 4, 382–383
(2019).
178

19.

Aurrecoechea, C. et al. EuPathDB: the eukaryotic pathogen genomics database resource.
Nucleic Acids Res. 45, D581–D591 (2017).

20.

Cherry, J. M. et al. Saccharomyces Genome Database: the genomics resource of budding
yeast. Nucleic Acids Res. 40, D700–D705 (2012).

21.

Keseler, I. M. et al. The EcoCyc database: reflecting new knowledge about Escherichia coli
K-12. Nucleic Acids Res. 45, D543–D550 (2017).

22.

Li, J., Wirtz, R. A., McConkey, G. A., Sattabongkot, J. & McCutchan, T. F. Transition of
Plasmodium vivax ribosome types corresponds to sporozoite differentiation in the
mosquito. Mol. Biochem. Parasitol. 65, 283–289 (1994).

23.

Zhu, J. D. et al. Stage-specific ribosomal RNA expression switches during sporozoite
invasion of hepatocytes. J. Biol. Chem. 265, 12740–4 (1990).

24.

Waters, A. P. Advances in Parasitology, Volume 34. (Academic Press, 1994).

25.

Trager, W. & Jensen, J. B. Human malaria parasites in continuous culture. 1976. J.
Parasitol. 91, 484–6 (2005).

26.

Fidock, D. A. & Wellems, T. E. Transformation with human dihydrofolate reductase
renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity
of proguanil. Proc. Natl. Acad. Sci. 94, 10931–10936 (1997).

27.

Lim, F., Downey, T. P. & Peabody, D. S. Translational Repression and Specific RNA Binding
by the Coat Protein of the Pseudomonas Phage PP7. J. Biol. Chem. 276, 22507–22513
(2001).

28.

Russo, I., Oksman, A. & Goldberg, D. E. Fatty acid acylation regulates trafficking of the
179

unusual Plasmodium falciparum calpain to the nucleolus. Mol. Microbiol. 72, 229–245
(2009).
29.

Cottrell, K. A. & Djuranovic, S. Urb-RIP – An Adaptable and Efficient Approach for
Immunoprecipitation of RNAs and Associated RNAs/Proteins. PLoS One 11, e0167877
(2016).

30.

Pagès, H., Aboyoun, P., Gentleman, R. & DebRoy, S. Biostrings: Efficient manipulation of
biological strings. (2019).

31.

Wright, E. S. Using DECIPHER v2.0 to Analyze Big Biological Sequence Data in R. R J. 8,
352–359 (2016).

32.

Wickham, H. ggplot2: Elegant Graphics for Data Analysis. (Springer-Verlag New York,
2016).

33.

Yu, G., Smith, D., Zhu, H., Guan, Y. & Lam, T. T.-Y. ggtree: an R package for visualization
and annotation of phylogenetic trees with their covariates and other associated data.
Methods Ecol. Evol. 8, 28–36 (2017).

34.

Yu, G., Lam, T. T.-Y., Zhu, H. & Guan, Y. Two methods for mapping and visualizing
associated data on phylogeny using ggtree. Mol. Biol. Evol. 35, 3041–3043 (2018).

35.

Arthur, L. L. et al. Translational control by lysine-encoding A-rich sequences. Sci. Adv. 1,
e1500154 (2015).

36.

Ganesan, S. M., Falla, A., Goldfless, S. J., Nasamu, A. S. & Niles, J. C. Synthetic RNA–
protein modules integrated with native translation mechanisms to control gene
expression in malaria parasites. Nat. Commun. 7, 10727 (2016).
180

37.

Goldfless, S. J., Wagner, J. C. & Niles, J. C. Versatile control of Plasmodium falciparum
gene expression with an inducible protein–RNA interaction. Nat. Commun. 5, 5329
(2014).

38.

Hogg, J. R. & Collins, K. Human Y5 RNA specializes a Ro ribonucleoprotein for 5S
ribosomal RNA quality control. Genes Dev. 21, 3067–3072 (2007).

39.

Hogg, J. R. & Collins, K. RNA-based affinity purification reveals 7SK RNPs with distinct
composition and regulation. Rna 13, 868–880 (2007).

40.

RNA Processing: Disease and Genome-Wide Probing. 907, (Springer International
Publishing, 2016).

41.

Youngman, E. M. & Green, R. Affinity purification of in vivo-assembled ribosomes for in
vitro biochemical analysis. Methods 36, 305–312 (2005).

42.

Halbeisen, R. E., Scherrer, T. & Gerber, A. P. Affinity purification of ribosomes to access
the translatome. Methods 48, 306–310 (2009).

43.

Gesnel, M.-C., Del Gatto-Konczak, F. & Breathnach, R. Combined Use of MS2 and PP7
Coat Fusions Shows that TIA-1 Dominates hnRNP A1 for K-SAM Exon Splicing Control. J.
Biomed. Biotechnol. 2009, 1–6 (2009).

44.

Lim, F. RNA recognition site of PP7 coat protein. Nucleic Acids Res. 30, 4138–4144 (2002).

45.

Mancio-Silva, L., Zhang, Q., Scheidig-Benatar, C. & Scherf, A. Clustering of dispersed
ribosomal DNA and its role in gene regulation and chromosome-end associations in
malaria parasites. Proc Natl Acad Sci U S A 107, 15117–15122 (2010).

181

3.7 Supplemental Material
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B

3xFlag-PP7cp

MBP-MS2cp
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Western Blot
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Western Blot

SUPPLEMENTAL FIGURE 3.1 | Ponceau Red and Western Blotting of Purified Recombinant 3xFlag-PP7cp and MBP-MS2cp Proteins.
(A) Ponceau red staining (left) and western blotting using anti-Flag mAb (right) of purified 3xFlag-PP7cp protein product. (B)
Ponceau red staining (left) and western blotting using anti-MBP mAb (right) of purified MBP-MS2cp protein product. Note: Arrows
indicate expected product band.
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Fold Enrichment (Log2 Scale)

8192.00
4096.00
2048.00
1024.00
512.00
256.00
128.00
64.00
32.00
16.00
8.00
4.00
2.00
1.00
Flow-Thru

Elution

SUPPLEMENTAL FIGURE 3.2 | RT-qPCR Analysis of PP7-mRIP. Eluates from PP7-mRIP were analyzed by qPCR to determine fold
enrichment.
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SWT MS2 Elu.

ANRD MS2 Elu.

AWT MS2 Elu.

NF54 Elu.

MS2cp Only Elu.
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ANRD MS2 FT
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MS2cp Only FT

220
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30
25
20

IgG Light

15
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SUPPLEMENTAL FIGURE 3.3 | SDS-PAGE, SYPRO Ruby Analysis of MS2-rRIP. Eluates from MS2-rRIP were separated by SDS-PAGE and
subsequently stained with SYPRO Ruby gel stain.
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SUPPLEMENTARY TABLE 3.1 | Cloning Primers and oligonucleotides.
Primer/Oligo Name

Sequence [5ʹ→3ʹ]

PP7ppsiteF1

CTTGAAGTCCTTTTCCAGGGTCCGTCCAAAACCATCGTTC

3xFlagppSiteNcoIF1

gagaccatggACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGAT
GACGATGACAAGCTTGAAGTCCTTTTC

PP76xHisXmaIR1

gagaCCCGGGCTAGTGGTGGTGGTGGTGGTGCTCGAGGGAACGGCCCAGCGGCACAAGG

Hsp863utrPP7AptClaIF
GFPTobAptNotIR

CAACAATAAGGAGTTTATATGGAAACCCTTACAACAACAA
atcgatgtcgagttatataatatatttatg
TTGTTGGGCACGAGTGTAGCTAAACCTCGTGCCTTGTTGTTG
gcggccgcTTATTTGTACAGTTC

GFPAptF

Gagacaattggcgatggcc

GFPAptR

CTCCTTATTGTTGTTGTTGGGCACGAG

UTRAptF

CTCGTGCCCAACAACAACAATAAGGAG

UTRAptSwaIRev

gcgcATTTAAATATTACTTTTTTCGgatctttattatttaaatattacttttttcg

GFPKpnI_R1

gagaGGTACCTTATTTGTACAGTTCATCCATGC

SP6ProTobPP7F1

ATTTAGGTGACACTATAGCCCTTGTTAATAGAATCGAG

SP6TobPP7R1

GTAGACCCCATTGTGAGTAC

Pf18S_atyp_MS2LpInstr_F1

TAGTAGTAGTTTTGATCATATGTAGAAACTGCGAAC

Pf18S_atyp_MS2LpInstr_R1

ATGTGTAGAAATGATCATATATATATATACTTTCAC

Pf18S_styp_MS2LpInstr_F1

TAGTAGTAGTTT TGATCA TAATATATTGAAACTGCG

Pf18S_styp_MS2LpInstr_R1

ATGTGTAGAAA TGATCA CTTACATATGTACTTTCAC

Pf18S:G584U_F1

TTAATTCCAGCTCCAATAGC

Pf18S:G584U_R1

CGCGGCTGCTGGCACCAGAC

Pf18S:G584U_F2

TCCATTCCAGCTCCAATAGC

Pf18S:A2047C_F1

CAGTCGTAACAAGGTTTCCG

Pf18S:A2047C_R1

CTCCTTCCTTTAAAAGATAG

Pf18S:A2047C_F2

CCTTCGTAACAAGGTTTCCG

PfS18S5UTR_F

GATAGTGTGTTTAATCGTTATAATATAC

PfS58_R

TTATATTTTAAAAATATTAATACATTTCTTTTCTTTC

Pf18SAtypRNAPILSpromF

gagaccgcggTAATTCTGTGTCTAAAGATAATAACATTAATAAAAC

Pf18SAtypRNAPIMpromF

gagaccgcggAATATAATTATATATAAACAGTAAAATAAATTTAAGC

Pf18SAtypRNAPIpromR

gagactcgagACTATATATATTATTTCTTATTCATAAAAAAATTTAG

PfRNAPI_termF00

CGATCTGTTGAGGCTTATCCCTAGTGGTAAAGTG

PfRNAPI_termR00

CACATTTTAAAAAGAAATAATAAAATGCAAGGG

dEOESacIISeqF

CTCGACTCCTCCCCGCGG

Pf18SBegAntiparallelSeq

GCATATGACTACTGGCAAGATCAACCAGGTT
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Pf18SEndAntiparallelSeq

GGTTTCCGTAGGTGAACCTGCGGAAGGATCATTA

dEOEMCSSeqR

CATATTTATTAAATCTAGAATTCGAGCTC

PfRNAPIp_atypF00

CGCAAATGAGCGTCAGGGCGCTGCTCG

PfRNAPIp_atypF

gagaccgcggTTAATAGACCATTTTATTAAAATTTTTGCTTCATATGAGG
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SUPPLEMENTARY TABLE 3.2 | RT-qPCR Primers.
Primer/Oligo Name

Sequence [5ʹ→3ʹ]

Pf18SAtypqPCR_F2 (WT A-type)

GTATATATATATTTTATATGTAGAAACTGCG

Pf18SAtypqPCR_R1b (WT A-type)

CAAATACTTATCCAAAGATAAAAATC

NheIMS2TagqPCRF1 (MS2 A-type and S-type)

GCTAGCTTTTGATGAGGATTACCCATCTTTG

Pf18SAtypqPCR_R3 (MS2 A-type)

CGATTGATACACACTAAATAAAATAAATTTATTACG

Pf18SStypqPCR_F1a (WT S-type)

GTACATATGTAAGTAATATATTGAAACTGCG

Pf18SStypqPCR_R2a (WT S-type)

CGATTGATAATACACATATTTTATG

Pf18SStypqPCR_R3 (MS2 S-type)

GAATTATTCCATGAATGCCT

Pf28S_AqPCRF1 (WT A-type)

CGTAATAAATTTATTTTATTTAGTGTGTATCAATCG

Pf28S_qPCRR1 (WT A-type)

CTATTTAATTGCTCATTCCTGAGTAC

gfpPP7aptTestqPCRF1

ATACTCCAATTGGCGATGGC

gfpPP7aptTestqPCRR1

TCGAAAGGGCAGATTGTGTG

gfpPP7aptTestqPCRF2

GTTTGTAACAGCTGCTGG

gfpPP7aptTestqPCRR2

GACCCCATTGTGAGTACAT

dEOEAptqPCRF1

GAAGATGGAAGCGTTCAAC

dEOEwAptqPCR1

CCTTATTGTTGTTGTTGGGC

dEOEwoAptqPCR1

TTATATAACTCGACGCGGC

dEOEAptqPCR1

GTAGACCCCATTGTGAGTACATA

SUPPLEMENTARY TABLE 3.3 | Antibodies.
Designation

Identifier

Dilution

anti-Flag (mouse)

Sigma Cat # F1804-1MG

1:1000

anti-MBP (mouse)

Sigma Cat # M6295

1:1000

Cell Signaling Cat # 7076S

1:2500

anti-mouse-HRP
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Chapter 4: Ribosomal Binding of RACK1 in
Plasmodium falciparum
4.1 Abstract
The receptor for activated C-kinase 1 (RACK1), a highly conserved eukaryotic protein, is known
to have many, varying biological roles and functions. Previous work has established that RACK1
binds ribosomes; exploring regions of importance in ribosome binding in human and yeast cells.
RACK1 has also been shown to be integral for multiple aspects of mRNA translation from
efficient, cap-dependent mRNA translation initiation to recruitment of factors necessary for
multiple mRNA/ribosome-associated quality control pathways. As such, most recent data has
established the primary role of RACK1 as a ribosomal protein in human and yeast cells. In
Plasmodium falciparum, RACK1 has been shown to be required for parasite growth. However,
conflicting evidence has been presented about the role of RACK1 in mRNA translation and
ribosome binding. Given the aforementioned importance of RACK1 as a regulatory component
of mRNA translation, the case could be made in parasites for either of the binary options:
bound or unbound to the ribosome. Here we explore the binding properties of the PfRACK1 to
the human and P. falciparum ribosome. Based on bioinformatic and structural analysis, as well
as previously explore modifications, mutant and chimeric RACK1 proteins were generated. The
mutant and chimeric proteins were then express in human and parasite cells. The ribosomal
binding of RACK1 variants in human and parasite cells shown here suggests that although
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RACK1 proteins have highly conserved sequences and structure across the species, variation
exists in the factors that drive ribosomal binding.

4.2 Introduction
The WD domain, which folds into a β-propeller structure, is typically characterized by the
repetition of glycine (G)–histidine (H) and tryptophan (W)-aspartic acid (D) dipeptide repeats1.
It also happens to be incredibly abundant throughout the eukaryotic tree of life2. This domain is
primarily associated with signalosome assembly3, providing the means for signal transduction,
and there are as yet no WD domain proteins with intrinsic enzymatic capabilities1. A typical
structure for WD domains is the seven-bladed WD β-propeller, with the N-terminus and Cterminus completing the final 7th blade to close the structure4. Besides signal transduction, WD
domains are involved in processes ranging from those involved in organism proliferation to
virulence in lower eukaryotes5 or immune response in higher eukaryotes1,6,7. One of the most
intensely studied WD domain containing proteins is the receptor for activated C-kinase 1
(RACK1).
RACK1 is a highly conserved, eukaryotic, seven-bladed WD β-propeller repeat scaffolding
protein7. RACK1 was initially associated with protein kinase C signaling, the reason for its
namesake8. However, RACK1 is now known to have many, varying biological roles and
functions. Recently, the primary role of RACK1 has been shown to be as a ribosomal protein9–11.
In this capacity, RACK1 has been shown to necessary for efficient, cap-dependent mRNA
translation initiation9,10,12–15 as well as activation of many ribosome quality control (RQC)189

associated pathways16–20. In P. falciparum, RACK1 is required for parasite growth during IDC
stages, with knockdown during ring stage result in growth arrest in the trophozoite stage21.
What remains unclear are the functions of RACK1 in the parasite, given the lack of a PKC IIβ
homolog15, particularly its role in protein synthesis.
Ostensibly conflicting evidence has been provide regarding RACK1 ribosomal binding if P.
falciparum. Structural data show that RACK1 does not copurify with schizont 80S ribosomes22,23,
while mass spectrometry of polysome profiling data paints a contradictory picture24. Here, we
demonstrate that RACK1 expression in P. falciparum follows that of other ribosomal proteins,
binds to the parasite ribosome, and is present during active translation. The data also suggests
that the RACK1::40S binding dynamics are quite different between mammalian and parasites,
with emphasis on binding being distributed throughout the protein or even on the C-terminal
region; potentially the loop motif. Finally, PfRACK1 is also localized to the parasite cytoplasm
during the schizont stage although previously thought to be distributed to the RBC cytoplasm.
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4.3 Results
4.3.1 PfRACK1 expression follows other ribosomal proteins.

FIGURE 4.1 | Transcriptional analysis of PfRACK1 in comparison with other parasite proteins throughout the P. falciparum life
cycle. RNASeq data from PlasmoDB showing all proteins (violin plot), ribosomal protein (dot plot), and PfRACK1 (red dot)
transcript expression in P. falciparum 3D7 throughout the parasite life cycle. The x-axis indicates the parasite stage and the y-axis
(log10 scale) represents transcript fragments per kilobase of exon model per million reads mapped.

Transcriptional analysis of PfRACK1 was performed to compare its expression with other
ribosomal proteins. The analysis shows that the PfRACK1 gene, like other ribosomal proteins, is
highly expressed in comparison to the average total protein transcript expression at each stage
and in a pattern similar to other ribosomal proteins (FIGURE 4.1). Interestingly, PfRACK1
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expression drops by approximately one log10 from the early trophozoite stage where translation
is high to when the parasites transition into the schizont stage. Thus, the data suggests that
PfRACK expression follows that of other ribosomal proteins and significant changes in
expression are seen during stages where protein synthesis dramatically increases of decreases.
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4.3.2 A de novo structure PfRACK1: the sequence and structure of PfRACK1 are
highly conserved

Figure 2
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FIGURE 4.2 | Comparative bioinformatic analysis of RACK1 homologs in S. cerevisiae (ScAsc1), H. sapiens (HsRACK1), and P.
falciparum (PfRACK1) homologs. (A) Sequence alignment of yeast Asc1, human RACK1, and P. falciparum RACK1 amino acid
sequences generated by Clustal Omega. The SS_Pred is the secondary structure prediction using MPI Bioinformatics toolkit
Quick2D tool. Arrows: beta strands. Arrows represent beta strands, with heads pointing from the N-terminal to C-terminal
direction showing the orientation of the beta strand in the β-propeller. Dotted lines represent loops found between beta strands
where grey notates solvent-facing loops and blue indicates ribosome-facing loops. Chimera (χ): proteins generated by region
exchanged between human and parasite RACK1 proteins shown in solid blue lines. Mutants: short RACK1 regions mutated from
HsRACK1 sequence to PfRACK1 sequence, or vice versa, and expressed in HAP1 (1-5) or parasite (3, 5) lines. Clustal Omega
consensus symbols: Asterisks (*) indicates fully conserved resdue. Colon (:) indicates conservation between residues of strongly
similar properties (approximation of > 0.5 in the Gonnet PAM 250 matrix). Period (.) indicates conservation between residues of
weakly similar properties (approximation of =< 0.5 and > 0 in the Gonnet PAM 250 matrix). (B-C) A SWISS-MODEL generated de
novo model of PfRACK1 displaying (B) chimeric region and (C) mutated regions in blue. Left: Ribosome facing surface. Right: 25degree rotation.
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Bioinformatic analysis was performed on the human, yeast, and P. falciparum RACK1/Acs1
proteins. The HsRACK1 and ScAsc1 proteins share a 53.82% sequence identity, while HsRACK1
and PfRACK1 have 59.55% sequence identity. The PfRACK1 and ScAsc1 proteins share less
sequence identity at 42.99%. A multiple sequence alignment combined with secondary
structure analysis of these RACK1 proteins was performed to further determine what features,
if any, would affect the binding of PfRACK1 to the 40S ribosome subunit. The analysis
demonstrates a conservation of the β-sheet blades and loop features and positioning (FIGURE
4.2A). Combining this data with the de novo structure of PfRACK1 modeled onto the parasite
80S ribosome, a majority of the ribosome facing loop residues appear conserved in nature
(FIGURE 4.2B–C).
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Figure 3
A
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FIGURE 4.3 | Structural analysis of the PfRACK1 protein binding to P. falciparum 40S Ribosome subunit. All structures displayed
are P falciparum proteins/RNA. (A) The structure of the P. falciparum 80S ribosome (RCSB PDB ID: 3jbo) was structurally aligned
with the human 80S ribosome (RCSB PDB ID: 3jag). The de novo model of PfRACK1 generated by SWISS-MODEL was structurally
aligned with that of the human 80S bound RACK1. The view shown is that which been previously published arguing for the
importance of the regions noted in RACK1 binding to the ribosome. Solid circle: region vital for HsRACK1:Hs80S binding. Dotted
circle: Loop region that varies highly species to species, and while not required, may influence binding. (B) The same view as
above, however ribosomal binding proteins with potential interactions are shown. (C) A 180-degree flipped view to show
additional RPS16 (uS9) and RACK1 interactions. Note: Region in blue is that when exchanged between human and P. falciparum
enabled binding of parasite RACK1 to the human 40S ribosome.
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HsRACK1 has been previously shown to bind to the human 40S ribosome, with emphasis placed
on helices 39 and 40 of the 18s rRNA and the N-terminal region of RACK1. This was modeled for
P. falciparum and displayed as previously published for HsRACK1 interaction with the human
80S ribosome25 (FIGURE 4.3A). The helices 39 and 40 of the parasite 18S rRNA reveal the
potential for highly similar interactions between the PfRACK1 protein and the P. falciparum 18S
rRNA. Previous work also examined ribosomal proteins in this region: RPS16 (uS9), RPS17
(eS17), and RPS3 (uS3) (FIGURE 4.3B–C), which are also in close proximity. Therefore, residues
that may interact with these proteins must also be taken into consideration. Those residues on
PfRPS16 and PfRPS17 within 3-5 Å range are also highly conserved (SUPPLEMENTAL FIGURE 4.1),
and therefore are not expected to hinder binding. The residues of PfRPS3 are also highly
conserved, however it appears that there may be a C-terminal truncation of 18 residues when
compared with HsRPS3 that may impact interaction of the disordered region of the protein
(SUPPLEMENTAL FIGURE 4.1).
Overall, the data shows high sequence and structural conservation of the PfRACK1 protein
compared with HsRACK1. This is particularly true of ribosomes facing residues. Additionally, the
potential rRNA interactions also appear to be conserved in the parasite, as do those of RPS16
(uS9), RPS17 (eS17), and RPS3 (uS3) with the exception of a potential alteration to the RPS3 Cterminal disordered region. Taken together, this data suggests that PfRACK1 should be able to
bind to the parasite 40S ribosomal subunit.
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4.3.3 Binding of RACK1 to the ribosome

Figure 4
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FIGURE 4.4 | Expression of RACK1 variants in mammalian HAP1 ΔRACK1 cells and P. falciparum parasites. (A) Schematic of
plasmid constructs for RACK1 variant expression in mammalian HAP1 cells (left) and P. falciparum parasites (right). (B) Western
blot using anti-Flag antibody of HAP1 ΔRACK1 cell expressing RACK1 variants. 40S ribosomal protein 16 (uS9) blotted as control.
(C) Western blot using anti-HA antibody of P. falciparum parasites expressing RACK1 variants. Haloacid dehalogenase-like
hydrolase (HAD) blotted as control.

To examine binding of PfRACK1, mutants were generated based on bioinformatic analysis
(FIGURE 4.2A), as well as previous work7,9,10, and expressed in HAP1 ΔRACK1 cells and P.
falciparum parasites (FIGURE 4.4). While most of the ribosome facing loop residues appear
conserved, previous work has shown that small single or double amino acid changes in key
regions are able to significantly change binding, thus the RDK->DDE mutation in the was
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included as a control to help demonstrate a loss or lack of binding (FIGURE 4.2A, MUTANT 3)7.
Previous work emphasized the importance of the N-terminal region in RACK1 binding to the
human 40S ribosomal subunit7. To address this, chimeric RACK1 variants were generated by
exchanging the N-terminal regions of the HsRACK1 (residues 1-79) and PfRACK1 (residues 1-88).
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FIGURE 4.5 | Ribosomal binding of RACK1 variants in mammalian HAP1 ΔRACK1 cells and P. falciparum parasites. (A) Western
blot of lysates and post-sucrose cushion centrifugation pellets of HAP1 ΔRACK1 cells expressing N-terminally 3xFlag tagged RACK1
variants. 40S ribosomal protein 16 (uS9) blotted as control. (B) Western blot of lysates and post-sucrose cushion centrifugation
pellets from P. falciparum parasites expressing C-terminally 3xHA-tagged RACK1 variants.

Binding to the 40S subunit was then assessed by isolation of crude ribosomes through a sucrose
cushion. The RACK1 variants expressing in HAP1 cells harboring the human RACK1 N-terminal
region were able to bind, while those that had the parasite RACK1 N-terminal region did not
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show significant binding; similar to the loss of binding of the RDK->DDE mutation (FIGURE 4.5A).
Interestingly, all variants appeared to bind in P. falciparum parasite, potentially even the RDK>DDE mutants, suggesting a different in RACK1::40S subunit binding dynamics in the parasite
(FIGURE 4.5B). This difference in binding dynamics was also seen in an RT-qPCR analysis of rRNAs
from total RNA isolated after HA-immunoprecipitation of RACK1 of crude ribosome pellets
(SUPPLEMENTAL FIGURE 4.3). The data suggests that while PfRACK1 does indeed bind, HsRACK1
and PfRACK1χ bind with significantly greater affinity (SUPPLEMENTAL FIGURE 4.3B).
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FIGURE 4.6 | Polysome profiling of HsRACK1, PfRACK1, and PfRACK1χ variants in P. falciparum Dd2 parasites. Polysome profiling
fractions generated from P. falciparum parasites expressing HsRACK1, PfRACK1, and PfRACK1χ variants were analyzed. Western
blot shows RACK1 variant polysome fraction localization. RT-qPCR analysis shows localization of 18S and 28S rRNAs associated
with the 40S and 80S subunits, respectively. Arrowhead indicates non-specific band found in parent line not correlating to RACK1
variants.

Polysome profiling was performed to determine if the variants are involved in active translation
and therefore truly bound to the 40S subunit. Western blot analysis of polysome profiling show
that PfRACK1 is indeed bound to the ribosome during translation (FIGURE 4.6, SUPPLEMENTAL
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FIGURE 4.3). While the 40S fractions show similar RACK1 variant binding between HsRACK1,
PfRACK1, and PfRACK1χ, the polysome fractions show exhibit a different binding pattern with a
reduction of PfRACK1 and an increase in the HsRACK1 and PfRACK1χ variants. Summarily, these
data suggest that while yeast RACK1 has been shown previously to bind to the human 40S
ribosome subunit, the P. falciparum PfRACK1 protein does not, even with an almost 60%
sequence similarity. However, all the RACK1 variants appear to bind in the parasite, suggesting
a difference in the factors that drive RACK1 binding in Plasmodium spp. Finally, PfRACK1 was
found in the 80S monosome and polysome fractions supporting its function as a ribosomal
protein in P. falciparum despite not being found in the schizont-generated parasite 80S
ribosome structure22,23.

4.3.4 PfRACK1 localizes to the parasite cytoplasm
Previous work has stated that in P. falciparum, RACK1 is dispersed from the parasite cytoplasm
into the red blood cell during the schizont stage, the stage from which all previous ribosome
structural data is based. To reevaluate this phenomenon, live imaging microscopy was
performed on P. falciparum Dd2 lines expressing C-terminally tagged mNeonGreen RACK1
variants. Images were taken of the Dd2 parent line (FIGURE 4.7A), Dd2 expressing PfRACK1
(FIGURE 4.7B), and Dd2 expressing PfRACK1c (FIGURE 4.7C).
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Figure 7
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FIGURE 4.7 | Airyscan confocal fluorescence imaging microscopy of mNeonGreen-tagged PfRACK1 expressed in P. falciparum.
(A) Hoechst Stain (DNA), mNeonGreen (RACK1), BODIPY TR ceramide (lipid bilayers). Top) Dd2 parent line. Bottom) Dd2 parent
line expressing mNeonGreen-tagged PfRACK1. (B) Two-dimensional overlay using Imaris software analysis of Airyscan images.
Left) Dd2 parent line. Right) Dd2 parent line expressing mNeonGreen-tagged PfRACK1.

Imaging of schizonts did not show dispersal of RACK1 into the red blood cell cytoplasm, but
rather the proteins remain in the parasite cytoplasm surrounding the daughter cells. Parasites
may not have been at a late enough stage to see this phenomenon or this is an artifact due to
perforation of the parasitophorous vacuole prior to daughter cell release26.
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4.4 Discussion
Transcriptional analysis of PfRACK1, one of the most abundant parasite proteins21,27,
demonstrates that the protein follows expression of other ribosomal proteins (FIGURE 4.1).
Bioinformatic and structural analysis reveal that PfRACK1 maintains all the hallmark
characteristics of homologs where ribosomal binding is seen (FIGURES 2–3). To examine PfRACK1
binding of the 40S ribosome subunit, RACK1 variants were generated based on bioinformatic
and structural analysis and subsequently expressed in HAP1 ΔRACK1 mammalian cells and P.
falciparum parasites (FIGURE 4.4). Previous work has demonstrated that the yeast RACK1
homologue Asc1 is able to bind the human 40S ribosome subunit9. Here the data show that
although PfRACK1 shares a higher identity with HsRACK1 than ScAsc1 (59.55 % vs. 53.82%),
however PfRACK1 was unable to bind the human ribosome (FIGURE 4.5A). Analysis of binding in
the parasite show that not only does PfRACK1 bind the ribosome (FIGURE 4.5B, FIGURE 4.6,
SUPPLEMENTAL FIGURE 4.3B), but that also the binding dynamics differ from that of human
ribosomes (FIGURE 4.5B, FIGURE 4.6, SUPPLEMENTAL FIGURE 4.3B), with less emphasis on the Nterminus for binding in the parasite. Polysome profiling data also show that PfRACK1 is indeed
found in the 80S and polysome fractions (FIGURE 4.6, SUPPLEMENTAL FIGURE 4.4), but that there is a
reduction in the presence of PfRACK1 in this faction compared to the HsRACK1 and PfRACK1χ
variants again suggesting an alteration in PfRACK1 binding of the 40S subunit. However, the
residues or post-translational modification that drive these differences remain unknown.
Lastly, previous work has suggested that PfRACK1 is exported during the schizont stage into the
RBC cytoplasm21. To explore RACK1 localization, mNeonGreen tagged RACK1 variants were
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expressed in the parasite. The E64-treated parasites were examined by confocal microscopy
with airyscan and the RACK1 locale determined in relation to parasite DNA and lipid bilayers.
This data shows that RACK1 variant remain within the parasite cytoplasm (FIGURE 4.7). While
this data suggests that RACK1 is found within the parasite during the schizont stage, it is
possible that the parasites were not incubated long enough to see release of the protein into
the RBC cytoplasm. However, this phenomenon is most likely due to the perforation of the
parasitophorous vacuole that occurs at this stage26.
RACK1 does not copurify with schizont 80S ribosomes22,23. The presences of RACK1 on the
ribosome seen in crude ribosomes and polysome profiling data here and from others28, while
indicating that PfRACK1 does indeed bind the ribosome, does not exclude the possibility for a
change in PfRACK1::40S ribosome binding dynamics in the schizont stage. Interestingly, there is
an almost log10 reduction in PfRACK1 transcript expression in the schizont stage (FIGURE 4.1).
One could speculate that drastic reduction of PfRACK1 expression and binding, which has
previously been shown to globally downregulate mRNA translation10, perhaps via a posttranslational modification event at key residues during the schizont stage would be
energetically favorable as the parasite prepares to release short-live merozoites; and may also
hold true for sporozoites.
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4.5 Materials and Methods
4.5.1 Mammalian cell culture, lentiviral production, and transduction
Human embryonic kidney (HEK) 293T cells were cultured in Dulbecco’s modified Eagle’s
medium (DMEM) (Gibco) and supplemented with 10% fetal bovine serum, 5% penicillin and
streptomycin (Gibco), and L-glutamine (Gibco). HAP1 cells were cultured in Iscove's Modified
Dulbecco's Medium (IMDM) (Gibco) and supplemented with 10% Fetalgro® Bovine Growth
Serum (RMBIO), 5% penicillin and streptomycin (Gibco), and L-glutamine (Gibco). Cells were
grown at 37 °C with 5% CO2.
Tools for lentiviral production were generously provided by the You Lab (Washington
University, St. Louis, MO). The RACK1 variants to be expressed were cloned into the pCDH
vector using the XbaI and NotI restriction sites and confirmed by Sanger sequencing. Plasmid
DNA from pCDH-RACK1, pCMV-VSVG vector (addgene 8454), and psPAX2 vector (addgene
12260) was isolated from bacterial midipreps (Invitrogen). Before transfection (20-24 hours),
1.5 million HEK 293T cells in a 6 cm dish. The packaging vectors, pCMV-VSVG and psPAX2, were
combined in a ratio of 1:9. For transfection, 3 μg of expression vector and 3 μg of combined
packaging vectors were also combined in 400 μL of OPTI-MEM (Gibco). To this, 18 μL (1:3 ratio
of DNA to transfection reagent) of X-tremeGENE™ 9 DNA transfection reagent (MilliPore
Sigma). The mixture was incubated for 30 mins at room temperature. The medium of HEK 293T
cells was replaced with pre-warmed regular growth medium. The transfection mixture was
added, and cell put back in the incubator at 37 °C with 5% CO2. On the next day, 1 mL of fetal
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bovine serum (FBS) was added. The medium containing virus was collected at 48 hours and 72
hours after transfection. The supernatant containing the virus was centrifugated at 15,000 x g
and then filtered using 0.45 μm filter to remove any 293T cells or debris. The virus was stored
at 4 °C for up to 1 week or kept at -80 °C for long term storage, and freeze-thawing avoided.
For lentiviral transduction, HAP1 cells were seed such that they will be about 60-70% confluent
at the time of transduction. To assess viral titer, cells were plated in 12-well plates. However, a
1:4 dilution was found to be sufficient enough for an almost 100% transduction. At 20-24 hours
after plating, polybrene was added to a final concentration of 8μg/mL to cells and the desired
amount of lentivirus was added. At 48 hours after transduction, cells were re-plated and
selected with 3 μg/mL puromycin for 24 hours, two to three times.

4.5.2 Parasite cell culture and transfection
P. falciparum Dd2 was cultured at 2-5% hematocrit in O+ erythrocytes in Malaria Culture
Medium (MCM): RPMI 1640 supplemented with 5 g/L Albumax II (Gibco), 0.12 mM
hypoxanthine (1.2 mL 0.1M hypoxanthine in 1 M NaOH), 10 μg/mL gentamicin29. Cultures were
grown statically in candle jar atmosphere. As required, cultures were synchronized with 5%
(wt/vol) sorbitol.
Asynchronous P. falciparum Dd2 parasites were washed twice in 15 mL incomplete Cytomix (25
mM HEPES, 0.15 mM CaCl2, 5 mM MgCl2, 2 mM EGTA, 120 mM KCl, 5 mM K2HPO4, 5 mM
KH2PO4) and resuspended in a total 525 μL with 100 μg of maxi-prep plasmid DNA dissolved in
incomplete cytomix (125 μL packed iRBCs and 400 μL DNA/incomplete cytomix), The parasites
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were transfected in Bio-Rad Gene Pulser cuvette (0.2 cm), 0.31 kV, 950 up, infinity resistance.
Selection (10 nM WR99210 or 2 μM DSM-1) was added to parasite 48 h after transfection and
used to select resistant parasites30.

4.5.3 Saponin lysis of infected red blood cells (iRBCs)
The cell iRBCs were resuspended in two volumes of PBS containing 0.15% saponin, and
incubated on ice for 10 min, with vigorous mixing every 3 min. Afterward, the samples were
centrifuged 7000g, 5 min, 4°C, and the pellets were washed three times more with the same
buffer.

4.5.4 Parasite staining and confocal microscopy with airyscan
To examine localization of RACK1 variants in the parasite, confocal microscopy using the Zeiss
LSM 880 Confocal with Airyscan was performed. Primarily late trophozoite, early schizont stage
parasites were treated for 6 hours with E64 to inhibit parasite release. Parasites were then
washed twice using parasite imaging medium (RPMI without phenol red and with
hypoxanthine) containing E64. Parasites were incubated for 30 min with Hoechst stain to label
DNA and BODIPY™ TR ceramide to label lipids. Parasites were again washed 3 times with
imaging medium containing E64. Cultures were dotted onto slides and sealed beneath
coverslips. Brightfield images and z-stacks were collected using a Zeiss LSM 880 Confocal with
Airyscan confocal microscope using a 40X oil objective. DNA was visualized by Hoechst stain
(diode: 405 nm, ex: 350 nm, em: 461 nm), RACK by mNeonGreen (laser: 488 nm, ex: 506, em:
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517), and lipid bilayers by BODIPY™ TR ceramide (laser: 561 nm, ex:589/em:617) Image analysis
and generation was done using Imaris (Oxford Instruments) and Fiji ImageJ software.

4.5.5 Transcriptional analysis of PfRACK1
Ribosomal proteins were queried from PlasmoDB31, excluding apicoplast and mitochondrial
genes. Ribosomal proteins during the human stage were defined as those with RNAseq
expression data in the minimum of the 80th percentile during ring, early trophozoite, late
trophozoite, schizont, gametocyte II, or gametocyte V32 or during sporozoite stage33. Ribosomal
proteins expressed during the mosquito stage were defined as those with RNAseq expression
data in the minimum of the 80th percentile during ookinete32, oocyte, or sporozoite stage33.

4.5.6 De novo RACK1 modeling
The RACK1 variants were modeled using SWISS-MODEL34–38. Briefly, the RACK1 variant amino
acid sequences were entered into the SWISS-MODEL server. The SWISS-MODEL software
generates a list of potential structural templates based on the input. The software then aligns
and models the input RACK1 variants on the selected templates and subsequently evaluates the
quality of the model. Templates are then selected initially based on the GMQE score, coverage,
and resolution. A final template is then selected based on the QMEAN score. Here, all RACK1
variants aligned and modeled well with the 4aow.1.A template, an X-ray crystallography
generated structure of human RACK139.
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4.5.7 Bioinformatic and structural analysis
Sequence analysis of RACK1 and ribosomal protein amino acid sequences was done by
alignment using the Clustal Omega multiple sequence alignment tool39. The NCBI blastp suit
was used to perform pair-wise sequence identity analysis on RACK1 amino acid sequences40,41.
The secondary structure prediction was performed using the Quick2D tool in the MPI
Bioinformatics Toolkit42–48. All structural alignments were performed using PyMOL (Schrodinger
LLC.). The resulting de novo PfRACK1 model was added to the previously generated P.
falciparum 80S structure (3JBO)23. First, the de novo PfRACK1 model was structurally aligned to
the human RACK1 protein found in the previously generated H. sapiens 80S structure (3JAG)49.
The P. falciparum 80S structure was then structurally to the H. sapiens 80S structure.
Interacting residues between the 80S ribosome and RACK1 protein were those found to be
within a 3-5 Å range.

4.5.8 RACK1 variant construction
The PfRACK1 gene was codon optimized for expression in human cells. The HsRACK1 gene was
cloned from cDNA. None of the expressed RACK1 variants have the typical intron that appears
to be conserved in the gene. Based on bioinformatic and structural analysis, RACK1 variants
were designed. The swapping of the N-terminal regions, and other mutants were generated by
mutagenesis PCR, whereby the 5’ and 3’ PCR products were produced overlapping in the
mutated regions. These products were combined by stitching PCR and cloned into the desired
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expression vectors. Clones of vectors with RACK1 variants were confirmed by Sanger
sequencing.

4.5.9 Crude ribosome preparation and polysome profiling
Crude ribosome pellets and polysome profiling in P. falciparum cells was done based on
previous work24. Parasites were grown to 7-10% parasitemia in 1.5 to 2.0 mL of packed iRBCs.
Parasites were treated with culture medium containing 200 μM cyclohexamide (CHX) for 10
minutes at 37℃. They were then washed three times with 1X PBS + 200 μM CHX. Samples were
then flash-frozen in liquid nitrogen and stored at -80℃ overnight. To the frozen samples, 2
volumes of lysis buffer (25 mM potassium HEPES pH 7.2, 400 mM potassium acetate, 15 mM
magnesium acetate, 1% IGEPAL® CA-360, 200 μM CHX, 1 mM DTT, 1 mM AEBSF, 40 U/mL
RNase inhibitor) and 0.5 mg of acid washed glass beads (Sigma #G8772) were added. Samples
were rotated end-over-end at 4℃ for 10 minutes. Samples were centrifugated for 5 minutes at
1000xg. Supernatants were transferred to a new tube and centrifugated at 14000 x g for 10
minutes. The supernatant was layered over 1 M sucrose cushion (1 M sucrose, 25 mM
potassium HEPES pH 7.2, 400 mM potassium acetate, 15 mM magnesium acetate, 200 μM CHX,
1 mM DTT, 1 mM AEBSF, 40 U/mL RNase inhibitor) in a ratio of 2 mL lysate to 1 mL sucrose
cushion. The balanced tubes were then placed in a TLA 100.3 rotor and centrifuged for 30
minutes at 335,000 x g at 4℃ using an Optima™ Max-XP Beckman Coulter ultracentrifuge. The
supernatants were removed. The crude ribosome pellets were washed with 500 μL wash buffer
(25 mM potassium HEPES pH 7.2, 400 mM potassium acetate, 15 mM magnesium acetate, 200
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μM CHX, 1 mM DTT, 0.1 mM AEBSF, 10 U/mL RNase inhibitor) three times. After washing, the
crude ribosome pellets were then resuspended in 200 μL of lysis buffer. The resuspensions
were again layered over 1 mL of 1 M sucrose cushion and the pelleting repeated as above.
Washing was repeated as previous. The crude ribosome pellets used in polysome profiling were
then resuspended in 200 μL of ribosome resuspension buffer and, if not immediately used, flash
frozen in liquid nitrogen and store at -80℃ for later use. Crude ribosome pellets used for
immunoblotting were resuspended in sample buffer at 37℃ for 20 minutes, boiled at 95℃ for 5
minutes, and chilled on ice. Sucrose gradients were generated using polysome profiling buffer
(25 mM potassium HEPES pH 7.2, 400 mM potassium acetate, 15 mM magnesium acetate, 200
μM CHX, 1 mM DTT, 1 mM AEBSF) with 10%, 20%, 30%, 40%, and 50% sucrose layers in 14 mm
x 89 mm polyallomer centrifuge tubes (Beckman #331372). Total RNA of resuspended crude
ribosomes was measured to ensure a minimum of 300 μg total was loaded onto the gradient.
Samples were layered over the gradient and balanced using polysome profiling buffer. The
gradients were centrifuged at 35,000 RPM (acceleration 3, deceleration 4) for 2 hours and 40
minutes at 4℃ using an Optima™ L-100 XP Beckman Coulter ultracentrifuge in a SW41 swing
bucket rotor. Centrifuged gradients were then fractionated using a density gradient
fractionation system (BRANDEL #BR188176). Samples were collected into 1.7 mL
microcentrifuge tubes with an equal volume of Ribozol™ (VWR #VWRVN580) with 1% SDS for
RNA or 3 volumes of 20% TCA in MilliQ water for protein. Samples were mixed by vortexing.
RNA was stored at -80℃ if not isolated immediately. RNA was isolated following manufacturer
protocol and used in RNA gel electrophoresis. Protein samples were stored or incubated at 4℃
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overnight to precipitate protein. Samples were then centrifuge at 20,000 x g, 4℃ for 30
minutes. Supernatant was removed. The pellets were washed with 100% acetone twice. Pellets
were then solubilized in sample buffer for western blot analysis.
Crude ribosome pellets and polysome profiling in mammalian cells was done based on previous
work50. HAP1 cells were grown to 80-90% confluency in a 10 cm dish. Cells were washed three
times with 5 mL of ice-cold PBS + 200 μM CHX. A 400 μL volume of lysis buffer (20 mM Tris-HCl
pH 7.4, 150 mM NaCl, 5 mM MgCl2, 1% v/v Triton X-100, 200 μM CHX, 1 mM DTT, 1 mM AEBSF,
40 U/mL RNase inhibitor) was then added dropwise to the place and cells were scraped off and
collected into a 1.7 mL microcentrifuge tube. The lysate was pipetted several times and
incubated on ice for 10 minutes. The samples were then centrifugated at 20,000 x g for 10
minutes at 4℃ to remove cell debris. The lysate was transferred into a new tube. If not used
immediately, lysates were flash frozen in liquid nitrogen and stored at -80℃. Crude ribosome
pellets were generated by layering 200 μL of lysate over 0.9 mL of 1M sucrose cushion (1 M
sucrose, 20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 200 μM CHX, 1 mM DTT, 1 mM
AEBSF, 40 U/mL RNase inhibitor). The balanced tubes were then placed in a TLA 100.3 rotor and
centrifuged for 1 hour at 100,000 x g at 4℃ using an Optima™ Max-XP Beckman Coulter
ultracentrifuge. The supernatants were removed. The crude ribosome pellets were washed
with 500 μL wash buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 0.1% v/v Tween
20, 200 μM CHX, 1 mM DTT, 0.1 mM AEBSF, 10 U/mL RNase inhibitor) three times. Crude
ribosome pellets used for immunoblotting were resuspended in sample buffer at 37℃ for 20
minutes, boiled at 95℃ for 5 minutes, and chilled on ice. Polysome profiling was performed by
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layering clarified HAP1 cell lysates over sucrose gradient generated with polysome profiling
buffer (20 mM Tris-HCl pH 7.4, 150 mM NaCl, 5 mM MgCl2, 200 μM CHX, 1 mM DTT, 1 mM
AEBSF, 40 U/mL RNase inhibitor) and centrifugation performed as above. Samples were
collected and isolated at above for RNA gel electrophoresis and western blot analysis.

4.5.10 Immunoblotting
Samples were loaded onto SDS-PAGE gels, running at 15 W, 1h 10 mins. The gels were then
transferred to PVDF membrane using semi-dry transfer method running at 25 V for 40 minutes.
The PVDF membranes were blocked in 5% milk in PBS + 0.1% Tween 20 (PBST) for 1 hour at
room temperature or overnight at 4℃. The membranes were probed with diluted primary
antibody (see SUPPLEMENTARY TABLE 4.3 for antibodies) in PBST with 5% milk. After incubation
with the primary antibody, the PVDF membranes were washed three times for 5 min in PBST.
Membranes incubated with HRP-conjugated primaries were incubated and washed similarly,
washing with PBST, and then proceeding to imaging instead of secondary. The membranes
were then incubated with HRP-conjugated secondary antibody diluted 1:2500 in PBST with 5%
milk for 1 hour at room temperature. The membranes were washed as above. Then rinsed with
PBS. Prepare Working Solution by mixing equal parts of the Stable Peroxide Solution and the
Luminol/Enhancer Solution (34577 SUPERSIGNAL WEST PICO PLUS, 34096 SUPERSIGNAL WEST
FEMTO MAXIMUM SENSITIVITY SUBSTRATE respectively). We incubate the blot in Working
Solution for 5 minutes. Remove the blot from Working Solution and drain excess reagent.
Afterward we took images were generated by BioRad Molecular Imager CHemiDoc XRS System
with Image Lab software.
214

4.5.11 Polysome rRNA analysis by RT-qPCR
RNA isolated from polysome profiling fractions were qPCR. Using the NanoDrop 2000c, 50 ng of
total RNA was used to generate cDNA via the iScript Advance cDNA Kit for RT-qPCR (BioRAD
#1725037), for each sample including no reverse transcriptase and no template controls
following the manufacturer’s protocol. The iTaq Universal SYBR Green Supermix (BioRAD
#1725121) protocol was used for qRT-PCR on the CFX96 Real-Time system with Bio-Rad CFX
Manager 3.0 software51. The 2-Ct value were calculated and plotted for each fraction.

4.5.12 HA-tag immunoprecipitation of P. falciparum Dd2 expressed RACK1
variants
Mixed Plasmodium falciparum Dd2 parasites were harvested at 7-10% parasitemia. For
examination of RACK1 variant expression, parasites were released from RBCs by saponin lysis as
previously described. Parasites were then lysed using passive lysis buffer (Promega #E1910) and
the total protein concentration was calculated by RC/DC kit (BioRad #5000122). For each
reaction, 25 μL of magnetic HA beads was washed twice in 1X PBS with 0.1% Tween 20 and
then twice in binding buffer (50 mM Tris pH7.5, 150 mM NaCl, 1% IGEPAL CA-630, 5% glycerol,
and protease inhibitors (Thermo Fisher #A32955): apoptin, leupeptin, bestatin, E-64, AEBSF,
pepstatin A). A total of 500 μg of protein was loaded onto the HA beads and bound overnight at
4℃. The beads were then washed three times with 1 mL of wash buffer (50 mM Tris pH7.5, 150
mM NaCl, 1% IGEPAL CA-630, 5% glycerol). Beads were then eluted in 50 μL of sample buffer
and examined by western blot analysis.
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4.5.13 Analysis of RACK1 variant rRNA binding by HA immunoprecipitation in P.
falciparum parasites
Mixed Plasmodium falciparum Dd2 parasites were harvested at 7-10% parasitemia. Parasites
were released lysed and crude ribosome pellets were generated as previously described. The
total protein concentration in each crude ribosome pellet was calculated by RC/DC kit (BioRad
#5000122). For each HA immunoprecipitation, 50 μL of magnetic HA beads was washed three
times with 1X PBS + 0.1% Tween 20 followed by three washes with polysome parasite lysis
buffer. The beads were then blocked with polysome parasite lysis buffer containing 4% BSA and
0.5 μg/mL S. cerevisiae tRNAs for one hour at 4℃ while rotating. A total of 680 μg of protein
was loaded onto the HA beads and bound for one hour at 4℃ while rotating. The beads were
then washed three times with 1 mL of polysome wash buffer. Beads were split in half. For
protein, beads were then eluted in 35 μL of sample buffer and examined by western blot
analysis as previously described. For RNA, beads were eluted with 400 μL Trizol + 1% SDS at
36℃ while shaking. RNA was isolated by per the manufacturer’s protocol. Using the NanoDrop
2000c, 50 ng of total RNA was used to generate cDNA via the iScript Advance cDNA Kit for RTqPCR (BioRAD #1725037), for each sample including no reverse transcriptase and no template
controls following the manufacturer’s protocol. The iTaq Universal SYBR Green Supermix
(BioRAD #1725121) protocol was used for qRT-PCR on the CFX96 Real-Time system with BioRad CFX Manager 3.0 software51. The ΔCt was calculated by subtracting the Dd2 parent line
values from each sample. The ΔΔCt value was then calculated by normalization to the wild-type
PfRACK1 variant. Plots were then generated using the calculated 2-ΔΔCt values for each variant.
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4.7 Supplemental Material
RPS3 (uS3) Alignment

RPS16 (uS9) Alignment

x

RPS17 (eS17) Alignment

SUPPLEMENTAL FIGURE 4.1 | Multiple sequence alignment of H. sapiens and P. falciparum RPS3 (uS3), RPS16 (uS9), RPS17 (eS17)
proteins. The H. sapiens and P. falciparum sequences were collected from the UniProt database52 and PlasmoDB31, respectively,
and aligned using the Clustal Ω MSA tool53. Residues in the 3-5 Å range were determined using PyMol.
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SUPPLEMENTARY TABLE 4.1 | Cloning Primers and oligonucleotides.
Primer/Oligo Name

Sequence [5ʹ→3ʹ]

PfRACK1R1

AACTGAGTGTTTTTTAACTTCATATAC

PfRACK1XhoIF1

cgcgCTCGAGATGgTaGATAATATAAAAGAAGCTG

HsRACK1FlagF1

GACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGAT
GACGATGACAAGATGACTGAGCAGATGACCC

HsRACK1Not1R1

gcgGCGGCCGCCTAGCGTGTGCCAATGGTC

rcPfRACK1FlagF1

GACTACAAAGACCATGACGGTGATTATAAAGATCATGACATCGATTACAAGGAT
GACGATGACAAGATGATGGACAACATCAAAGAGG

rcPfRACK1Not1R1

gcgGCGGCCGCTCAGACGCTGTGCTTCTTC

FlagXbaIF1

gcgTCTAGAATGGACTACAAAGACCATGACGG

NtermHsrcPFRACK1F1

cctcagatggccagtttgccctc agcggctcttgggatcac

NtermHsrcPfRACK1R1

gtgatcccaagagccgct gagggcaaactggccatctg

NtermrcPfHsRACK1F1

gcgacggcctgtttgccctg tcaggctcctgggatggaacc

NtermrcPfHsRACK1R1

ggttccatcccaggagcctga cagggcaaacaggccgtcgc

mNeonGreenHsRACK1F1

GGTGACCATTGGCACACGC gctagc GGAAGTGGAGGAGTGAGCAAG

mNeonGreenrcPfRACK1F1

CGAAGTGAAGAAGCACAGCGTC

HAStpNotIR1

gcg gcggccgc TCAGGCATAATCTGGAACATCGTAAGG

mNeonGreenStpNotIR1

gcg gcggccgc TCACTTGTACAGCTCGTCCATGCC

HsRACK1SalIF1

gcgc gtcgac ATGACTGAGCAGATGACCCTTCG

HsRACK1mNeonGreenR1

CTTGCTCACTCCTCCACTTCC gctagc GCGTGTGCCAATGGTCACC

rcPfRACK1SalIF1

gcgc gtcgac ATGATGGACAACATCAAAGAGGCC

rcPfRACK1mNeonGreenR1

CTTGCTCACTCCTCCACTTCC gctagc GACGCTGTGCTTCTTCACTTCG

FlagAvrIIF1

gcg cctagg GACTACAAAGACCATGACGG

FlagStpNotIR1

gcg gcggccgc TCACTTGTCATCGTCATCCTTGT

HsRACK1DEMutF1

CATGATCCTCTCCGCCTCT GACGATGAG ACCATCATCATGTGGAAACTGAC
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gctagc GGAAGTGGAGGAGTGAGCAAG

HsRACK1DEMutR1

GTCAGTTTCCACATGATGATGGT CTCATCGTC AGAGGCGGAGAGGATCATG

rcPfRACK1DEMutF1

CCATCGTGTCCGCCAGC GACGACGAG AAACTGATCGTGTGGAACATCAAC

rcPfRACK1DEMutR1

GTTGATGTTCCACACGATCAGTTT CTCGTCGTC GCTGGCGGACACGATGG

HsRACk1mutF1 (IPQRALR -> TAKKSLT)

CCAGGGATGAGACCAACTATGGA acagccaagaagtctctgaca
GGTCACTCCCACTTTGTTAGTGATG

HsRACk1mutR1 (IPQRALR -> TAKKSLT)

CATCACTAACAAAGTGGGAGTGACC tgtcagagacttcttggctgt
TCCATAGTTGGTCTCATCCCTGG

rcPfRACK1mutF1 (TAKKSLT -> IPQRALR)

GACAGCGGCGAGATCGGC attccacagcgtgctctgcgg
GGCCACAGCCAGGCC

rcPfRACK1mutR1 (TAKKSLT -> IPQRALR)

GGCCTGGCTGTGGCC ccgcagagcacgctgtggaat
GCCGATCTCGCCGCTGTC

HsRACK1ybbREag1R1

gcg CGGCCG CTA GGCCAGCTTGCTGGCGATGAACTCCAGGCTGTC
GCGTGTGCCAATGG

rcPfRACK1ybbREag1R1

gcg CGGCCG TCA GGCCAGCTTGCTGGCGATGAACTCCAGGCTGTC
GACGCTGTGCTTCT

HsRACK1mutF2 (QFPD -> PKLK)

CCCAGATCGCTACTACCCCG cccaagctgaaa ATGATCCTCTCCGCCTCTCG

HsRACK1mutR2 (QFPD -> PKLK)

CGAGAGGCGGAGAGGATCAT tttcagcttggg CGGGGTAGTAGCGATCTGGG

rcPfRACK1mutF2 (PKLK -> QFPD)

GCGTGTCCACACCTACAGAC cagttcccggac ACCATCGTGTCCGCCAGCCG

rcPfRACK1mutR2 (PKLK -> QFPD)

CGGCTGGCGGACACGATGGT gtccgggaactg GTCTGTAGGTGTGGACACGC

HsRACK1mutF3
aacaccgacgacgacagcggcgag ATTCCACAGCGTGCTCTGCG
(TRDETNYG -> NTDDDSGE
HsRACK1mutR3
(TRDETNYG -> NTDDDSGE

ctcgccgctgtcgtcgtcggtgtt
CAGTTTCCACATGATGATGGTCTTATCTCG

rcPfRACK1mutF3
accagggatgagaccaactatgga ATCGGCACAGCCAAGAAGTCTC
(NTDDDSGE -> TRDETNYG)
rcPfRACK1mutR3 (
tccatagttggtctcatccctggt GATGTTCCACACGATCAGTTTCTTGTCC
NTDDDSGE -> TRDETNYG)
HsRACK1mutF4 (GHNG -> GGHSD)

CTTCGTGGCACCCTCAAG ggcggacactctgat
TGGGTAACCCAGATCGCTACTAC

HsRACK1mutR4 (GHNG -> GGHSD)

GTAGTAGCGATCTGGGTTACCCA atcagagtgtccgcc
CTTGAGGGTGCCACGAAG
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rcPfRACK1mutF4 (GGHSD -> GHNG)

TGCGGGGAGTTCTGGAA ggccacaacggc TGGGTCACCAGCGTGTC

rcPfRACK1mutR4 (GGHSD -> GHNG)

GACACGCTGGTGACCCA gccgttgtggcc TTCCAGAACTCCCCGCA
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SUPPLEMENTARY TABLE 4.2 | RT-qPCR Primers.
Primer/Oligo Name

Sequence [5ʹ→3ʹ]

Pf18SAtypqPCR_F2 (WT A-type)

GTATATATATATTTTATATGTAGAAACTGCG

Pf18SAtypqPCR_R1b (WT A-type)

CAAATACTTATCCAAAGATAAAAATC

Pf28S_AqPCRF1 (WT A-type)

CGTAATAAATTTATTTTATTTAGTGTGTATCAATCG

Pf28S_qPCRR1 (WT A-type)

CTATTTAATTGCTCATTCCTGAGTAC

SUPPLEMENTARY TABLE 4.3 | Antibodies.
Designation

Identifier

Dilution

anti-Flag (mouse)

Sigma Cat # F1804-1MG

1:1000

anti-HA (mouse)

Santa Cruz # sc-7392 (F-7)

1:1000

anti-HA-HRP (mouse)

Santa Cruz #sc-7392 (F-7)

1:1000

anti-RPS16 (rabbit)

Sigma # SAB1100505

1:1000

anti-hDHFR (mouse)

Santa Cruz # sc-377091 (A-9)

1:1000

anti-mouse-HRP

Cell Signaling Cat # 7076S

1:2500

anti-rabbit-HRP

Cell Signaling Cat # 7076S

1:2500
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Chapter 5: Future Directions
5.1 Translation fidelity, frame maintenance, and quality
control in P. falciparum
To date, only the NMD pathway has been indirectly characterized in P. falciparum1,2. Like any
other organism, P. falciparum must contend with all the issues surrounding the translation of
mRNA into protein3–12. This suggests that these pathways might be necessary to ensure proper
protein synthesis and subsequently parasite survival. However, with the exception of recent
publish work13, this area remains largely unexplored.
It has been demonstrated that polyA tracts are translated in P. falciparum with high fidelity, no
apparently frameshifting, and do not elicit activation of quality control pathways13. While the
lack of PfRACK1 on schizont-derived 80S ribosome structures14,15 could be proposed as an
adaptation of polyA tract translation, it conflicts with the data presented here in Chapter 4 and
that of others16. It also poses a host of new problems when considering the protein’s
importance in translation initiation17–22 and translation quality control mechanisms5,6,9,12,23–27.
An absence of RACK1 would also not explain the lack of frameshifting on polyA tracts in the
parasite13,27. Nor would it prevent the formation of the stall-inducing α-helical structure caused
by consecutive adenosine π-stacking6,7 within the conserved mRNA channel and decoding
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center of the parasite14,15. The question remains: How does P. falciparum efficiently translation
polyA tracts with high fidelity, while maintaining reading frame, and without eliciting
translation-associated quality control mechanisms?
The parasite proteins discovered in Chapter 3 found to be differentially bound to mRNAs in a
substrate-dependent manner may be responsible for the high-fidelity translation of polyA and
structure-containing messages. The AU-rich RNA binding proteins, mRNA structure-binding
proteins, and RNA helicases found to be bound to the mRNAs may be contributing to this
fidelity and warrant further study. Proteins found on all mRNAs, particularly those unique to
the parasite, perhaps with RNA helicase activity, and an association with the ribosome should
not be overlooked. Previous work has demonstrated a precedence for parasite-specific
helicases such as the kDDX60 RNA helicase found to be associated with the head of the 40S
subunit in Trypanosoma brucei brucei, as well as other kinetoplastids, and thought to be
associated with aiding 40S scanning of the highly methylated mRNA splice leader sequences in
the organism28. Thus, Plasmodium spp. may also have evolved a genus specific protein to aid in
polyA translation, but this protein may always be found on the ribosome or mRNA, unseen in
structures so far due to purification techniques29, and therefore remains elusive.
The answer may also be found in the recent work that has shown multi-protein bridging factor
1 (Mbf1), Rps3 (uS3), and yeast RACK1 homolog Asc1 are all involved in reading frame
maintenance27. Wang et al., 2018 proposed that Asc1 acts to trigger abortive translation while
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MBF1 and Rps3 work cooperatively to prevent stalled ribosomes from frameshifting27. An MBF1
homolog is present30 in P. falciparum, is potentially essential31, but has yet to be characterized.
The P. falciparum MBF1 shows only a 37.96% shared identity with the yeast homology and
43.52% identity with the human homolog, but residues that result in frameshifting upon
mutation are conserved in nature, if not entirely, with the yeast and human homologs27. Work
in Chapter 4 describes the potential for PfRACK1 involvement given its conservation; as well as
the conserved but altered nature of the PfRPS3 protein whereby it shares a relatively high
identity with human (and yeast) homologs, but a truncation of the disordered C-terminal tail
thought to be important for RQC-mediated quality control. Nevertheless, all residues implicated
in frame maintenance are conserved in the parasite. Future study utilizing the methods
developed in Chapter 3 combined with mutations in parasite proteins RACK1, MBF1, and RPS3
examining the effects and interactions of these proteins in P. falciparum are required,
potentially providing insight into its hallmark, paradigm-breaking polyA translation ability.

5.2 Mechanism of ribosome switching in P. falciparum
The multiple, distinct ribosomes of Plasmodium spp. have been well documented32,33,42,43,34–41.
Interestingly, whether 80S ribosome 60S and 40S subunit composition is homogeneously or
heterogeneously has not been explored. It is known that the parasite actively regulates the
dynamics of its heterogeneous ribosome population through increased transcription and
ribosome degradation, which are associated with progression through the parasite life cycle
and host temperature changes35–37,42,44,45. However, the factors involved in these processes
remain unclear. Simplistically, how does the parasite know which rRNA gene expression to
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increase and which rRNAs to degrade? Ribosome biogenesis is an energetically costly affair, and
thus efficient ribosome maintenance would be a necessity for parasite survival46–48.
While changes in temperature may explain increases and decreases in rRNA transcript
production45, how the parasite goes about actively selecting and degrading the most abundant
RNA in the cell is ostensibly less clear. The notion of combing through thousands of ribosomes
would be costly in and of itself. A self-reporting mechanism would be more efficient. The Nonfunctional Ribosome Decay (NRD) pathway is one such mechanism that would provide an
eloquent means of selectively altering the parasite ribosome population by utilizing the
inefficiency of a given ribosome type at a given temperature4,10–12,49–53.
This pathway has yet to be discerned in Plasmodium, although evidence of its constituents can
be found in PlasmoDB30. Given the conservation of the parasite ribosome decoding region14,15,
experiments could be performed using the methodologies developed in Chapter 3 combined
with ribosomes harboring NRD-inducing mutations4 to capture those factors involved. Future
experimentation would then rely on inhibition of NRD factors, perhaps by knockdown, to
examine changes in rRNA population dynamics at different temperatures.

5.3 Origin and evolution of homopolymeric tracts in P.
falciparum
While polyadenosine (polyA) and polylysine (polyK) tracts in Plasmodium spp. are clearly linked,
the factors driving their presence within the parasite genome may not be. Plasmodium spp.
have gone to great lengths to enable the translation of polyA stretches in order to generate
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polyK tract-containing proteins. While previous work has shown the presence40,54,55 of these
tracts and the ability to translate them without issue13, why they exist is less understood.
Plasmodium spp. show not only an increase in intergenic AT-richness, but also that of the
coding region, including the ribosomal RNA, which has not affected genome
organization13,40,56,57. The factors driving polyA track retention in the parasite have been widely
explored from lowered metabolic cost of A+T nucleotides, environmental factors like oxidative
stress, nutrient availability, and an AT-driven positive feedback loop causing increased indels
and amplicon breakpoints40,55,58–64. A specific mechanism for polyA retention remains unknown.
However, it is likely driven by the combination of these factors with an additional factor being
the production of proteins that contain polyK stretches, with the previous driving them to be
encoded by polyA tracts.
While previous studies have attempted to the determine role of homopolymeric amino acids
found in the parasite genome40,65,66, such details remain elusive. Although polyK-containing
proteins are found in all stages of the parasite, we did find that Plasmodium also has polyK
enrichment in those proteins found in the cellular and pathological cell adhesion ontology
group13. Thus, we have hypothesized that polyK may help with initial red blood cell (RBC)
attachment and human immune system evasion. As the Plasmodium merozoite is non-motile, it
relies on chance interaction with a new RBC driven by flow through the circulatory system.
Therefore, having patches of charged protein could help to improve that initial cell-to-cell
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adhesion, facilitating invasion. Homopolymeric lysine residues have been shown to make poor
antigens67, which may aid the parasite in host immune evasion for a majority of its proteins.

FIGURE 5.1 | Treatment of P. falciparum parasites with polyamino acids, heparin, and PEG 3550. Plasmodium falciparum parasites
were treated with varying concentrations of PEG 3550, poly-L-glutamic acid, heparin, poly-L-lysine, and poly-L-ornithine for 96
hours in triplicate. Parasitemia for each concentration was calculated as a percentage of the untreated control.

Polylysine compounds has been previously employed as antimicrobials68–71. Interestingly, initial
investigation of poly-L-lysine as an antimalarial showed that treatment of parasites with poly-Llysine, and poly-L-ornithine, resulted in a significant reduction in parasitemia while the
negatively charged poly-L-glutamic acid had no effect (FIGURE 5.1). These data suggest the
potential for poly-L-lysine, poly-L-ornithine, as well as analogues or combination molecules, as
antimalarials with great efficacy. The mechanism by which poly-L-lysine impacts parasitemia –
be it through parasite invasion, development, or egress – requires further study. Elucidation of
this mechanism, particularly in vivo, may provide insights into the long sought after function(s)
of polyK tracts in Plasmodium spp. proteins.
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